<SEC-DOCUMENT>0001213900-25-095449.txt : 20251002
<SEC-HEADER>0001213900-25-095449.hdr.sgml : 20251002
<ACCEPTANCE-DATETIME>20251002163028
ACCESSION NUMBER:		0001213900-25-095449
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250927
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251002
DATE AS OF CHANGE:		20251002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41375
		FILM NUMBER:		251369674

	BUSINESS ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0259804-8k_actelis.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ASNS="http://actelis.com/20250927">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_ASNS_actelis.com_20250927 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20250927_20250927 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001141284 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000004" name="dei:EntityCentralIndexKey">0001141284</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asns-20250927.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001141284</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-27</xbrli:startDate>
        <xbrli:endDate>2025-09-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20250927__20250927_zPIec7PydvO"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of report (Date of earliest event reported):
<span id="xdx_902_edei--DocumentPeriodEndDate_c20250927__20250927_zuRU09IEzvg6"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 27, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20250927__20250927_zVQnrtW8Zl3a"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000011" name="dei:EntityRegistrantName">Actelis Networks, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250927__20250927_zdh36UwSE7vk"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20250927__20250927_zjGFdTsMOYIh"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000013" name="dei:EntityFileNumber">001-41375</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20250927__20250927_zv6xYgfodWx5"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000014" name="dei:EntityTaxIdentificationNumber">52-2160309</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification Number)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_908_edei--EntityAddressAddressLine1_c20250927__20250927_zOnnr1HVEgU8"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000015" name="dei:EntityAddressAddressLine1">4039 Clipper Court</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressCityOrTown_c20250927__20250927_zgsMAHArpQyf"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000016" name="dei:EntityAddressCityOrTown">Fremont</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20250927__20250927_zQu8FGC4VVt6"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250927__20250927_z69t30CLxwO7"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000018" name="dei:EntityAddressPostalZipCode">94538</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">(<span id="xdx_909_edei--CityAreaCode_c20250927__20250927_zKpnr6sTucte"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000019" name="dei:CityAreaCode">510</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20250927__20250927_z3cuzEfqUAfk"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000020" name="dei:LocalPhoneNumber">545-1045</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instructions A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20250927__20250927_zeT9j8rvk4d8"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20250927__20250927_zVRSK4VLvV49"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20250927__20250927_zJmVF3wwGhSf"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20250927__20250927_z18OU4uAuHIg"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20250927__20250927_zQTkAmTMKBcl"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20250927__20250927_zMPBRW72Ptgg"><ix:nonNumeric contextRef="AsOf2025-09-27" id="Fact000026" name="dei:TradingSymbol">ASNS</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20250927__20250927_zv6VZvJXFNx8"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20250927__20250927_zPIY8rou99mk"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_908_edei--EntityExTransitionPeriod_c20250927__20250927_zj9GyXxPXx67"><ix:nonNumeric contextRef="AsOf2025-09-27" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Line of Credit Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September 27, 2025, Actelis
Networks, Inc. (the &#8220;Company&#8221;) entered into a common stock purchase agreement (the &#8220;Common Stock Purchase Agreement&#8221;)
with an effective date of October 1, 2025 (the &#8220;Effective Date&#8221;) and a related registration rights agreement (the &#8220;White
Lion RRA&#8221;) with White Lion Capital LLC, a Nevada limited liability company (&#8220;White Lion&#8221;). Pursuant to the Common Stock
Purchase Agreement, the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to $30,000,000
in aggregate gross purchase price (the &#8220;Commitment Amount&#8221;) of newly issued shares of the Company&#8217;s common stock, par
value $0.0001 per share (the &#8220;Common Stock&#8221;), subject to certain limitations and conditions set forth in the Common Stock
Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is obligated under
the Common Stock Purchase Agreement and the White Lion RRA to file a registration statement (the &#8220;Resale Registration Statement&#8221;)
with the SEC to register the Common Stock under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) for the resale
by White Lion of shares of Common Stock that the Company may issue to White Lion under the Common Stock Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The maximum number of shares issuable
under the Common Stock Purchase Agreement shall be no more than 19.99% of the Company&#8217;s outstanding Common Stock as of the Effective
Date (the &#8220;Exchange Cap&#8221;), unless shareholder approval is obtained to issue shares of Common Stock in excess of the Exchange
Cap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, pursuant to the Common
Stock Purchase Agreement, the Company agreed to call a special meeting of its shareholders (the &#8220;Special Meeting&#8221;) to obtain
shareholder approval for the issuance of Common Stock under the Common Stock Purchase Agreement beyond the Exchange Cap (&#8220;Shareholder
Approval&#8221;) within 120 days of the Effective Date. If the Company fails to call the Special Meeting within this timeframe, it shall
pay liquidated damages to White Lion, as more fully described in the Common Stock Purchase Agreement. If Shareholder Approval is not obtained
at the Special Meeting, the Company is obligated to call an additional Special Meeting every ninety (90) days thereafter, for a total
period of 360 days, until Shareholder Approval is obtained. However, that this deadline shall be tolled by one Business Day for each Business
Day that the SEC is closed due to a shutdown of the United States government.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As consideration for White Lion&#8217;s
irrevocable commitment to purchase the Company&#8217;s Common Stock up to the Commitment Amount, the Company agreed to issue shares of
Common Stock to White Lion (the &#8220;Commitment Shares&#8221;) equal to $750,000 (the &#8220;Commitment Fee Amount&#8221;) divided by
the lowest traded price of the Company&#8217;s common stock during the 30 business days prior to the issuance of the Commitment Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If, at any point during the term
of the Common Stock Purchase Agreement, the Company fails to be listed on the Nasdaq Capital Market, the Commitment Fee Amount will increase
to $1,000,000 if remedied within six months or less, to $1,250,000 if remedied after six months but before twelve months, and $1,500,000
if not remedied within twelve months (the &#8220;Delisting Penalty Provision&#8221;). If the Common Stock Purchase Agreement is terminated,
the Delisting Penalty Provision shall automatically be waived on the date that is six (6) months after the later of (A) the date on which
Shareholder Approval is obtained and (B) the date on which the Resale Registration Statement has been declared effective by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The number of shares sold pursuant
to any such notice may not exceed 40% of the Average Daily Trading Volume for the common stock traded on Nasdaq immediately preceding
receipt of the applicable Purchase Notice, and can be increased at any time at the sole discretion of White Lion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under a Regular Purchase Notice,
the purchase price to be paid by White Lion for any such shares will equal 97.5% multiplied by the lower of the (i) lowest daily VWAP
of the Common Stock during the Regular Purchase Valuation Period (as such term is defined in the Common Stock Purchase Agreement) or (ii)
the closing price of the Common Stock one business day prior to the delivery of the Regular Purchase Notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under a Rapid Purchase Notice,
the purchase price to be paid by White Lion for any such shares will equal (i) the lowest traded price of the Common Stock on the Rapid
Purchase Notice Date with respect to Rapid Purchase Price Option 1, or (ii) 99% multiplied by the lowest traded price of the Common Stock
two hours following written confirmation of the acceptance of the Rapid Purchase Notice by White Lion with respect to Rapid Purchase Price
Option 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company may terminate the
Common Stock Purchase Agreement at any time by delivering written notice to White Lion. In addition, the Common Stock Purchase Agreement
shall automatically terminate on the earlier of (i) the end of the Commitment Period or (ii) the date that, pursuant to or within the
meaning of any bankruptcy law, the Company commences a voluntary case or any person commences a proceeding against the Company, a custodian
is appointed for the Company or for all or substantially all of its property, or the Company makes a general assignment for the benefit
of its creditors. Certain provisions of the Common Stock Purchase Agreement survive termination, as described more fully in the text of
the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Common Stock Purchase
Agreement, the Company agreed to register the shares of Common Stock purchased by White Lion under the Common Stock Purchase Agreement
with the SEC for resale within 5 business days of the Effective Date; provided, however, that this deadline shall be tolled by one Business
Day for each Business Day that the SEC is closed due to a shutdown of the United States government.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Company fails to have the
Resale Registration Statement declared effective by October 31, 2025 (the &#8220;Required Registration Date&#8221;), it shall issue to
White Lion shares of Common Stock equal to $250,000 divided by the lowest traded price of the Common Stock between October 1, 2025 and
October 31, 2025; provided, however, that this deadline shall be tolled by one Business Day for each Business Day that the SEC is closed
due to a shutdown of the United States government. The Required Registration Date shall be extended to November 15, 2025 if the SEC notifies
the Company there will be a &#8220;review&#8221; of such Registration Statement. For every thirty (30) days after the Required Registration
Date that the Registration Statement is not declared effective, the Company will issue to White Lion a number of additional shares of
Common Stock equal to $250,000 divided by the lowest traded price of the Common Stock during such thirty (30) day period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Common Stock Purchase Agreement
and the White Lion RRA contain customary representations, warranties, conditions, and indemnification obligations of the parties. The
representations, warranties, and covenants contained in such agreements were made only for purposes of such agreements and as of specific
dates, were solely for the benefit of the parties to such agreements, and may be subject to limitations agreed upon by the contracting
parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
of the Common Stock Purchase Agreement and the White Lion RRA are qualified in their entirety by reference to the full text of the Common
Stock Purchase Agreement and the White Lion RRA, which are attached as Exhibits 10.1 and 10.2, respectively, to this Current Report on
Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offer and sale of the
Common Stock and the Commitment Shares pursuant to the Common Stock Purchase Agreement have not been registered under the Securities Act
or any state securities laws. The Common Stock may not be offered or sold in the United States absent registration or an applicable exemption
from registration requirements. Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the
solicitation of an offer to buy the Common Stock described herein or therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the Common Stock Purchase
Agreement, White Lion represented to the Company that it is an &#8220;accredited investor&#8221;, as defined in Rule 501 promulgated under
the Securities Act, and the Company&#8217;s offer and sale of the Common Stock under the Common Stock Purchase Agreement are being made
in reliance upon the exemptions from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and Rule
506(b) of Regulation D promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Private Placement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Concurrently on September 27,
2025, the Company entered into a securities purchase agreement (the &#8220;PIPE Purchase Agreement&#8221;) with White Lion, pursuant to
which the Company agreed to issue and sell to White Lion in a private placement (the &#8220;Offering&#8221;) (i) 871,766 shares (the &#8220;Shares&#8221;)
of Common Stock, and (ii) pre-funded warrants to purchase up to 3,128,234 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;)
for a purchase price of $0.2125 per share of Common Stock and $0.2124 per Pre-Funded Warrant, for a total aggregate gross proceeds of
approximately $850,000. The Offering closed on September 29, 2025. The Company has a right to redeem 488,263 of the Shares at a redemption
price of $0.0001 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Pre-Funded Warrants are
immediately exercisable at an exercise price of $0.0001 per share of Common Stock and will not expire until exercised in full. However,
the Company may not issue a number of shares of Common Stock pursuant to exercise of the Pre-Funded Warrants in an amount that will not
exceed the Exchange Cap, when combined with the number of Shares issued in the Offering, before shareholder approval for further issuance
beyond the Exchange Cap is obtained. The Company intends to obtain such shareholder approval concurrently with the Shareholder Approval
required for the issuance of shares of Common Stock under the Common Stock Purchase Agreement beyond the Exchange Cap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation to file the
Resale Registration Statement described above also covers the registration of the shares of Common Stock and shares underlying the Pre-Funded
Warrants issued pursuant to the PIPE Purchase Agreement. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Offering of the shares
of Common Stock and Pre-Funded Warrants, including any shares of Common Stock issuable thereunder, was not registered under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;) and the Securities were offered and sold pursuant to the exemption provided
in Section 4(a)(2) under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
of the PIPE Purchase Agreement and the Pre-Funded Warrant are qualified in their entirety by reference to the full text of the Common
Stock Purchase Agreement and the White Lion RRA, which are attached as Exhibits 10.3 and 10.4, respectively, to this Current Report on
Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 3.02. Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
matters described in Item 1.01 of this Current Report on Form 8-K with respect to the issuances of securities under the PIPE Purchase
Agreement are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea025980401ex10-1_actelis.htm">Form of Common Stock Purchase Agreement</a></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea025980401ex10-2_actelis.htm">Form of White Lion RRA</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="ea025980401ex10-3_actelis.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of PIPE Purchase Agreement</span></a></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea025980401ex10-4_actelis.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACTELIS NETWORKS, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: October 2, 2025</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Yoav Efron</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160; </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoav Efron</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deputy Chief Executive Officer and Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoO5sMeHSrilDFEfC0uk+LWjLTO+Un+pXVDDIGQ3HtuhJiJLW1MgwyXVZnDCduu0R6hxBoZ7RWDI9vtUwizxJtxnrX14/oDMwoMBmY5j3W4j87eOKxSUHIh1SJOQCapUlAcRPTVM7K1qdB6oxvQtoKCqWODXvNrSjjpgSy1r/HTGdkZsiFuLif5DbFUMRyp10/iu4M8z0Q0GysSW6ZHF1zrwaP9krBusA3v3ET/O/oAxLVKUQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea025980401ex10-1_actelis.htm
<DESCRIPTION>FORM OF COMMON STOCK PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COMMON STOCK PURCHASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Common Stock Purchase
Agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) is dated as of September 27, 2025 (the &ldquo;<B><U>Signing Date</U></B>&rdquo;)
and effective as of October 1, 2025 (the &ldquo;<B><U>Effective Date</U></B>&rdquo;), by and between Actelis Networks Inc., a Delaware
corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and White Lion Capital, LLC, a Nevada limited liability company (the &ldquo;<B><U>Investor</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the parties
desire that, upon the terms and subject to the conditions contained herein, the Investor shall purchase, from time to time, as provided
herein, and the Company shall issue and sell up to Thirty Million Dollars ($30,000,000) of the Company&rsquo;s Common Stock (as defined
below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, such sales
of Common Stock by the Company to the Investor will be made in reliance upon the exemption provided by Section 4(a)(2) of the Securities
Act (&ldquo;<B><U>Section&nbsp;4(a)(2)</U></B>&rdquo;) and Rule 506(b) of Regulation D (&ldquo;<B><U>Regulation D</U></B>&rdquo;) promulgated
thereunder, and upon such other exemption from the registration requirements of the Securities Act as may be available with respect to
any or all of the issuances and sales of Common Stock by the Company to the Investor to be made hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the parties
hereto are concurrently entering into the Registration Rights Agreement (as defined below), pursuant to which the Company shall register
the resale of the Registrable Securities (as defined in the Registration Rights Agreement), upon the terms and subject to the conditions
set forth therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> in consideration
for the Investor&rsquo;s execution and delivery of this Agreement, the Company shall issue to the Investor the Commitment Shares (as defined
herein), pursuant to and in accordance with <U>Section 6.4</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, the
parties hereto agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
I<BR>
CERTAIN DEFINITIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 1.1 <U>DEFINED
TERMS</U></B>. As used in this Agreement, the following terms shall have the following meanings specified or indicated (such meanings
to be equally applicable to both the singular and plural forms of the terms defined):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Agreement</U></B>&rdquo;
shall have the meaning specified in the preamble hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Average Daily
Trading Volume</U></B>&rdquo; shall mean the median daily trading volume of the Company&rsquo;s Common Stock over the most recent five
(5)&nbsp;Business Days immediately preceding the date of delivery of a Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Bankruptcy Law</U></B>&rdquo;
shall mean Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Beneficial Ownership
Limitation</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;7.2(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Business Day</U></B>&rdquo;
shall mean any full day on which the Principal Market is open.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Claim Notice</U></B>&rdquo;
shall have the meaning specified in <U>Section&nbsp;9.3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: left; margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Clearing Costs</U></B>&rdquo;
shall mean the Investor&rsquo;s broker and Transfer Agent costs with respect to each deposit of Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Closing</U></B>&rdquo;
shall mean the closing of a purchase and sale of shares of Common Stock as described in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Commitment Amount</U></B>&rdquo;
shall mean Thirty Million Dollars ($30,000,000).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Commitment Fee
Amount</U></B>&rdquo; shall mean Seven Hundred Fifty Thousand Dollars ($750,000), subject to adjustment as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Commitment Period</U></B>&rdquo;
shall mean the period commencing on the Effective Date and ending on the earlier of (i)&nbsp;the date on which the Investor shall have
purchased an aggregate number of Purchase Notice Shares pursuant to this Agreement equal to the Commitment Amount or (ii)&nbsp;thirty
six (36) months following the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Commitment Shares</U></B>&rdquo;
shall have the meaning specified in <U>Section&nbsp;6.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;<U>Commitment Fee
Price</U>&rdquo; </B>shall mean the lowest traded price of the Common Stock during the 30 Business Days prior to the issuance of Commitment
Shares pursuant to <U>Section 6.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Common Stock</U></B>&rdquo;
shall mean the Company&rsquo;s common stock, $0.0001 par value, and any shares of any other class of ordinary shares, whether now or hereafter
authorized, having the right to participate in the distribution of dividends (as and when declared) and assets (upon liquidation of the
Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Common Stock
Equivalents</U></B>&rdquo; shall mean any securities of the Company entitling the holder thereof to acquire at any time Common Stock,
including, without limitation, any debt, preferred stock, right, option, warrant, or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Company</U></B>&rdquo;
shall have the meaning specified in the preamble to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Current Report</U></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;6.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Custodian</U></B>&rdquo;
shall mean any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Damages</U></B>&rdquo;
shall mean any loss, claim, damage, liability, cost, and expense (including, without limitation, reasonable attorneys&rsquo; fees and
disbursements and costs and expenses of expert witnesses and investigation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Designated Brokerage
Account</U></B>&rdquo; shall mean the brokerage account provided by the Investor for the delivery of the applicable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Document Preparation
Fee</U></B>&rdquo; shall mean Twenty Five Thousand Dollars ($25,000).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>DTC/FAST Program</U></B>&rdquo;
shall mean the DTC&rsquo;s Fast Automated Securities Transfer Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>DTC</U></B>&rdquo;
shall mean The Depository Trust Company, or any successor performing substantially the same function for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>DWAC Eligible</U></B>&rdquo;
shall mean that (a)&nbsp;the Common Stock are eligible at DTC for full services pursuant to DTC&rsquo;s Operational Arrangements, including,
without limitation, transfer through DTC&rsquo;s DWAC system, (b)&nbsp;the Company has been approved (without revocation) by the DTC&rsquo;s
underwriting department, (c)&nbsp;the Transfer Agent is approved as an agent in the DTC/FAST Program, (d)&nbsp;the Securities are otherwise
eligible for delivery via DWAC, and (e)&nbsp;the Transfer Agent does not have a policy prohibiting or limiting delivery of the Securities,
as applicable, via DWAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>DWAC Shares</U></B>&rdquo;
shall mean shares of Common Stock that are (i)&nbsp;issued in electronic form, (ii)&nbsp;freely tradable and transferable and without
restriction on resale, and (iii)&nbsp;timely credited by the Company to the Investor&rsquo;s or its designee&rsquo;s specified DWAC account
with DTC under the DTC/FAST Program, or any similar program hereafter adopted by DTC performing substantially the same function.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>DWAC</U></B>&rdquo;
shall mean Deposit Withdrawal at Custodian as defined by the DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;<U>Eligible Market</U>&rdquo;</B>
shall mean the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital
Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Exchange Act</U></B>&rdquo;
shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Exchange Cap</U></B>&rdquo;
shall have the meaning set forth in <U>Section&nbsp;7.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Effective Date</U></B>&rdquo;
shall have the meaning set forth in the first paragraph of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Indemnified Party</U></B>&rdquo;
shall have the meaning specified in <U>Section&nbsp;9.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Indemnifying
Party</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;9.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Indemnity Notice</U></B>&rdquo;
shall have the meaning specified in <U>Section&nbsp;9.3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Investment Amount</U></B>&rdquo;
shall mean the gross price of the Purchase Notice Shares, less Clearing Costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Investor</U></B>&rdquo;
shall have the meaning specified in the preamble to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Irrevocable Transfer
Agent Instructions</U></B>&rdquo; shall mean a signed form of irrevocable transfer agent instructions, substantially in the form of Exhibit
D attached hereto, instructing the Transfer Agent to immediately deliver any Purchase Notice Shares to the Investor upon the Transfer
Agent&rsquo;s receipt of the copy of a Purchase Notice from the Company, without further instruction from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Lien</U></B>&rdquo;
shall mean a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right, or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Material Adverse
Effect</U></B>&rdquo; shall mean any effect on the business, operations, properties, or financial condition of the Company that is material
and adverse to the Company and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with
the ability of the Company to enter into and perform its obligations under any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>PEA Period</U></B>&rdquo;
shall mean the period commencing at 9:30 a.m., New York City time, on the fifth (5th)&nbsp;Business Day immediately prior to the filing
of any post-effective amendment to the Registration Statement or any new registration statement, or any annual and quarterly report, and
ending at 9:30 a.m., New York City time, on the Business Day immediately following (i)&nbsp;the effective date of such post-effective
amendment of the Registration Statement or such new registration statement, or (ii)&nbsp;the date of filing of such annual and quarterly
report, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Person</U></B>&rdquo;
shall mean an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government
or political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Principal Market</U></B>&rdquo;
shall mean the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Purchase</U></B>&rdquo;
shall mean a purchase of Purchase Notice Shares in accordance with the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Purchase Notice</U></B>&rdquo;
shall mean a written notice from Company, substantially in the form of <U>Exhibit&nbsp;A</U> attached hereto (a &ldquo;<B><U>Rapid Purchase
Notice Form</U></B>&rdquo;) or <U>Exhibit&nbsp;B</U> attached hereto (a &ldquo;<B><U>Regular Purchase Notice Form</U></B>&rdquo;), to
the Investor and the Transfer Agent setting forth the Purchase Notice Shares which the Company requires the Investor to purchase pursuant
to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Purchase Notice
Limit</U></B>&rdquo; shall mean, for any Purchase Notice, the maximum amount of Purchase Notice Shares the Company may require the Investor
to purchase per each Purchase Notice, which shall be forty percent (40%) of the Average Daily Trading Volume immediately preceding receipt
of the applicable Purchase Notice. Notwithstanding the foregoing, the Investor may waive the Purchase Notice Limit at any time to allow
the Investor to purchase additional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Purchase Notice
Shares</U></B>&rdquo; shall mean all shares of Common Stock that the Company shall be entitled to issue as set forth in all applicable
Purchase Notices in accordance with the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Closing
Date</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;2.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Purchase
Investment Amount</U></B>&rdquo; shall mean the applicable Purchase Notice Shares referenced in the Rapid Purchase Notice multiplied by
the applicable Rapid Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Purchase
Notice Date</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;2.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Purchase
Notice</U></B>&rdquo; shall mean the closing of a purchase and sale of Common Stock pursuant to a Rapid Purchase Notice as described in
<U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Purchase
Price Option 1</U></B>&rdquo; shall mean the lowest traded price of the Common Stock on Rapid Purchase Notice Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rapid Purchase
Price Option 2</U></B>&rdquo; shall mean ninety nine percent (99%) multiplied by the lowest traded price of the Common Stock two hours
following the written confirmation of the acceptance of the Rapid Purchase Notice by Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Registration
Rights Agreement</U></B>&rdquo; means the Registration Rights Agreement entered into by and among the Company and the Investor, in the
form attached hereto as <U>Exhibit&nbsp;C</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Registration
Statement</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;6.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Closing Date</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;2.2(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Investment Amount</U></B>&rdquo; shall mean the applicable Purchase Notice Shares referenced in the Regular Purchase Notice multiplied
by the Regular Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Notice Date</U></B>&rdquo; shall have the meaning specified in <U>Section&nbsp;2.2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Notice</U></B>&rdquo; shall mean the closing of a purchase and sale of Common Stock pursuant to a Regular Purchase Notice, as described
in <U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Price</U></B>&rdquo; shall mean (i) ninety-seven and one-half percent (97.5%) multiplied by the lower of (i) the lowest daily VWAP of
the Common Stock during the Regular Purchase Valuation Period or (ii) the closing price of Common Stock one Business Day prior to the
delivery of the applicable Regular Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regular Purchase
Valuation Period</U></B>&rdquo; shall mean the two (2) consecutive Business Days commencing on and including the Regular Purchase Notice
Date. For the avoidance of doubt, the Regular Purchase Notice Date shall be the first Business Day in the Regular Purchase Valuation Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Regulation D</U></B>&rdquo;
shall mean Regulation D promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rule 144</U></B>&rdquo;
shall mean Rule 144 under the Securities Act or any similar provision then in force under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>SEC Documents</U></B>&rdquo;
shall have the meaning specified in <U>Section&nbsp;4.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>SEC</U></B>&rdquo;
shall mean the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Securities</U></B>&rdquo;
mean (i) the Purchase Notice Shares issued to the Investor by the Company pursuant to this Agreement and (ii) the Commitment Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Securities Act</U></B>&rdquo;
shall mean the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Securities Purchase
Agreement</U></B>&rdquo; shall mean the Securities Purchase Agreement entered into by and among the Company and the Investor concurrently
herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Signing Date</U></B>&rdquo;
shall have the meaning set forth in the first paragraph of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Subsidiary</U></B>&rdquo;
means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly, owns a majority of the voting stock
or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of Regulation S-K promulgated under the
Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Termination</U></B>&rdquo;
shall mean any termination outlined in <U>Section&nbsp;10.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transaction Documents</U></B>&rdquo;
shall mean this Agreement, the Registration Rights Agreement, the Securities Purchase Agreement, and all schedules and exhibits hereto
and thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transfer Agent</U></B>&rdquo;
shall mean the transfer agent of the Company as of the Effective Date and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>VWAP</U></B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its &ldquo;VWAP&rdquo; function (set to 09:30:01 start time and 15:59:59 end time) or, if the foregoing
does not apply, the dollar volume-weighted average price of such security on the OTCQB or OTCQX tiers of OTC Markets for such security
during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg, or, if no dollar
volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price
and the lowest closing ask price of any of the market makers for such security as reported in the OTCID tier of OTC Markets Group Inc.
If the VWAP cannot be calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date
shall be the fair market value as mutually determined by the Company and the Investor. If the Company and the Investor are unable to agree
upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in <U>Section&nbsp;10.16</U>.
All such determinations shall be appropriately adjusted for any share dividend, share split, share combination, recapitalization, or other
similar transaction during such period.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
II<BR>
PURCHASE AND SALE OF COMMON STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.1 <U>PURCHASE
NOTICES</U></B>. Subject to the terms and conditions set forth herein (including, without limitation, the provisions of <U>Article&nbsp;VII</U>),
the Company shall have the right, but not the obligation, to require the Investor, by its delivery to the Investor of a Purchase Notice,
from time to time, with a copy to the Transfer Agent, to purchase Purchase Notice Shares, provided that (i) the amount of Purchase Notice
Shares shall not exceed the Purchase Notice Limit or the Beneficial Ownership Limitation set forth in <U>Section&nbsp;7.2(g)</U>, (each
such purchase, a &ldquo;<U>Closing</U>&rdquo;). The Company may not deliver a subsequent Purchase Notice until the Closing of an active
Purchase Notice, except if waived by the Investor in writing. Furthermore, the Company shall not deliver any Purchase Notices to the
Investor during the PEA Period.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.2 <U>MECHANICS</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(a)
</FONT><B><U>RAPID PURCHASE NOTICE</U></B>. At any time and from time to time during the Commitment Period, except during a PEA Period,
and except as otherwise provided in this Agreement, the Company may deliver a Rapid Purchase Notice to Investor, subject to satisfaction
of the conditions set forth in <U>Article&nbsp;VII</U> and otherwise provided herein. The Company shall provide the Transfer Agent with
a copy of such Rapid Purchase Notice concurrently with its delivery to the Investor. The Company shall deliver the Purchase Notice Shares
as DWAC Shares to the Designated Brokerage Account alongside the delivery of the Rapid Purchase Notice. A Rapid Purchase Notice shall
be deemed delivered on the Business Day (i) a Rapid Purchase Notice Form is received and accepted by email by the Investor and (ii) the
DWAC of the applicable Purchase Notice Shares has been initiated and completed as confirmed by the Investor&rsquo;s Designated Brokerage
Account by 6:00 a.m. Pacific time (the &ldquo;<B><U>Rapid Purchase Notice Date</U></B>&rdquo;). If the applicable Rapid Purchase Notice
Form is received after 6:00 a.m. Pacific time or the DWAC of the applicable Purchase Notice Shares has not been completed as confirmed
by the Investor&rsquo;s Designated Brokerage Account by 6:00 a.m. Pacific time, then the next Business Day shall be the Rapid Purchase
Notice Date, unless waived by the Investor in writing. Each party shall use its commercially reasonable efforts to perform or fulfill
all conditions and obligations to be performed or fulfilled by it under this Agreement so that the transactions contemplated hereby shall
be consummated as soon as practicable. Each party also agrees that it shall use its commercially reasonable efforts to take, or cause
to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable laws and regulations
to consummate and make effective <U>Section&nbsp;2.2(a)</U> of this Agreement and the transactions contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(b)
</FONT><B><U>RAPID PURCHASE CLOSING</U></B>. The Closing of a Rapid Purchase Notice shall occur no later than two (2)&nbsp;Business Days
following the Rapid Purchase Notice Date (the &ldquo;<B><U>Rapid Closing Date</U></B>&rdquo;), whereby the Investor shall deliver to
the Company, by 3:00 p.m. Pacific time on the Rapid Closing Date, the Rapid Purchase Investment Amount in lawful money of the United
States of America by wire transfer of immediately available funds to an account designated by the Company, provided that the Investor
has received the applicable Purchase Notice Shares as DWAC Shares. The Company shall not issue any fraction of a Common Stock pursuant
to any Rapid Purchase Notice. If the issuance would result in the issuance of a fraction of a Common Stock, the Company shall round such
fraction of a Common Stock up to the nearest whole Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(c)
</FONT><B><U>REGULAR PURCHASE NOTICE</U></B>. At any time and from time to time during the Commitment Period, except during a PEA Period
and except as otherwise provided in this Agreement, the Company may deliver a Regular Purchase Notice to Investor, subject to satisfaction
of the conditions set forth in <U>Article&nbsp;VII</U> and otherwise provided herein. The Company shall provide the Transfer Agent with
a copy of such Regular Purchase Notice concurrently with its delivery to the Investor. The Company shall deliver the Purchase Notice
Shares as DWAC Shares to the Designated Brokerage Account alongside the delivery of the Regular Purchase Notice. A Regular Purchase Notice
shall be deemed delivered on the Business Day (i)&nbsp;a Regular Purchase Notice Form is received and confirmed by 6:00 a.m. Pacific
time by email by the Investor and (ii)&nbsp;the DWAC of the applicable Purchase Notice Shares has been initiated and completed as confirmed
by the Investor&rsquo;s Designated Brokerage Account by 6:00 a.m. Pacific time (the &ldquo;<B><U>Regular Purchase Notice Date</U></B>&rdquo;).
If the applicable Regular Purchase Notice Form is received after 6:00 a.m. Pacific time or the DWAC of the applicable Purchase Notice
Shares has not been completed as confirmed by the Investor&rsquo;s Designated Brokerage Account by 6:00 a.m. Pacific time, then the next
Business Day shall be the Regular Purchase Notice Date, unless waived by the Investor in writing. Each party shall use its commercially
reasonable efforts to perform or fulfill all conditions and obligations to be performed or fulfilled by it under this Agreement so that
the transactions contemplated hereby shall be consummated as soon as practicable. Each party also agrees that it shall use its commercially
reasonable efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable
under applicable laws and regulations to consummate and make effective <U>Section&nbsp;2.2(c)</U> of this Agreement and the transactions
contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(d)
</FONT><B><U>REGULAR PURCHASE NOTICE CLOSING</U></B>. The Closing of a Regular Purchase Notice shall occur within no later than two (2)&nbsp;Business
Days following the Regular Purchase Valuation Period (the &ldquo;<B><U>Regular Purchase Closing Date</U></B>&rdquo;); whereby the Investor
shall deliver to the Company, by 3:00 p.m. Pacific time on the Regular Purchase Closing Date, the Regular Purchase Investment Amount
in lawful money of the United States of America by wire transfer of immediately available funds to an account designated by the Company,
provided that the Investor has received the applicable Purchase Notice Shares as DWAC Shares. The Company shall not issue any fraction
of a Common Stock pursuant to any Regular Purchase Notice. If the issuance would result in the issuance of a fraction of a Common Stock,
the Company shall round such fraction of a Common Stock up to the nearest whole Common Stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
III<BR>
REPRESENTATIONS AND WARRANTIES OF INVESTOR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Investor represents and
warrants the following to the Company:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.1 <U>INTENT</U></B>.
The Investor is entering into this Agreement and purchasing the Securities for its own account, and not as nominee or agent, for investment
purposes and not with a view towards, or for a sale in connection with, a &ldquo;distribution&rdquo; (as such term is defined in the
Securities Act), and the Investor has no present arrangement (whether or not legally binding) at any time to sell the Securities to or
through any Person in violation of the Securities Act or any applicable state securities laws; <U>provided</U>, <U>however</U>, that
the Investor reserves the right to dispose of the Securities at any time in accordance with federal and state securities laws applicable
to such disposition.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.2 <U>NO LEGAL
ADVICE FROM THE COMPANY</U></B>. The Investor acknowledges that it has had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such counsel
and advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax, or investment
advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.3 <U>ACCREDITED
INVESTOR</U></B>. The Investor is an &ldquo;accredited investor&rdquo; (as defined in Rule 501(a)(3) of Regulation D), and the Investor
has such experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Securities.
The Investor acknowledges that an investment in the Securities is speculative and involves a high degree of risk. The Investor represents
that it is able to bear any loss associated with an investment in the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.4 <U>AUTHORITY</U></B>.
The Investor has the requisite power and authority to enter into and perform its obligations under the Transaction Documents and to consummate
the transactions contemplated hereby and thereby. The execution and delivery of the Transaction Documents and the consummation by it
of the transactions contemplated hereby and thereby have been duly authorized by all necessary action and no further consent or authorization
of the Investor is required. The Transaction Documents to which it is a party has been duly executed by the Investor, and when delivered
by the Investor in accordance with the terms hereof, will constitute the valid and binding obligation of the Investor enforceable against
it in accordance with its terms, subject to applicable bankruptcy, insolvency, or similar laws relating to, or affecting generally the
enforcement of, creditors&rsquo; rights and remedies or by other equitable principles of general application.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.5 <U>NOT AN
AFFILIATE</U></B>. The Investor is not an officer, director, or &ldquo;affiliate&rdquo; (as that term is defined in Rule 405 of the Securities
Act) of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.6 <U>ORGANIZATION
AND STANDING; COMPLIANCE WITH LAWS</U></B>. The Investor is an entity duly incorporated or formed, validly existing and in good standing
under the laws of the State of Nevada with full right and limited liability company power and authority to enter into and to consummate
the transactions contemplated by the Transaction Documents. The Investor will comply with all U.S. federal securities laws applicable
to its purchase and resale of Common Stocks.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.7 <U>ABSENCE
OF CONFLICTS</U></B>. The execution and delivery of the Transaction Documents and the consummation of the transactions contemplated hereby
and thereby and compliance with the requirements hereof and thereof, will not (a)&nbsp;violate any law, rule, regulation, order, writ,
judgment, injunction, decree or award binding on the Investor, (b)&nbsp;violate any provision of any indenture, instrument or agreement
to which the Investor is a party or is subject, or by which the Investor or any of its assets is bound, or conflict with or constitute
a material default thereunder, (c)&nbsp;result in the creation or imposition of any lien pursuant to the terms of any such indenture,
instrument or agreement, or constitute a breach of any fiduciary duty owed by the Investor to any third party, or (d)&nbsp;require the
approval of any third-party (that has not been obtained) pursuant to any material contract, instrument, agreement, relationship or legal
obligation to which the Investor is subject or to which any of its assets, operations or management may be subject.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.8 <U>DISCLOSURE;
ACCESS TO INFORMATION</U></B>. The Investor had an opportunity to review copies of the SEC Documents filed on behalf of the Company and
has had access to all publicly available information with respect to the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.9 <U>MANNER
OF SALE</U></B>. At no time was the Investor presented with or solicited by or through any leaflet, public promotional meeting, television
advertisement, or any other form of general solicitation or advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.10 <U>PRIOR
COMMUNICATION</U></B>. The Investor confirms that it is not relying on any communication (written or oral) of the Company or any of its
affiliates, as investment or tax advice or as a recommendation to purchase the Common Stock. It is understood that information and explanations
related to the terms and conditions of the Securities provided by the Company or any of its affiliates shall not be considered investment
or tax advice or a recommendation to purchase the Securities, and that neither the Company nor any of its affiliates is acting or has
acted as an advisor to the undersigned in deciding to invest in the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
IV<BR>
REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in the
SEC Documents, which SEC Documents shall be deemed a part hereof and shall qualify any representation or otherwise made herein, the Company
represents and warrants the following to the Investor, as of the Effective Date:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.1 <U>ORGANIZATION
OF THE COMPANY</U></B>. The Company is an entity duly incorporated or otherwise organized, validly existing, and in good standing under
the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions of
its certificate of incorporation, bylaws, or other organizational or charter documents. The Company is duly qualified to conduct business
and is in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in a Material Adverse Effect and no proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. The Company has one
subsidiary, as disclosed in the SEC Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.2 <U>AUTHORITY</U></B>.
The Company has the requisite corporate power and authority to enter into and perform its obligations under the Transaction Documents.
The execution and delivery of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby
and thereby have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its
Board of Directors or shareholders is required. The Transaction Documents have been duly executed and delivered by the Company and constitutes
a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, or similar laws relating to, or affecting generally the enforcement of, creditors&rsquo;
rights and remedies or by other equitable principles of general application.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><B>Section 4.3 <U>CAPITALIZATION</U></B>.
As of the Effective Date, the Company is authorized to issue a maximum of 30,000,000 shares of Common Stock, of which there are 16,598,509
shares of Common Stock issued and outstanding as of the Effective Date. Except as set forth in the SEC Documents, the Company has not
issued any capital stock, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans,
the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the
conversion and/or exercise of Common Stock Equivalents outstanding as of the Effective Date. Except as set forth in the SEC Documents,
no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in the SEC Documents, there are no outstanding options, warrants, scrip
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of Common Stock or
Common Stock Equivalents. Except as set forth in the SEC Documents, the issuance and sale of the Securities will not obligate the Company
to issue shares of Common Stock or other securities to any Person (other than the Investor) and will not result in a right of any holder
of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no shareholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.4 <U>LISTING
AND MAINTENANCE REQUIREMENTS</U></B>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act. Except as set forth
in the SEC Documents, the Company has not, in the twelve (12) months preceding the Effective Date, received notice from the Principal
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Principal Market. Except as set forth in the SEC Documents, the Company is and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.5 <U>SEC DOCUMENTS;
DISCLOSURE</U></B>. The Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by
the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) thereof, for the one (1) year preceding
the Effective Date (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<B>SEC
Documents</B>&rdquo;). As of their respective dates, the SEC Documents complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and other federal laws, rules and regulations applicable to such SEC Documents, and
none of the SEC Documents when filed contained any untrue statement of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. The financial statements of the Company included in the SEC Documents comply as to form and substance in all material respects
with applicable accounting requirements and the published rules and regulations of the SEC or other applicable rules and regulations
with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles applied
on a consistent basis during the periods involved (except (a)&nbsp;as may be otherwise indicated in such financial statements or the
notes thereto or (b)&nbsp;in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed
or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and
the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments). Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or its agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Investor will rely on the foregoing representation in effecting transactions in securities of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.6 <U>VALID ISSUANCES</U></B>.
The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid, and non-assessable, free and clear of all Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.7 <U>NO CONFLICTS</U></B>.
The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby, including, without limitation, the issuance of the Purchase Notice Shares, do not and will not: (a)&nbsp;result
in a violation of the Company&rsquo;s certificate or articles of incorporation, by-laws or other organizational or charter documents,
(b)&nbsp;conflict with, or constitute a material default (or an event that with notice or lapse of time or both would become a material
default) under, result in the creation of any Lien upon any of the properties or assets of the Company, or give to others any rights
of termination, amendment, acceleration or cancellation of, any agreement, indenture, instrument or any &ldquo;<U>lock-up</U>&rdquo;
or similar provision of any underwriting or similar agreement to which the Company is a party, or (c)&nbsp;result in a violation of any
federal, state or local law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations)
applicable to the Company or by which any property or asset of the Company is bound or affected (except for such conflicts, defaults,
terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material
Adverse Effect) nor is the Company otherwise in violation of, conflict with or in default under any of the foregoing. The business of
the Company is not being conducted in violation of any law, ordinance or regulation of any governmental entity, except for possible violations
that either singly or in the aggregate do not and will not have a Material Adverse Effect. The Company is not required under federal,
state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any
court or governmental agency in order for it to execute, deliver or perform any of its obligations under the Transaction Documents (other
than (i) any SEC or state securities filings that may be required to be made by the Company in connection with the issuance of Purchase
Notice Shares or subsequent to any Closing or any registration statement that may be filed pursuant hereto, or (ii) the filing of a Listing
of Additional Shares Notification Form with the Principal Market, which, in each case, have been made or will be made in a timely manner);
provided that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the
relevant representations and agreements of Investor herein.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.8 <U>NO MATERIAL
ADVERSE EFFECT</U></B>. No event has occurred that would have a Material Adverse Effect on the Company that has not been disclosed in
subsequent SEC Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.9 <U>LITIGATION
AND OTHER PROCEEDINGS</U></B>. Except as disclosed in the SEC Documents and the Disclosure Schedule, there are no material actions, suits,
investigations, inquiries (including, without limitation, SEC inquiries, FINRA inquiries, or inquiries of the Principal Market) or similar
proceedings (however any governmental agency may name them) pending or, to the knowledge of the Company, threatened against or affecting
the Company or its properties, nor has the Company received any written or oral notice of any such action, suit, proceeding, inquiry
or investigation, which would have a Material Adverse Effect. No judgment, order, writ, injunction, or decree or award has been issued
by or, to the knowledge of the Company, requested of any court, arbitrator or governmental agency which would have a Material Adverse
Effect. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving
the Company or any current or former director or officer of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.10 <U>REGISTRATION
RIGHTS</U></B>. Except as set forth in the SEC Documents, no Person (other than the Investor) has any right to cause the Company to effect
the registration under the Securities Act of any securities of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.11 <U>ACKNOWLEDGMENT
REGARDING INVESTOR&rsquo;S PURCHASE OF SECURITIES</U></B>. The Company acknowledges and agrees that the Investor is acting solely in
the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and
thereby and that the Investor is not (i)&nbsp;an officer or director of the Company, or (ii)&nbsp;an &ldquo;affiliate&rdquo; (as defined
in Rule 144) of the Company. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of
the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby,
and any advice given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the transactions
contemplated hereby and thereby is merely incidental to the Investor&rsquo;s purchase of the Purchase Notice Shares. The Company further
acknowledges that the Investor is not acting as a dealer of the Company&rsquo;s Common Stock (or any other securities of the Company).
The Company further represents to the Investor that the Company&rsquo;s decision to enter into the Transaction Documents has been based
solely on the independent evaluation by the Company and its representatives.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.12 <U>NO GENERAL
SOLICITATION</U></B>. Neither the Company, nor any Person acting on its behalf, has engaged in any form of general solicitation or general
advertising (within the meaning of Regulation D under the Securities act) in connection with the offer or sale of the Securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.13 <U>NO INTEGRATED
OFFERING</U></B>. Except as set forth on the Disclosure Schedule, none of the Company, its affiliates, and any Person acting on their
behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would cause this offering of the Securities to be integrated with prior offerings for purposes of any applicable shareholder approval
provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any
of the securities of the Company are listed or designated, but excluding shareholder consents required to authorize and issue the Securities
or waive any anti-dilution provisions in connection therewith.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.14 <U>PLACEMENT
AGENT; OTHER COVERED PERSONS</U></B>. The Company is not aware of any other Person that has been or will be paid (directly or indirectly)
remuneration for solicitation of the Investor in connection with the sale of any Regulation D Securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
V<BR>
COVENANTS OF INVESTOR</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.1 <U>SHORT SALES
AND CONFIDENTIALITY</U></B>. Neither the Investor, nor any affiliate of the Investor acting on its behalf or pursuant to any understanding
with it, (i) has executed any Short Sales prior to the Effective Date, and (ii) will execute any Short Sales during the period from the
Effective Date to the end of the Commitment Period. For the purposes hereof, and in accordance with Regulation SHO, the sale of Common
Stock purchased under the applicable Purchase Notice after delivery of the Purchase Notice shall not be deemed a Short Sale. The parties
acknowledge and agree that during the Rapid Purchase Notice Date and Regular Purchase Valuation Period, the Investor may contract for,
or otherwise effect, the resale of the subject purchased Purchase Notice Shares to third parties. The Investor shall, until such time
as the transactions contemplated by the Transaction Documents are publicly disclosed by the Company in accordance with the terms of the
Transaction Documents, maintain the confidentiality of the existence and terms of this transaction and the information included in the
Transaction Documents. &ldquo;Short Sales&rdquo; shall mean &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation
SHO under the Exchange Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.2 <U>COMPLIANCE
WITH LAW; TRADING IN SECURITIES</U></B>. The Investor&rsquo;s trading activities with respect to shares of Common Stock will be in compliance
with all applicable state and federal securities laws and regulations and the rules and regulations of FINRA and the Principal Market.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
VI<BR>
COVENANTS OF THE COMPANY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.1 <U>LISTING
OF COMMON STOCK</U></B>. The Company shall use commercially reasonable efforts to maintain, so long as any shares of Common Stock shall
be so listed, the listing, if required, of all such Common Stock on the Principal Market or any other Eligible Market during the Commitment
Period. The Company shall use its commercially reasonable efforts to continue the listing or quotation and trading of the Common Stock
on the Principal Market or any other Eligible Market (including, without limitation, maintaining sufficient net tangible assets, if required)
and will comply in all respects with the Company&rsquo;s reporting, filing, and other obligations under the bylaws or rules of the Principal
Market or any other Eligible Market. If the Company fails to be listed on any Eligible Market for a period of six (6) months or less,
the Commitment Fee Amount shall be $1,000,000. If the Company fails to be listed on any Eligible Market for a period of twelve (12) months
or less but in excess of six (6) months, the Commitment Fee Amount shall be $1,250,000. If the Company fails to be listed on any Eligible
Market for a period in excess of twelve (12) months, the Commitment Fee Amount shall be $1,500,000.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.2 <U>FILING
OF CURRENT REPORT</U></B>. The Company agrees that it shall file a Current Report on Form 8-K, including the Transaction Documents as
exhibits thereto, with the SEC within the time required by the Exchange Act, relating to the execution of the transactions contemplated
by, and describing the material terms and conditions of, the Transaction Documents (the &ldquo;<B><U>Current Report</U></B>&rdquo;).
The Company shall permit the Investor to review and comment upon the final pre-filing draft version of the Current Report at least two
(2)&nbsp;Business Days prior to its filing with the SEC, and the Company shall give reasonable consideration to all such comments. The
Investor shall use its reasonable best efforts to comment upon the final pre-filing draft version of the Current Report within one (1)&nbsp;Business
Day from the date the Investor receives it from the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.3 <U>FILING
OF REGISTRATION STATEMENT</U></B>. The Company shall file with the SEC, within five (5) Business&nbsp;Days after the Effective Date,
a new Registration Statement on Form S-1 (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;) in compliance with the terms of the
Registration Rights Agreement, covering only the resale by the Investor of the Securities (including the Commitment Securities) by the
Investor; provided, however, that this deadline shall be tolled by one Business Day for each Business Day that the SEC is closed due
to a shutdown of the United States government. The Registration Statement shall relate to the transactions contemplated by, and describing
the material terms and conditions of, this Agreement and disclosing all information relating to the transactions contemplated hereby
required to be disclosed in the Registration Statement and the prospectus supplement as of the date of the Registration Statement, including,
without limitation, information required to be disclosed in the section captioned &ldquo;Plan of Distribution&rdquo; in the Registration
Statement. The Company shall permit the Investor to review and comment upon the Registration Statement within a reasonable time prior
to their filing with the SEC, the Company shall give reasonable consideration to all such comments, and the Company shall not file the
Current Report or the Registration Statement with the SEC in a form to which the Investor reasonably objects. The Investor shall furnish
to the Company such information regarding itself, the Company&rsquo;s securities beneficially owned by the Investor and the intended
method of distribution thereof, including any arrangement between the Investor and any other person or relating to the sale or distribution
of the Company&rsquo;s securities, as shall be reasonably requested by the Company in connection with the preparation and filing of the
Current Report and the Registration Statement, and shall otherwise cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of the Current Report and the Registration Statement with the SEC. The Company shall have
no knowledge of any untrue statement (or alleged untrue statement) of a material fact or omission (or alleged omission) of a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, in any pre-existing registration statement filed or any new registration statement or prospectus which is a part of the
foregoing. The Company shall promptly give the Investor notice of any event (including the passage of time) which makes the final prospectus
not to be in compliance with Section 5(b) or 10 of the Securities Act and shall use its commercially reasonable efforts thereafter to
file with the SEC any Post-Effective Amendment to the Registration Statement, amended prospectus or prospectus supplement in order to
comply with Section 5(b) or 10 of the Securities Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.4 <U>COMMITMENT
SHARES</U></B>. In consideration for the Investor&rsquo;s execution and delivery of, and agreement to perform under this Agreement, the
Company shall issue and deliver to Investor, within thirty (30) Business Days following the effectiveness of the Registration Statement,
as directed by the Investor, a number of shares of Common Stock (the &ldquo;<B><U>Commitment Shares</U></B>&rdquo;) equal to the Commitment
Fee Amount divided by the Commitment Fee Price. Notwithstanding the foregoing, to the extent that the issuance of Commitment Shares pursuant
to this Section 6.4 would result in the Investor exceeding the Beneficial Ownership Limitation or in the Company exceeding the Exchange
Cap, then the Company shall not issue such Commitment Shares and the portion of such Commitment Shares shall be held in abeyance for
the Investor until such time or times as its right thereto would not result in the Investor exceeding the Beneficial Ownership Limitation
and would not result in the Company exceeding the Exchange Cap, unless shareholder approval is obtained to issue in excess of the Exchange
Cap, at which time or times the Company shall issue such Commitment Shares in such tranches as directed by the Investor to the same extent
as if there had been no such limitations. The foregoing Exchange Cap limitation shall not apply if (A) at any time the Exchange Cap is
reached and at all times thereafter the average price paid for all Common Stock issued under this Agreement and the Securities Purchase
Agreement is equal to or greater than the <FONT STYLE="font-weight: normal">Minimum Price</FONT> or (B) the Company is exempt from obtaining
shareholder approval for the issuance of shares of Common Stock above the Exchange Cap under the rules of the Principal Market. <FONT STYLE="background-color: white">For
the avoidance of doubt, all of the Commitment Shares shall be fully earned as of the Effective Date, and the issuance of the Commitment
Shares is not contingent upon any other event or condition, including, without limitation, the Company&rsquo;s submission of a Purchase
Notice to the Investor or the filing or effectiveness of any Registration Statement, and irrespective of any termination of this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.5 </B></FONT><U>SHAREHOLDER APPROVAL</U><FONT STYLE="font-weight: normal">. The Company shall take all action necessary to duly call,
give notice of, convene, and hold a shareholder meeting (the &ldquo;</FONT><U>Shareholder Meeting</U><FONT STYLE="font-weight: normal">&rdquo;)
as soon as reasonably practicable, but in no event later than one hundred twenty (120) days after the Effective Date, for the approval
by the Company&rsquo;s shareholders of the issuance of the Securities pursuant to this Agreement in excess of the Exchange Cap (the &ldquo;</FONT><U>Shareholder
Approval</U><FONT STYLE="font-weight: normal">&rdquo;). In connection with such Shareholder Meeting, the Company shall provide each shareholder
with a proxy statement and shall use its best efforts to solicit the Shareholder Approval. Notwithstanding the foregoing, if at any such
time, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common Stock
to approve the issuance of the Securities pursuant to this Agreement in excess of the Exchange Cap, the Company may satisfy this obligation
by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.6 <U>NON-PUBLIC INFORMATION</U></B></FONT>. <FONT STYLE="font-weight: normal">Except with respect to the material terms and conditions
of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section&nbsp;6.2 and otherwise provided
herein, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide the Investor or its agents
or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless
prior thereto the Investor shall have consented in writing to the receipt of such information and agreed with the Company to keep such
information confidential. The Company understands and confirms that the Investor shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to the Investor
without such prior written consent, the Company hereby covenants and agrees that the Investor shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees, or affiliates, not to trade
on the basis of, such material, non-public information, provided that the Investor shall remain subject to applicable law. The Company
represents that as of the Effective Date, except with respect to the material terms and conditions of the transaction contemplated by
the Transaction Documents, neither it nor any other Person acting on its behalf has previously provided the Investor or its agents or
counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information. After
the Effective Date, to the extent that any notice or communication made by the Company, or information provided by the Company, to the
Investor constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
file such notice or other material information with the SEC pursuant to a Current Report on Form 8-K. The Company understands and confirms
that the Investor shall be relying on the foregoing covenant in effecting transactions in securities of the Company. In addition to any
other remedies provided by this Agreement or other Transaction Documents, if the Company provides any material, non-public information
to the Investor without its prior written consent, and it fails to promptly (no later than by 9:00 am New York City time the next Business
Day) file a Form 8-K disclosing this material, non-public information, it shall pay the Investor as partial liquidated damages and not
as a penalty a sum equal to $1,000 per day beginning with the day the information is disclosed to the Investor and ending and including
the day the Form 8-K disclosing this information is filed.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B></B></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.7 <U>OTHER EQUITY LINE TRANSACTIONS</U></B><FONT STYLE="font-weight: normal">. </FONT></FONT><FONT STYLE="font-weight: normal">From
the Effective Date until the end of the Commitment Period, without the Investor&rsquo;s prior written consent, the Company shall be prohibited
from entering into any &ldquo;equity line&rdquo; or substantially similar transaction whereby an investor is irrevocably bound to purchase
securities over a period of time from the Company at a price based on the market price of the Common Stock at the time of such purchase;
provided, however, that this Section&nbsp;6.6 shall not be deemed to prohibit the issuance of shares of Common Stock pursuant to (i)&nbsp;an
&ldquo;at-the-market offering&rdquo; by the Company through a registered broker-dealer acting as agent of the Company pursuant to a written
agreement between the Company and such registered broker-dealer or (ii)&nbsp;the conversion or exercise of derivative securities where
the conversion or exercise price varies based on the market price of the Common Stock. The Investor shall be entitled to seek injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages, without the
necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.8 <U>COMPENSATION FOR BUY-IN ON FAILURE TO TIMELY DELIVER PURCHASE NOTICE SHARES</U>. </B></FONT><FONT STYLE="font-weight: normal">In
addition to any other rights available to the Investor, if the Company fails to cause the Transfer Agent to transmit to the Investor the
Purchase Notice Shares in accordance with the provisions of Section&nbsp;2 above pursuant to a Purchase Notice on or before a Regular
Purchase Closing Date or a Rapid Closing Date, as applicable, and if after such date the Investor is required by its broker to purchase
(in an open market transaction or otherwise) or the Investor&rsquo;s brokerage firm otherwise purchases, Common Stock to deliver in satisfaction
of a sale by the Investor of the Purchase Notice Shares which the Investor anticipated receiving upon such Purchase in accordance with
the provisions of Section 2 above (a &ldquo;</FONT><U>Buy-In</U><FONT STYLE="font-weight: normal">&rdquo;), then the Company shall (A)
pay in cash to the Investor the amount, if any, by which (x) the Investor&rsquo;s total purchase price (including reasonable and documented
brokerage commissions, if any) for the Common Stock so purchased in the Buy-In exceeds (y) the amount obtained by multiplying (1) the
number of Purchase Notice Shares that the Company was required to deliver to the Investor in connection such Purchase times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Investor, either treat the
Purchase as rescinded under this Agreement (which would result in no reduction in the Commitment Amount as a result of such attempted
Purchase) or deliver to the Investor the number of Purchase Notice Shares that would have been issued had the Company timely complied
with its delivery obligations hereunder. For example, if the Investor purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted Purchase with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A) of the immediately preceding sentence the Company shall be required to pay the Investor $1,000. The Investor shall provide
the Company written notice indicating the amounts payable to the Investor in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit the Investor&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Purchase Notice as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.9 <U>REGISTRATION
FAILURE PAYMENTS</U><FONT STYLE="font-weight: normal">. If the Registration Statement is not declared effective within thirty (30) days
of the Effective Date (the &ldquo;</FONT><U>Required Registration Date</U><FONT STYLE="font-weight: normal">&rdquo;), the Company shall
issue and deliver to the Investor a number of shares of Common Stock equal to $250,000 divided by the lowest traded price of the Common
Stock between the Effective Date and the Required Registration Date; provided, however, that this deadline shall be tolled by one Business
Day for each Business Day that the SEC is closed due to a shutdown of the United States government; provided, further, that the Required
Registration Date shall be the date that is forty five (45) days after the Effective Date if the SEC notifies the Company there will be
a &ldquo;review&rdquo; of such Registration Statement. For every thirty (30) days after the Required Registration Date that the Registration
Statement is not declared effective, the Company shall issue and deliver to the Investor a number of additional shares of Common Stock
equal to $250,000 divided by the lowest traded price of the Common Stock during such thirty (30) day period. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.10 <U>SHAREHOLDER
APPROVAL FAILURE PAYMENTS</U><FONT STYLE="font-weight: normal">. If the Shareholder Meeting is not held within one hundred twenty (120)
days after the Effective Date (the &ldquo;</FONT><U>Required Shareholder Meeting Date</U><FONT STYLE="font-weight: normal">&rdquo;), the
Company shall issue and deliver to the Investor a number of shares of Common Stock equal to $250,000 divided by the lowest traded price
of the Common Stock between the Effective Date and the Required Shareholder Meeting Date. For every thirty (30) days after the Required
Shareholder Meeting Date that the Shareholder Meeting is not held, the Company shall issue and deliver to the Investor a number of additional
shares of Common Stock equal to $250,000 divided by the lowest traded price of the Common Stock during such thirty (30) day period.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.11 <U>SHAREHOLDER
APPROVAL FAILURE</U><FONT STYLE="font-weight: normal">. If the Shareholder Approval is not obtained by the first Required Shareholder
Meeting Date, the Company shall, during the period beginning on such date and continuing 360 days thereafter, cause an additional Shareholder
Meeting to be held every ninety (90) days until the Shareholder Approval is obtained. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.12 <U>REDEMPTION
OF COMMITMENT SECURITIES</U><FONT STYLE="font-weight: normal">. If (a) the Shareholder Meeting is not held within one hundred eighty (180)
days after the Effective Date, (b) the Company fails to register all Commitment Securities on the Registration Statement, or (c) the Company
fails to timely deliver any Commitment Shares owed, the Investor may require the Company to redeem all or any of the Commitment Securities
by delivering written notice thereof (the &ldquo;</FONT><U>Redemption Notice</U><FONT STYLE="font-weight: normal">&rdquo;) to the Company,
which Redemption Notice shall indicate the number of the Commitment Shares the Investor is electing to redeem (including any undelivered
Commitment Shares owed by the Company). Upon receipt of any Redemption Notice, the Company shall immediately redeem, out of funds legally
available therefor, each of the Commitment Shares indicated in the Redemption Notice at a redemption price equal to the highest traded
price of the Common Stock between the Effective Date and the date of the Redemption Notice.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.13 <U>RESERVATION
OF SECURITIES</U><FONT STYLE="font-weight: normal">. The Company covenants that until the later of (a) the end of the Commitment Period,
and (b) while any Commitment Fee Amount (including any increased amount that may result pursuant to Section 6.1), remains outstanding,
the Company will reserve from its authorized and unissued Common Stock, six million (6,000,000) of shares of Common Stock (subject to
adjustment for reverse and forward share splits, share dividends, share combinations and other similar transactions of the Common Stock
that occur after the date of this Agreement), free from pre-emptive rights, which such reserved amounts shall be increased by the Company
from time to time, and in no event less than every three (3) months, as reasonably requested by the Investor (the &ldquo;Required Minimum&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
VII<BR>
CONDITIONS TO DELIVERY OF<BR>
PURCHASE NOTICE AND CONDITIONS TO CLOSING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.1 <U>CONDITIONS
PRECEDENT TO THE RIGHT OF THE COMPANY TO ISSUE AND SELL PURCHASE NOTICE SHARES</U></B>. The right of the Company to issue and sell the
Purchase Notice Shares to the Investor is subject to the satisfaction of each of the conditions set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(a)
</FONT><B><U>ACCURACY OF INVESTOR&rsquo;S REPRESENTATIONS AND WARRANTIES</U></B>. The representations and warranties of the Investor
shall be true and correct in all material respects as of the date of this Agreement and as of the date of each Closing as though made
at each such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(b)
</FONT><B><U>PERFORMANCE BY INVESTOR</U></B>. Investor shall have performed, satisfied, and complied in all respects with all covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Investor at or prior to such
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(c)
</FONT><B><U>PRINCIPAL MARKET REGULATION</U></B>. Notwithstanding anything in this Agreement to the contrary, and in addition to the
limitations set forth herein, the Company shall not issue more than 19.99% of the Company&rsquo;s outstanding Common Stock as of the
Effective Date (the &ldquo;<B><U>Exchange Cap</U></B>&rdquo;) under this Agreement and the Securities Purchase Agreement unless shareholder
approval is obtained to issue in excess of the Exchange Cap; <U>provided</U>, <U>however</U>, that the foregoing limitation shall not
apply if (A) at any time the Exchange Cap is reached and at all times thereafter the average price paid for all Common Stock issued under
this Agreement and the Securities Purchase Agreement is equal to or greater than $0.394 (the &ldquo;<B><U>Minimum Price</U></B>&rdquo;),
a price equal to the lower of (i)&nbsp;the Nasdaq Official Closing Price of the Common Stock immediately preceding the execution of this
Agreement or (ii)&nbsp;the arithmetic average of the five (5)&nbsp;Nasdaq Official Closing Prices for the Common Stock immediately preceding
the execution of this Agreement, as calculated in accordance with the rules of the Principal Market (such that, in such circumstance,
for purposes of the Principal Market, the transaction contemplated hereby would not be &ldquo;below market&rdquo; and the Exchange Cap
would not apply) or (B) the Company is exempt from obtaining shareholder approval for the issuance of shares of Common Stock above the
Exchange Cap under the rules of the Principal Market. Notwithstanding the foregoing, the Company shall not be required or permitted to
issue, and the Investor shall not be required to purchase, any Securities under this Agreement if such issuance would violate the rules
or regulations of the Principal Market. The Exchange Cap shall be reduced, on a share-for-share basis, by the number of shares of Common
Stock issued or issuable that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Principal
Market.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.2 <U>CONDITIONS
PRECEDENT TO THE OBLIGATION OF INVESTOR TO PURCHASE THE PURCHASE NOTICE SHARES</U></B>. The obligation of the Investor hereunder to purchase
the Purchase Notice Shares is subject to the satisfaction of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(a)
</FONT><B><U>EFFECTIVE REGISTRATION STATEMENT</U></B>. The Registration Statement, and any amendment or supplement thereto, shall have
been declared effective and shall remain effective for the resale of the Securities,&nbsp;the Company shall not have received notice
that the SEC has issued or intends to issue a stop order with respect to such Registration Statement or that the SEC otherwise has suspended
or withdrawn the effectiveness of such Registration Statement, either temporarily or permanently, or intends or has threatened to do
so, and no other suspension of the use of, or withdrawal of the effectiveness of, such Registration Statement or related prospectus shall
exist. The Investor shall not have received any notice from the Company that the prospectus and/or any prospectus supplement or amendment
thereto fails to meet the requirements of Section 5(b) or Section 10 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(b)
</FONT><B><U>ACCURACY OF THE COMPANY&rsquo;S REPRESENTATIONS AND WARRANTIES</U></B>. The representations and warranties of the Company
shall be true and correct in all material respects as of the date of this Agreement and as of the date of each Closing (except for representations
and warranties specifically made as of a particular date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(c)
</FONT><B><U>PERFORMANCE BY THE COMPANY</U></B>. The Company shall have performed, satisfied and complied in all material respects with
all covenants, agreements, and conditions required by this Agreement to be performed, satisfied, or complied with by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(d)
</FONT><B><U>NO INJUNCTION</U></B>. No statute, rule, regulation, executive order, decree, ruling, or injunction shall have been enacted,
entered, promulgated, or adopted by any court or governmental authority of competent jurisdiction that prohibits or directly and materially
adversely affects any of the transactions contemplated by the Transaction Documents, and no proceeding shall have been commenced that
may have the effect of prohibiting or materially adversely affecting any of the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(e)
</FONT><B><U>ADVERSE CHANGES</U></B>. Since the date of filing of the Company&rsquo;s most recent quarterly report on Form 10-Q , no
event that had or is reasonably likely to have a Material Adverse Effect has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(f)
</FONT><B><U>NO SUSPENSION OF TRADING IN OR DELISTING OF COMMON STOCK</U></B>. The trading of the Common Stock shall not have been suspended
by the SEC or the Principal Market, or otherwise halted for any reason, and the Common Stock shall have been approved for listing or
quotation on and shall not have been delisted from or no longer quoted on the Principal Market. In the event of a suspension, delisting,
or halting for any reason, of the trading of the Common Stock during an active Purchase Notice, as contemplated by this <U>Section&nbsp;7.2(f)</U>,
the Investor shall purchase the Purchase Notice Shares in the respective Purchase Notice at a value equal to $0.0001 per share of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(g)
</FONT><B><U>BENEFICIAL OWNERSHIP LIMITATION</U></B>. The number of Purchase Notice Shares then to be purchased by the Investor shall
not exceed the number of such shares that, when aggregated with all other shares of Common Stock then owned by the Investor beneficially
or deemed beneficially owned by the Investor, would result in the Investor owning more than the Beneficial Ownership Limitation (as defined
below), as determined in accordance with Section 13 of the Exchange Act. For purposes of this <U>Section&nbsp;7.2(g)</U>, in the event
that the amount of Common Stock outstanding is greater or lesser on a date of a Closing (a &ldquo;<B><U>Closing Date</U></B>&rdquo;)
than on the date upon which the Purchase Notice associated with such Closing Date is given, the amount of Common Stock outstanding on
such issuance of a Purchase Notice shall govern for purposes of determining whether the Investor, when aggregating all purchases of Common
Stock made pursuant to this Agreement, would own more than the Beneficial Ownership Limitation following a purchase on any such Closing
Date. In the event the Investor claims that compliance with a Purchase Notice would result in the Investor owning more than the Beneficial
Ownership Limitation, upon request of the Company the Investor will provide the Company with evidence of the Investor&rsquo;s then existing
shares beneficially or deemed beneficially owned. The &ldquo;<B><U>Beneficial Ownership Limitation</U></B>&rdquo; shall be 4.99% of the
number of shares of the Common Stock outstanding immediately prior to the issuance of shares of Common Stock issuable pursuant to a Purchase
Notice, provided that, the Investor may increase the Beneficial Ownership Limitation up to 9.99% at its sole discretion upon sixty-one
(61)&nbsp;days prior written notice to the Company. To the extent that the Beneficial Ownership Limitation is exceeded, the number of
shares of Common Stock issuable to the Investor shall be reduced so it does not exceed the Beneficial Ownership Limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(h)
</FONT><B><U>STOCK PROMOTION</U></B>. The Company shall be free from any &ldquo;stock promotion&rdquo; flag.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i)
</FONT><B><U>NO KNOWLEDGE</U></B>. The Company shall have no knowledge of any event more likely than not to have the effect of causing
the effectiveness of the Registration Statement to be suspended or any prospectus or prospectus supplement failing to meet the requirement
of Sections 5(b) or 10 of the Securities Act (which event is more likely than not to occur within the fifteen (15)&nbsp;Business Days
following the Business Day on which such Purchase Notice is deemed delivered).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(j)
</FONT><B><U>NO VIOLATION OF SHAREHOLDER APPROVAL REQUIREMENT</U></B>. The issuance of the Purchase Notice Shares shall not violate the
shareholder approval requirements of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(k)
</FONT><B><U>DWAC ELIGIBLE</U></B>. The Common Stock must be DWAC Eligible and not subject to a &ldquo;DTC chill&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(l)
</FONT><B><U>SEC DOCUMENTS</U></B>. All reports, schedules, registrations, forms, statements, information and other documents required
to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act after the Effective Date (the
&ldquo;Future SEC Documents&rdquo;) shall have been filed with the SEC within the applicable time periods prescribed for such filings
under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(m)
</FONT><B><U>EXCHANGE CAP</U></B>. The Exchange Cap has not been reached, unless Shareholder Approval is obtained to issue in excess
of the Exchange Cap; <U>provided</U>, <U>however</U>, that the foregoing limitation shall not apply if (A) at any time the Exchange Cap
is reached and at all times thereafter the average price paid for all Common Stock issued under this Agreement and the Securities Purchase
Agreement is equal to or greater than the <FONT STYLE="font-weight: normal">Minimum Price</FONT> or (B) the Company is exempt from obtaining
shareholder approval for the issuance of shares of Common Stock above the Exchange Cap under the rules of the Principal Market. Notwithstanding
the foregoing, the Company shall not be required or permitted to issue, and the Investor shall not be required to purchase, any Securities
under this Agreement if such issuance would violate the rules or regulations of the Principal Market. The Exchange Cap shall be reduced,
on a share-for-share basis, by the number of shares of Common Stock issued or issuable that may be aggregated with the transactions contemplated
by this Agreement under applicable rules of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(n)
</FONT><B><U>IRREVOCABLE TRANSFER AGENT INSTRUCTIONS</U></B>. <FONT STYLE="background-color: white">The Irrevocable Transfer Agent Instructions
shall have been delivered by the Company to, and acknowledged in writing (email being sufficient) by, the Transfer Agent (or any successor
transfer agent)</FONT>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
VIII<BR>
LEGENDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8.1 <U>NO RESTRICTIVE
STOCK LEGEND</U></B>. No restrictive stock legend shall be placed on the share certificates representing the Purchase Notice Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8.2 <U>INVESTOR&rsquo;S
COMPLIANCE</U></B>. Nothing in this <U>Article&nbsp;VIII</U> shall affect in any way the Investor&rsquo;s obligations hereunder to comply
with all applicable securities laws upon the sale of the Common Stock.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
IX<BR>
INDEMNIFICATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.1 <U>INDEMNIFICATION</U></B>.
Each party (an &ldquo;<B><U>Indemnifying Party</U></B>&rdquo;) agrees to indemnify and hold harmless the other party along with its officers,
directors, employees, and authorized agents, and each Person or entity, if any, who controls such party within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act (an &ldquo;<B><U>Indemnified Party</U></B>&rdquo;) from and against any Damages,
and any action in respect thereof to which the Indemnified Party becomes subject to, resulting from, arising out of this Agreement or
relating to (i)&nbsp;any misrepresentation, breach of warranty or nonfulfillment of or failure to perform any covenant or agreement on
the part of the Indemnifying Party contained in this Agreement, (ii)&nbsp;any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement or any post-effective amendment thereof or prospectus or prospectus supplement, or the omission
or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading,
(iii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus or contained in
the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the
omission or alleged omission to state therein any material fact necessary to make the statements made therein, in the light of the circumstances
under which the statements therein were made, not misleading, or (iv)&nbsp;any violation or alleged violation by the Company of the Securities
Act, the Exchange Act, any state securities law or any rule or regulation under the Securities Act, the Exchange Act or any state securities
law, as such Damages are incurred, except to the extent such Damages result primarily from the Indemnified Party&rsquo;s failure to perform
any covenant or agreement contained in this Agreement or the Indemnified Party&rsquo;s, recklessness or willful misconduct in performing
its obligations under this Agreement; <I>provided</I>, <I>however</I>, that the foregoing indemnity agreement shall not apply to any
Damages of an Indemnified Party to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue
statement or omission or alleged omission made by an Indemnifying Party in reliance upon and in conformity with written information furnished
to the Indemnifying Party by the Indemnified Party expressly for use in the Registration Statement, any post-effective amendment thereof,
prospectus, prospectus supplement thereto, or any preliminary prospectus or final prospectus (as amended or supplemented).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.2 <U>INDEMNIFICATION
PROCEDURE</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) A
party that seeks indemnification under must promptly give the other party notice of any legal action; however, a delay in notice does
not relieve an Indemnifying Party of any liability to any Indemnified Party, except to the extent the Indemnifying Party shows that the
delay prejudiced the defense of the action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Indemnifying Party may participate in the defense at any time or it may assume the defense by giving notice to the Indemnified Parties.
After assuming the defense, the Indemnifying Party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) must
select counsel (including local counsel if appropriate) that is reasonably satisfactory to the Indemnified Parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(ii) is
not liable to the other party for any later attorney&rsquo;s fees or for any other later expenses that the Indemnified Parties incur,
except for reasonable investigation costs;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(iii) must
not compromise or settle the action without the Indemnified Parties consent (which may not be unreasonably withheld); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(iv) is
not liable for any compromise or settlement made without its consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) If
the Indemnifying Party fails to assume the defense within 10 days after receiving notice of the action, the Indemnifying Party shall be
bound by any determination made in the action or by any compromise or settlement made by the Indemnified Parties, and also remains liable
to pay the Indemnified Parties&rsquo; legal fees and expenses.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.3 <U>METHOD
OF ASSERTING INDEMNIFICATION CLAIMS</U></B>. All claims for indemnification by any Indemnified Party under <U>Section&nbsp;9.2</U> shall
be asserted and resolved as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) If
any claim or demand in respect of which an Indemnified Party might seek indemnity under <U>Section&nbsp;9.2</U> is asserted against or
sought to be collected from such Indemnified Party by a Person other than a party hereto or an affiliate thereof (a &ldquo;<B><U>Third
Party Claim</U></B>&rdquo;), the Indemnified Party shall deliver a written notification, enclosing a copy of all papers served, if any,
and specifying the nature of and basis for such Third Party Claim and for the Indemnified Party&rsquo;s claim for indemnification that
is being asserted under any provision of <U>Section&nbsp;9.2</U> against an Indemnifying Party, together with the amount or, if not then
reasonably ascertainable, the estimated amount, determined in good faith, of such Third Party Claim (a &ldquo;<B><U>Claim Notice</U></B>&rdquo;)
with reasonable promptness to the Indemnifying Party. If the Indemnified Party fails to provide the Claim Notice with reasonable promptness
after the Indemnified Party receives notice of such Third Party Claim, the Indemnifying Party shall not be obligated to indemnify the
Indemnified Party with respect to such Third Party Claim to the extent that the Indemnifying Party&rsquo;s ability to defend has been
prejudiced by such failure of the Indemnified Party. The Indemnifying Party shall notify the Indemnified Party as soon as practicable
within the period ending thirty (30)&nbsp;calendar days following receipt by the Indemnifying Party of either a Claim Notice or an Indemnity
Notice (as defined below) (the &ldquo;<B><U>Dispute Period</U></B>&rdquo;) whether the Indemnifying Party disputes its liability or the
amount of its liability to the Indemnified Party under <U>Section&nbsp;9.2</U> and whether the Indemnifying Party desires, at its sole
cost and expense, to defend the Indemnified Party against such Third Party Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If the Indemnifying Party notifies
the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the Indemnified Party with respect to the
Third Party Claim pursuant to this <U>Section&nbsp;9.3(a)</U>, then the Indemnifying Party shall have the right to defend, with counsel
reasonably satisfactory to the Indemnified Party, at the sole cost and expense of the Indemnifying Party, such Third Party Claim by all
appropriate proceedings, which proceedings shall be vigorously and diligently prosecuted by the Indemnifying Party to a final conclusion
or will be settled at the discretion of the Indemnifying Party (but only with the consent of the Indemnified Party in the case of any
settlement that provides for any relief other than the payment of monetary damages, that provides for the payment of monetary damages
as to which the Indemnified Party shall not be indemnified in full pursuant to <U>Section&nbsp;9.2</U>, or that does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect
to such claim or litigation). The Indemnifying Party shall have full control of such defense and proceedings, including any compromise
or settlement <U>thereof</U>; <U>provided</U>, however, that the Indemnified Party may, at the sole cost and expense of the Indemnified
Party, at any time prior to the Indemnifying Party&rsquo;s delivery of the notice referred to in the first sentence of this clause&nbsp;(i),
file any motion, answer or other pleadings or take any other action that the Indemnified Party reasonably believes to be necessary or
appropriate to protect its interests; and <U>provided</U>, <U>further</U>, that if requested by the Indemnifying Party, the Indemnified
Party will, at the sole cost and expense of the Indemnifying Party, provide reasonable cooperation to the Indemnifying Party in contesting
any Third Party Claim that the Indemnifying Party elects to contest. Counsel for the Indemnifying Party, who shall conduct the defense
of such Third Party Claim or any litigation resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not
be unreasonably withheld), and the Indemnified Party may participate in such defense at such party&rsquo;s expense unless (w) the Indemnifying
Party has agreed in writing to pay such fees or expenses, (x) the Indemnifying Party shall have failed to assume the defense of such claim
within a reasonable time after receipt of notice of such claim from the Indemnified Party hereunder and employ counsel reasonably satisfactory
to the Indemnified Party, (y) the Indemnified Party has reasonably concluded (based upon advice of its counsel) that there may be legal
defenses available to it or other indemnified parties that are different from or in addition to those available to the Indemnifying Party,
or (z) in the reasonable judgment of any such person (based upon advice of its counsel) a conflict of interest may exist between such
person and the Indemnifying Party with respect to such claims (in which case, if the person notifies the Indemnifying Party in writing
that such person elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the
right to assume the defense of such claim on behalf of such person). Notwithstanding the foregoing, the Indemnified Party may take over
the control of the defense or settlement of a Third Party Claim at any time if it irrevocably waives its right to indemnity under <U>Section&nbsp;9.2</U>
with respect to such Third Party Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) If
the Indemnifying Party fails to notify the Indemnified Party within the Dispute Period that the Indemnifying Party desires to defend the
Third Party Claim pursuant to <U>Section&nbsp;9.3(a)</U>, or if the Indemnifying Party gives such notice but fails to prosecute vigorously
and diligently or settle the Third Party Claim, or if the Indemnifying Party fails to give any notice whatsoever within the Dispute Period,
then the Indemnified Party shall have the right to defend, at the sole cost and expense of the Indemnifying Party, the Third Party Claim
by all appropriate proceedings, which proceedings shall be prosecuted by the Indemnified Party in a reasonable manner and in good faith
or will be settled at the discretion of the Indemnified Party (with the consent of the Indemnifying Party, which consent will not be unreasonably
withheld). The Indemnified Party will have full control of such defense and proceedings, including any compromise or settlement thereof;
provided, however, that if requested by the Indemnified Party, the Indemnifying Party will, at the sole cost and expense of the Indemnifying
Party, provide reasonable cooperation to the Indemnified Party and its counsel in contesting any Third Party Claim which the Indemnified
Party is contesting. Notwithstanding the foregoing provisions of this clause&nbsp;(ii), if the Indemnifying Party has notified the Indemnified
Party within the Dispute Period that the Indemnifying Party disputes its liability or the amount of its liability hereunder to the Indemnified
Party with respect to such Third Party Claim and if such dispute is resolved in favor of the Indemnifying Party in the manner provided
in clause&nbsp;(iii) below, the Indemnifying Party will not be required to bear the costs and expenses of the Indemnified Party&rsquo;s
defense pursuant to this clause&nbsp;(ii) or of the Indemnifying Party&rsquo;s participation therein at the Indemnified Party&rsquo;s
request, and the Indemnified Party shall reimburse the Indemnifying Party in full for all reasonable costs and expenses incurred by the
Indemnifying Party in connection with such litigation. The Indemnifying Party may participate in, but not control, any defense or settlement
controlled by the Indemnified Party pursuant to this clause&nbsp;(ii), and the Indemnifying Party shall bear its own costs and expenses
with respect to such participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(ii) If
the Indemnifying Party notifies the Indemnified Party that it does not dispute its liability or the amount of its liability to the Indemnified
Party with respect to the Third Party Claim under <U>Section&nbsp;9.2</U> or fails to notify the Indemnified Party within the Dispute
Period whether the Indemnifying Party disputes its liability or the amount of its liability to the Indemnified Party with respect to such
Third Party Claim, the amount of Damages specified in the Claim Notice shall be conclusively deemed a liability of the Indemnifying Party
under <U>Section&nbsp;9.2</U> and the Indemnifying Party shall pay the amount of such Damages to the Indemnified Party on demand. If the
Indemnifying Party has timely disputed its liability or the amount of its liability with respect to such claim, the Indemnifying Party
and the Indemnified Party shall proceed in good faith to negotiate a resolution of such dispute; <U>provided</U>, <U>however</U>, that
if the dispute is not resolved within thirty (30)&nbsp;days after the Claim Notice, the Indemnifying Party shall be entitled to institute
such legal action as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If
any Indemnified Party should have a claim under <U>Section&nbsp;9.2</U> against the Indemnifying Party that does not involve a Third Party
Claim, the Indemnified Party shall deliver a written notification of a claim for indemnity under <U>Section&nbsp;9.2</U> specifying the
nature of and basis for such claim, together with the amount or, if not then reasonably ascertainable, the estimated amount, determined
in good faith, of such claim (an &ldquo;<B><U>Indemnity Notice</U></B>&rdquo;) with reasonable promptness to the Indemnifying Party. The
failure by any Indemnified Party to give the Indemnity Notice shall not impair such party&rsquo;s rights hereunder except to the extent
that the Indemnifying Party demonstrates that it has been irreparably prejudiced thereby. If the Indemnifying Party notifies the Indemnified
Party that it does not dispute the claim or the amount of the claim described in such Indemnity Notice or fails to notify the Indemnified
Party within the Dispute Period whether the Indemnifying Party disputes the claim or the amount of the claim described in such Indemnity
Notice, the amount of Damages specified in the Indemnity Notice will be conclusively deemed a liability of the Indemnifying Party under
<U>Section&nbsp;9.2</U> and the Indemnifying Party shall pay the amount of such Damages to the Indemnified Party on demand. If the Indemnifying
Party has timely disputed its liability or the amount of its liability with respect to such claim, the Indemnifying Party and the Indemnified
Party shall proceed in good faith to negotiate a resolution of such dispute; provided, however, that if the dispute is not resolved within
thirty (30)&nbsp;days after the Claim Notice, the Indemnifying Party shall be entitled to institute such legal action as it deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) The
Indemnifying Party agrees to pay the Indemnified Party, promptly as such expenses are incurred and are due and payable, for any reasonable
legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Third Party Claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) The
indemnity provisions contained herein shall be in addition to (i)&nbsp;any cause of action or similar rights of the Indemnified Party
against the Indemnifying Party or others, and (ii)&nbsp;any liabilities to which the Indemnifying Party may be subject.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">Article
X<BR>
MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.1 <U>GOVERNING
LAW; JURISDICTION</U></B>. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without
regard to the principles of conflicts of law.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.2 <U>JURY TRIAL
WAIVER</U></B>. The Company and the Investor hereby waive a trial by jury in any action, proceeding or counterclaim brought by either
of the parties hereto against the other in respect of any matter arising out of or in connection with the Transaction Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.3 <U>ASSIGNMENT</U></B>.
The Transaction Documents shall be binding upon and inure to the benefit of the Company and the Investor and their respective successors.
Neither this Agreement nor any rights of the Investor or the Company hereunder may be assigned by either party to any other Person.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.4 <U>NO THIRD-PARTY
BENEFICIARIES</U></B>. This Agreement is intended for the benefit of the Company and the Investor and their respective successors, and
is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as contemplated by <U>Article&nbsp;IX</U>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.5 <U>TERMINATION</U></B>.
The Company may terminate this Agreement at any time, which shall be effected by written notice being sent by the Company to the Investor.
In addition, this Agreement shall automatically terminate on the earlier of (i)&nbsp;the end of the Commitment Period or (ii)&nbsp;the
date that, pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a
proceeding against the Company, a Custodian is appointed for the Company or for all or substantially all of its property or the Company
makes a general assignment for the benefit of its creditors. Notwithstanding the foregoing, the provisions of <U>Articles&nbsp;III</U>,
<U>IV</U>, <U>V</U>, <U>VI</U>, <U>IX</U> and the agreements and covenants of the Company and the Investor set forth in this <U>Article&nbsp;X</U>
shall survive the termination of this Agreement; provided, however, that if this Agreement is terminated at any time on or after the
Effective Date, Section 6.1 shall automatically terminate on the date that is six (6) months after the later of (A) the date on which
Shareholder Approval is obtained and (B) the date on which the Registration Statement is deemed effective by the SEC; provided further,
however, that if this Agreement is terminated prior to the Effective Date, <U>Section 6.4</U> shall not survive the termination of this
Agreement. For avoidance of doubt, Section 6.4 shall survive the termination of this Agreement if this Agreement is terminated on or
after the Effective Date.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.6 <U>ENTIRE
AGREEMENT</U></B>. The Transaction Documents, together with the exhibits thereto, contain the entire understanding of the Company and
the Investor with respect to the matters covered herein and therein and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents and exhibits.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.7 <U>FEES AND
EXPENSES</U></B>. Except as expressly set forth in the Transaction Documents or any other writing to the contrary, each party shall pay
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement. Notwithstanding the foregoing, the Parties
agree that Document Preparation Fee shall be deducted from the applicable Purchase Investment Amount to be paid by the Investor to the
Company for the Purchase Notice Shares, pursuant to the first Purchase Notice delivered pursuant to this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.8 <U>COUNTERPARTS</U></B>.
The Transaction Documents may be executed in multiple counterparts, each of which may be executed by less than all of the parties, all
of which together will constitute one instrument, will be deemed to be an original, and will be enforceable against the parties. The
Transaction Documents may be delivered to the other party hereto by email of a copy of the Transaction Documents bearing the signature
of the party so delivering the Transaction Documents. The parties agree that this Agreement shall be considered signed when the signature
of a party is delivered by .PDF, DocuSign or other generally accepted electronic signature. Such .PDF, DocuSign, or other generally accepted
electronic signature shall be treated in all respects as having the same effect as an original signature. The signatories to this Agreement
each represent and warrant that they are duly authorized by the parties with the power and authority to bind the parties to the terms
and conditions thereof.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.9 <U>SEVERABILITY</U></B>.
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void,
this Agreement shall continue in full force and effect without said provision; provided that such severability shall be ineffective if
it materially changes the economic benefit of this Agreement to any party.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.10 <U>FURTHER
ASSURANCES</U></B>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments, and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.11 <U>NO STRICT
CONSTRUCTION</U></B>. The Parties acknowledge that they have had an adequate opportunity to review each and every provision contained
in this Agreement and to submit the same to legal counsel for review and comment. The parties agree with each and every provision contained
in this Agreement and agree that the rule of construction that a contract be construed against the drafter, if any, shall not be applied
in the interpretation and construction of this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.12 <U>EQUITABLE
RELIEF</U></B>. The Company recognizes that if it fails to perform, observe, or discharge any or all of its obligations under this Agreement,
any remedy at law may prove to be inadequate relief to the Investor. The Company therefore agrees that the Investor shall be entitled
to temporary and permanent injunctive relief in any such case without the necessity of proving actual damages. In addition to being entitled
to exercise all rights provided herein or granted by law, both parties will be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of
obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance
of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.13 <U>TITLE
AND SUBTITLES</U></B>. The titles and subtitles used in this Agreement are used for the convenience of reference and are not to be considered
in construing or interpreting this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.14 <U>AMENDMENTS;
WAIVERS</U></B>. No provision of this Agreement may be amended or waived by the parties from and after the date that is one (1)&nbsp;Business
Day immediately preceding the initial filing of the prospectus to the Registration Statement with the SEC. Subject to the immediately
preceding sentence, (i)&nbsp;no provision of this Agreement may be amended other than by a written instrument signed by both parties
hereto, and (ii)&nbsp;no provision of this Agreement may be waived other than in a written instrument signed by the party against whom
enforcement of such waiver is sought. No failure or delay in the exercise of any power, right, or privilege hereunder shall operate as
a waiver thereof, nor shall any single or partial exercise of any such power, right, or privilege preclude other or further exercise
thereof or of any other right, power, or privilege.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.15 <U>PUBLICITY</U></B>.
The Company and the Investor shall consult with each other in issuing any press releases or otherwise making public statements with respect
to the transactions contemplated hereby and no party shall issue any such press release or otherwise make any such public statement,
other than as required by law, without the prior written consent of the other parties, which consent shall not be unreasonably withheld
or delayed, except that no prior consent shall be required if such disclosure is required by law, in which such case the disclosing party
shall provide the other party with prior notice of such public statement. Notwithstanding the foregoing, the Company shall not publicly
disclose the name of the Investor without the prior written consent of the Investor, except to the extent required by law. The Investor
acknowledges that the Transaction Documents may be deemed to be &ldquo;<U>material contracts</U>,&rdquo; as that term is defined by Item
601(b)(10) of Regulation S-K, and that the Company may therefore be required to file such documents as exhibits to reports or registration
statements filed under the Securities Act or the Exchange Act. The Investor further agrees that the status of such documents and materials
as material contracts shall be determined solely by the Company, in consultation with its counsel.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.16 <U>DISPUTE
RESOLUTION</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a) <U>GOVERNANCE OF ALL
DISPUTES</U></B>. The parties recognize that disagreements as to certain matters may from time to time arise out of these Transaction
Documents. The parties agree that any disagreements that arise from these Transaction Documents are to be governed in accordance with
this <U>Section 10.16.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b) <U>SUBMISSION TO DISPUTE
RESOLUTION</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) In
the case of a dispute relating to the Average Daily Trading Volume, Purchase Notice Limit, VWAP, or highest or lowest traded price (as
the case may be) (including, without limitation, a dispute relating to the determination of any of the foregoing), the Company or the
Investor (as the case may be) shall submit the dispute to the other party via facsimile or electronic mail (A)&nbsp;if by the Company,
within two (2)&nbsp;Business Days after the occurrence of the circumstances giving rise to such dispute or (B)&nbsp;if by the Investor
at any time after the Investor learned of the circumstances giving rise to such dispute. If the Investor and the Company are unable to
promptly resolve such dispute relating to such Average Daily Trading Volume, Purchase Notice Limit, VWAP, or highest or lowest traded
price (as the case may be), at any time after the second (2nd)&nbsp;Business Day following such initial notice by the Company or the Investor
(as the case may be) of such dispute to the Company or the Investor (as the case may be), then the Company and the Investor may select
an independent, reputable investment bank as mutually agreed upon to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(ii) The
Investor and the Company shall each deliver to such investment bank (A)&nbsp;a copy of the initial dispute submission so delivered in
accordance with the first sentence of this <U>Section&nbsp;10.16</U> and (B)&nbsp;written documentation supporting its position with respect
to such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5th)&nbsp;Business Day immediately following the
date on which such investment bank was selected (the &ldquo;<B><U>Dispute Submission Deadline</U></B>&rdquo;) (the documents referred
to in the immediately preceding clauses&nbsp;(A) and (B) are collectively referred to herein as the &ldquo;<B><U>Required Dispute Documentation</U></B>&rdquo;)
(it being understood and agreed that if either the Investor or the Company fails to so deliver all of the Required Dispute Documentation
by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be
entitled to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with
respect to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was
delivered to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company
and the Investor or otherwise requested by such investment bank, neither the Company nor the Investor shall be entitled to deliver or
submit any written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute
Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 120.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(iii) The
Company and the Investor shall cause such investment bank to determine the resolution of such dispute and notify the Company and the Investor
of such resolution no later than ten (10)&nbsp;Business Days immediately following the Dispute Submission Deadline. The fees and expenses
of such investment bank shall be borne by the losing party, and such investment bank&rsquo;s resolution of such dispute shall be final
and binding upon all parties absent manifest error. The terms of this Agreement, each other applicable Transaction Document, and the Required
Dispute Documentation shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment
bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment bank
determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving such dispute
such investment bank shall apply such findings, determinations and the like to the terms of this Agreement and any other applicable Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c) <FONT STYLE="text-transform: uppercase"><U>Good
Faith Attempt To Resolve Other Disputes</U></FONT></B>. If either the Company or the Investor believes that a dispute not covered by
Section 10.16(b) has arisen under these Transaction Documents, that party, prior to commencing arbitration, must provided the other side
with written notice detailing the nature of the alleged dispute. Upon receipt of such written notice, the parties are required to engage
in good faith negotiations in an attempt to resolve the dispute for a period of not less than fourteen (14) days, such time as may be
extended by mutual agreement of the parties. If the Company and the Investor are unable to resolve such dispute within that fourteen
(14) day period (or any period of extension as agreed by the parties), then either party may pursue resolution of the dispute pursuant
to Section 10.16(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d) <U>ARBITRATION</U></B>.
Any dispute, controversy, difference or claim that may arise between the Company and the Investor in connection with these Transaction
Documents (including, without limitation, any claim that, for whatever reason, was not resolved by the procedures of Section 10.16(b);
and all claims arising out of or relating to the validity, construction, interpretation, enforceability, breach, performance, application
or termination of these Transaction Documents), shall be submitted to binding arbitration to be held in New York, New York, in accordance
with <FONT STYLE="font-family: Times New Roman, Times, Serif">the rules and protocols of the New York International Arbitration Center</FONT>.
There shall be only one arbitrator selected in accordance with the rules and <FONT STYLE="font-family: Times New Roman, Times, Serif">protocols
of the New York International Arbitration Center</FONT>. The arbitration shall be conducted in English and may be conducted in a virtual
setting. The arbitrator&rsquo;s decision shall be final and binding and judgment may be entered thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e) <U>COSTS AND AWARD</U></B>.
Each side must bear its own costs and legal fees during the pendency of the arbitration. A party&rsquo;s failure to pay any costs or
fees required to proceed in the arbitration, as they timely come due, shall result in an immediate default against that party. The prevailing
party in the arbitration shall be entitled to recoup all its reasonable attorneys&rsquo; fees and costs from the nonprevailing, including,
without limitation, all of its costs relating to the arbitration, excluding only the costs incurred in connection with the procedures
of Section 10.16(b). The arbitrator&rsquo;s final award shall include this assessment of costs and fees. That award also shall include
interest from the date of any damages incurred for breach of these Transaction Documents, and from the date of the award until paid in
full assessed at the prevailing statutory rate. The nonprevailing party must promptly pay that award in U.S. dollars, free of any tax,
deduction or offset. Further, in the event a party fails to proceed with arbitration, unsuccessfully challenges the arbitrator&rsquo;s
award, or fails to comply with the arbitrator&rsquo;s award, the other party is entitled to all costs of suit including all reasonable
attorneys&rsquo; fees and costs incurred in respect to any of these further actions. With respect to damages, the only damages recoverable
under these Transaction Documents are compensatory; both the Company and the Investor expressly disclaim the right to seek punitive or
other exemplary damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f) <U>INJUNCTIVE RELIEF</U></B>.
Provided a party has made a sufficient showing under applicable law, the arbitrator shall have the power and authority to invoke, and
the parties agree to abide by, equitable relief or interim or provisional relief from the abritrator, including a temporary restraining
order, preliminary injunction, or other interim or permanent equitable relief. Additionally, nothing in this Section 10.16 shall preclude
either party from seeking equitable relief or interim or provisional relief from a court of competent jurisdiction, including a temporary
restraining order, preliminary injunction, or other interim or permanent equitable relief, concerning a dispute either prior to or during
arbitration if necessary to protect the interests of such party or to preserve the status quo pending the arbitration proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g) <FONT STYLE="text-transform: uppercase"><U>Confidentiality</U></FONT></B>.
The arbitration proceeding and subsequent award shall be confidential. The arbitrator shall issue appropriate protective orders to safeguard
each party&rsquo;s confidential information. Except as required by law (or if necessary to enforce the award), including without limitation
securities regulations, neither party is to make any public announcement with respect to the proceedings or decision of the arbitrator
without the prior written consent of the other party. The existence of any dispute submitted to arbitration, and the award, shall be
kept in confidence by the parties thereto and the arbitrator, except as required in connection with the enforcement of such an award
or as otherwise required by law.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 10.17 <U>NOTICES</U></B>.
All notices, demands, requests, consents, waivers, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (a)&nbsp;personally served, (b)&nbsp;delivered by reputable air courier service with
charges prepaid next Business Day delivery, or (c)&nbsp;transmitted by hand delivery, or email as a PDF, addressed as set forth below
or to such other address as such party shall have specified most recently by written notice given in accordance herewith. Any notice
or other communication required or permitted to be given hereunder shall be deemed effective upon hand delivery or delivery by email
at the address designated below (if delivered on a business day during normal business hours where such notice is to be received), or
the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice
is to be received).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The addresses for such communications
shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>If to the Company</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Actelis Networks Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">4039 Clipper Court</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Fremont, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Yoav Efron, Chief Financial Officer and Deputy
Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: yoave@actelis.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy (not constituting notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Eyal Peled, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Greenberg Traurig, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">One Vanderbilt Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: eyal.peled@gtlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>If to the Investor</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">WHITE LION CAPITAL LLC<BR>
21031 Ventura Blvd., Suite 920<BR>
Encino, CA 91316<BR>
Attention: Nathan Yee, Managing Director<BR>
E-mail: team@whitelioncapital.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">With a copy (not constituting notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Marc A. Indeglia, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Glaser Weil Fink Howard Jordan &amp; Shapiro LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">10250 Constellation Boulevard, 19<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Los Angeles, CA 90067</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: mindeglia@glaserweil.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Either party hereto may from
time to time change its address or email for notices under this <U>Section&nbsp;10.17</U> by giving prior written notice of such changed
address to the other party hereto.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>** Signature Page Follows **</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>IN WITNESS WHEREOF</B>, the
parties have caused this Agreement to be duly executed by their respective officers thereunto duly authorized as of the Signing Date,
such Agreement being effective as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><B>Actelis Networks Inc</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">By:</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:&nbsp;</TD><TD STYLE="text-align: justify">Tuvia Barlev</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left"><B>White Lion Capital LLC</B></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">By:</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:</TD><TD STYLE="text-align: justify">Nathan Yee</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">Managing Director</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT A</U><BR>
<BR>
FORM OF RAPID PURCHASE NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: WHITE LION CAPITAL LLC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We refer to the Common Stock Purchase
Agreement, dated as of September 27, 2025, (the &ldquo;<B><U>Agreement</U></B>&rdquo;), entered into by and between Actelis Networks Inc.,
and White Lion Capital LLC. Capitalized terms defined in the Agreement shall, unless otherwise defined herein, have the same meaning when
used herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">Give you notice that we require you to purchase __________ Purchase Notice Shares at the Rapid Purchase
Price Option below; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">Rapid Purchase Price Option 1: __</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">Rapid Purchase Price Option 2: __</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">2)</TD><TD STYLE="text-align: justify">Certify that, as of the date hereof, the conditions set forth
in <U>Section&nbsp;7</U> of the Agreement are satisfied.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><B>Actelis Networks Inc</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">By:</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:</TD><TD STYLE="text-align: justify"></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify"></TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT B</U><BR>
<BR>
FORM OF REGULAR PURCHASE NOTICE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: WHITE LION CAPITAL LLC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We refer to the Common Stock Purchase
Agreement, dated as of September 27, 2025, (the &ldquo;<B><U>Agreement</U></B>&rdquo;), entered into by and between Actelis Networks Inc.,
and White Lion Capital LLC. Capitalized terms defined in the Agreement shall, unless otherwise defined herein, have the same meaning when
used herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">Give you notice that we require you to purchase __________ Purchase Notice Shares at the Regular Purchase
Price; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">2)</TD><TD STYLE="text-align: justify">Certify that, as of the date hereof, the conditions set forth
in <U>Section&nbsp;7</U> of the Agreement are satisfied.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><B>Actelis Networks Inc</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 60%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">By:</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Name:</TD><TD STYLE="text-align: justify"></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify"></TD></TR>
     </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT C</U></B><BR>
<BR>
REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT D</U></B><BR>
<BR>
<FONT STYLE="text-transform: uppercase; background-color: white">Irrevocable Transfer Agent Instructions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">33</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea025980401ex10-2_actelis.htm
<DESCRIPTION>FORM OF WHITE LION RRA
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into effective as of September 26, 2025 (the &ldquo;<B><I>Execution Date</I></B>&rdquo;),
by and between Actelis Networks Inc, a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), and White Lion Capital, LLC, a
Nevada limited liability company (the &ldquo;<B><I>Investor</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A.
WHEREAS, in connection with the Common Stock Purchase Agreement, dated as of September 26, 2025, by and between the Company and the Investor
(the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;), the Company may issue and sell to the Investor, from time to time, and the Investor
shall purchase from the Company, up to $30,000,000 in aggregate gross purchase price of newly issued Purchase Notice Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">B.
WHEREAS, in consideration for the Investor&rsquo;s execution and delivery of the Purchase Agreement, the Company shall issue to the Investor
the &ldquo;<B><I>Commitment Shares</I></B>&rdquo;) (as defined in the Purchase Agreement),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">C.
WHEREAS, in connection with the Securities Purchase Agreement, dated as of September 26, 2025, by and between the Company and the Investor
(the &ldquo;<B><I>Securities Purchase Agreement</I></B>&rdquo;), the Company has agreed, upon the terms and subject to the conditions
of the Securities Purchase Agreement, to issue and sell to the Investor $850,000 of shares of Common Stock (the &ldquo;<B><I>SPA Shares</I></B>&rdquo;);
provided, however, that, to the extent that the Investor determines that the Investor (together with the Investor&rsquo;s Affiliates,
and any Person acting as a group together with the Investor or any of the Investor&rsquo;s Affiliates) would beneficially own in excess
of the &ldquo;<B><I>Beneficial Ownership Limitation</I></B>&rdquo; (as defined in the Securities Purchase Agreement), or as the Investor
may otherwise choose, in lieu of purchasing SPA Shares, the Investor shall purchase &ldquo;<B><I>Prefunded Warrants</I></B>&rdquo; (as
defined in the Securities Purchase Agreement) in lieu of SPA Shares in such manner to result in the same aggregate purchase price being
paid by such Investor to the Company, and such Prefunded Warrants will be exercisable to purchase &ldquo;<B><I>Prefunded Warrant Shares</I></B>&rdquo;
(as defined in the Securities Purchase Agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">D.
WHEREAS, pursuant to the terms of, and in consideration for the Investor entering into the Purchase Agreement and the Securities Purchase
Agreement, and to induce the Investor to execute and deliver the Purchase Agreement and the Securities Purchase Agreement, the Company
has agreed to provide the Investor with certain registration rights with respect to the Registrable Securities (as defined herein) as
set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>NOW,
THEREFORE,</B>&nbsp;in consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase
Agreement and the Securities Purchase Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, intending to be legally bound hereby, the Company and the Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Definitions</U>.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement and the Securities
Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
&ldquo;<B><I>Agreement</I></B>&rdquo; shall have the meaning assigned to such term in the preamble of this Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
&ldquo;<B><I>Allowable Grace Period</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;3(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
&ldquo;<B><I>Blue Sky Filing</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
&ldquo;<B><I>Business Day</I></B>&rdquo; means any day other than Saturday, Sunday or any other day on which commercial banks in New York,
New York are authorized or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(e)
&ldquo;<B><I>Claims</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<B><I>Commission</I></B>&rdquo;
means the U.S. Securities and Exchange Commission or any successor entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(g)
&ldquo;<B><I>Company</I></B>&rdquo; shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(h)
&ldquo;<B><I>Effective Date</I></B>&rdquo; means the date that the applicable Registration Statement has been declared effective by the
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(i)
&ldquo;<B><I>Indemnified Damages</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(j)
&ldquo;<B><I>Initial Registration Statement</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(k)
&ldquo;<B><I>Investor</I></B>&rdquo; shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(l)
&ldquo;<B><I>Investor Party</I></B>&rdquo; and &ldquo;<B><I>Investor Parties</I></B>&rdquo; shall have the meaning assigned to such terms
in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(m)
&ldquo;<B><I>Legal Counsel</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(n)
&ldquo;<B><I>New Registration Statement</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(o)
&ldquo;<B><I>Common Stock</I></B>&rdquo; shall have the meaning assigned to such term in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(p)
&ldquo;<B><I>Person</I></B>&rdquo; means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership,
limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(q)
&ldquo;<B><I>Prospectus</I></B>&rdquo; means the prospectus in the form included in the Registration Statement at the applicable Effective
Date of the Registration Statement, as supplemented from time to time by any Prospectus Supplement, including the documents incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(r)
&ldquo;<B><I>Prospectus Supplement</I></B>&rdquo; means any prospectus supplement to the Prospectus filed with the Commission from time
to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(s)
&ldquo;<B><I>Purchase Agreement</I></B>&rdquo; shall have the meaning assigned to such term in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(t)
&ldquo;<B><I>register</I></B>,&rdquo; &ldquo;<B><I>registered</I></B>,&rdquo; and &ldquo;<B><I>registration</I></B>&rdquo; refer to a
registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant to
Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(u)
&ldquo;<B><I>Registrable Securities</I></B>&rdquo; means Common Stock representing (i)&nbsp;an aggregate of up to $30,000,000 Purchase
Notice Shares, (ii) the Commitment Shares, (iii) the SPA Shares, (iv) the Prefunded Warrant Shares, (v) any and all other Common Stock
issued or issuable to the Investor pursuant to the Purchase Agreement or the Securities Purchase Agreement, and (vi) any capital stock
of the Company issued or issuable with respect to the Purchase Notice Shares, the Commitment Shares, the SPA Shares, the Prefunded Warrant
Shares, or other capital stock, including, without limitation, (1)&nbsp;as a result of any stock split, stock dividend, recapitalization,
exchange or similar event or otherwise and (2)&nbsp;shares of capital stock of the Company into which the Common Stock are converted or
exchanged and shares of capital stock of a successor entity into which the shares of Common Stock are converted or exchanged, in each
case until such time as such securities cease to be Registrable Securities pursuant to <U>Section&nbsp;2(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(v)
&ldquo;<B><I>Registration Period</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(w)
&ldquo;<B><I>Registration Statement</I></B>&rdquo; means a registration statement or registration statements of the Company filed under
the Securities Act registering the resale by the Investor of Registrable Securities, including without limitation a New Registration Statement,
as such registration statement or registration statements may be amended and supplemented from time to time, including all documents filed
as part thereof or incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(x)
&ldquo;<B><I>Rule 144</I></B>&rdquo; means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(y)
&ldquo;<B><I>Rule 415</I></B>&rdquo; means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on a delayed
or continuous basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(z)
&ldquo;<B><I>Securities Purchase Agreement</I></B>&rdquo; shall have the meaning assigned to such term in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(aa)
&ldquo;<B><I>SPA Shares</I></B>&rdquo; shall have the meaning assigned to such term in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(bb)
&ldquo;<B><I>Staff</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(cc)
&ldquo;<B><I>Violations</I></B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B><U>Registration</U>.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)<B>&nbsp;<U>Mandatory
Registration</U>.</B> The Company shall, no later than five (5) Business Days following the Execution Date, file with the Commission an
initial Registration Statement on Form&nbsp;S-1&nbsp;(or any successor form) registering the resale by the Investor of the maximum number
of Registrable Securities as shall be permitted to be included thereon in accordance with applicable Commission rules, regulations and
interpretations (determined as of two Business Days prior to such submission or filing) so as to permit the resale of such Registrable
Securities by the Investor under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices) (the &ldquo;<B><I><U>Initial
Registration Statement</U></I></B>&rdquo;). The Initial Registration Statement shall contain a Prospectus describing the material terms
and conditions of the Purchase Agreement and the Securities Purchase Agreement, and disclosing all information relating to the transactions
contemplated thereby required to be disclosed in the Prospectus, including, without limitation, &ldquo;Selling Stockholder&rdquo; and
&ldquo;Plan of Distribution&rdquo; sections in substantially the forms approved in writing by the Investor, in order to conform, in all
material respects when filed with the Commission pursuant to Rule 424(b) under the Securities Act, and shall otherwise conform to the
requirements of the Securities Act and the rules and regulations thereunder. The Company shall use its commercially reasonable best efforts
to have the Initial Registration Statement declared effective by the Commission as soon as reasonably practicable following the filing
thereof with the Commission; <I>provided, however</I>, that the Company&rsquo;s obligations to include the Registrable Securities in the
Initial Registration Statement are contingent upon the Investor furnishing in writing to the Company such information, and executing such
documents, in connection with such registration as the Company may reasonably request in accordance with <U>Section 4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<B><U>Legal Counsel</U>.</B>
Subject to <U>Section&nbsp;5</U> hereof, the Investor shall have the right to select one legal counsel to review and oversee, solely on
its behalf, any registration pursuant to this <U>Section&nbsp;2</U> (&ldquo;<B><I><U>Legal Counsel</U></I></B>&rdquo;), which shall be
Glaser Weil Fink Howard Jordan &amp; Shapiro LLP, or such other counsel as thereafter designated by the Investor. The Company shall have
no obligation to reimburse the Investor for any legal fees and expenses of the Legal Counsel incurred in connection with the transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)&nbsp;<B><U>Sufficient
Number of Shares Registered</U>.</B> If at any time all Registrable Securities are not covered by the Initial Registration Statement filed
pursuant to <U>Section&nbsp;2(a)</U> as a result of <U>Section&nbsp;2(e)</U> or otherwise, or the Initial Registration Statement is no
longer effective, the Company shall use its commercially reasonable best efforts, to the extent necessary and permissible, amend the Initial
Registration Statement, cause an existing registration statement that has been filed but not declared effective by the Commission to become
effective, or to file with the Commission one or more additional Registration Statements (which, if the Company shall at such time have
qualified for the use of a Registration Statement on Form S-3 or any successor form thereto, may be Registration Statement(s) on Form
S-3 or any similar short-form Registration Statement in lieu of a Registration Statement on Form S-1) so as to cover all of the Registrable
Securities not covered by the Initial Registration Statement, in each case, as soon as practicable (taking into account any position of
the staff of the Commission (&ldquo;<B><I>Staff</I></B>&rdquo;) with respect to the date on which the Staff will permit such additional
Registration Statement(s) to be filed with the Commission and the rules and regulations of the Commission) (each such additional Registration
Statement, a &ldquo;<B><I>New Registration Statement</I></B>&rdquo;). The Company shall use its commercially reasonable best efforts to
cause each such New Registration Statement to become effective as soon as reasonably practicable following the filing thereof with the
Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)&nbsp;<B><U>No
Inclusion of Other Securities; Statutory Underwriter Status</U>.</B> In no event shall the Company include any securities other than Registrable
Securities on any Registration Statement pursuant to Section&nbsp;2(a) or Section&nbsp;2(c) without consulting the Investor and Legal
Counsel and receiving the written consent of the Investor, prior to filing such Registration Statement with the Commission. The Investor
acknowledges that it will be disclosed as an &ldquo;underwriter&rdquo; and a &ldquo;selling stockholder&rdquo; in each Registration Statement
and in any Prospectus contained therein to the extent required by applicable law and to the extent the Prospectus is related to the resale
of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(e)&nbsp;
<B><U>Offering</U>.</B> If the Staff or the Commission seeks to prevent the Company from including any or all of the Registrable Securities
proposed to be registered under a Registration Statement due to limitations on the use of Rule 415, or if after the filing of any Registration
Statement, or any Prospectus or Prospectus Supplement, pursuant to <U>Section&nbsp;2(a)</U> or <U>Section&nbsp;2(c)</U>, the Company is
otherwise required by the Staff or the Commission to reduce the number of Registrable Securities included in such Registration Statement,
then the Company shall reduce the number of Registrable Securities to be included in such Registration Statement (after consultation with
the Investor and Legal Counsel as to the specific Registrable Securities to be removed therefrom), to no more than the maximum number
of securities as is permitted to be registered by the Commission until such time as the Staff and the Commission shall so permit such
Registration Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary, if after
giving effect to the actions referred to in the immediately preceding sentence, the Staff or the Commission does not permit such Registration
Statement to become effective and be used for resales by the Investor of Registrable Securities on a delayed or continuous basis under
Rule 415 at then-prevailing market prices (and not fixed prices), the Company shall not request acceleration of the Effective Date of
such Registration Statement, the Company shall promptly (but in no event later than 48 hours) request the withdrawal of such Registration
Statement pursuant to Rule 477 under the Securities Act. In the event of any reduction in Registrable Securities pursuant to this paragraph,
the Company shall use its commercially reasonable best efforts to file one or more New Registration Statements with the Commission in
accordance with <U>Section&nbsp;2(c)</U> until such time as all Registrable Securities have been included in Registration Statements that
have been declared effective and the Prospectuses contained therein are available for use by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(f)
Any Registrable Security shall cease to be a &ldquo;Registrable Security&rdquo; at the earliest of the following: (i)&nbsp;when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement by the Investor; (ii)&nbsp;when such Registrable Security is
held by the Company or one of its Subsidiaries; (iii) such securities are sold by the Investor under circumstances in which all of the
applicable conditions of Rule 144 under the Securities Act are met and (iv) such securities become eligible for sale pursuant to Rule
144 without volume or manner-of-sale restrictions, without the requirement for the Company to be in compliance with the current public
information requirement under Rule 144(c) or Rule 144(i)(2) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(g)
<B><U>No Inclusion of Other Securities</U></B>. In no event shall the Company include any securities other than Registrable Securities
on any Registration Statement pursuant to Section&nbsp;2(a) or Section&nbsp;2(c) without consulting the Investor and Legal Counsel and
receiving the written consent of the Investor, prior to filing such Registration Statement with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><B><U>Related Obligations</U>. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the duration of the
Registration Period, the Company shall use its commercially reasonable best efforts to effect the registration of the Registrable Securities
in accordance with the intended method of disposition thereof, and, pursuant thereto, during the term of this Agreement, the Company shall
have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
Following the Execution Date, the Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant
to <U>Section&nbsp;2(a</U>) hereof and one or more New Registration Statements pursuant to <U>Section&nbsp;2(c)</U> hereof with respect
to the Registrable Securities, and the Company shall use its commercially reasonable best efforts to cause each such Registration Statement
to become effective as soon as practicable after such filing. Subject to Allowable Grace Periods, the Company shall use its commercially
reasonable best efforts to keep each Registration Statement effective (and the Prospectus contained therein available for use) pursuant
to Rule 415 for resales by the Investor of Registrable Securities on a continuous basis at then-prevailing market prices (and not fixed
prices) at all times until the earlier of (i)&nbsp;the date on which the Investor shall have sold all of the Registrable Securities covered
by such Registration Statement, (ii)&nbsp;the later of the date of termination of the Purchase Agreement and the date of the Securities
Purchase Agreement if as of such termination date the Investor holds no Registrable Securities (or, if applicable, the date on which such
securities cease to be Registrable Securities after the date of termination of the Purchase Agreement or the Securities Purchase Agreement,
as applicable) and (iii) all such securities cease to be Registrable Securities pursuant to Section 2(f)(iii) or Section 2(f)(iv) (the
&ldquo;<B><I><U>Registration Period</U></I></B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement (but subject
to the provisions of <U>Section&nbsp;3(o)</U> hereof), the Company shall ensure that, when filed and at all times while effective, each
Registration Statement (including, without limitation, all amendments and supplements thereto) and the Prospectus (including, without
limitation, all amendments and supplements thereto) used in connection with such Registration Statement shall not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the
case of Prospectuses, in light of the circumstances in which they were made) not misleading. The Company shall submit to the Commission,
as soon as reasonably practicable after the date that the Company learns that no review of a particular Registration Statement will be
made by the Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be), a request for
acceleration of effectiveness of such Registration Statement to a time and date as soon as reasonably practicable in accordance with Rule
461 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
Subject to <U>Section&nbsp;3(o)</U> of this Agreement, the Company shall use its commercially reasonable best efforts to prepare and file
with the Commission such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement
and the Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated
under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein
current and available for use) at all times during the Registration Period for such Registration Statement, and, during such period, comply
with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required to be
covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the Investor as set forth in such Registration Statement. Without limiting the generality
of the foregoing, the Company covenants and agrees that (i)&nbsp;on the second (2<SUP>nd</SUP>) Business Day immediately following the
Effective Date of the Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the
Company shall file with the Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection
with sales pursuant to such Registration Statement (or post-effective amendment thereto), and (ii)&nbsp;if the transactions contemplated
by any Purchase Notice are material to the Company (individually or collectively with all other prior Purchase Notices, the consummation
of which have not previously been reported in any Prospectus Supplement filed with the Commission under Rule 424(b) under the Securities
Act or in any report, statement or other document filed by the Company with the Commission under the Exchange Act), or if otherwise required
under the Securities Act (or the interpretations of the Commission thereof), in each case as reasonably determined by the Company and
the Investor, then, on the first (1<SUP>st</SUP>) Business Day immediately following the Closing Date, if a Purchase Notice was properly
delivered to the Investor hereunder in connection with such purchase, the Company shall file with the Commission<B>&nbsp;</B>a Prospectus
Supplement pursuant to Rule 424(b) under the Securities Act with respect to the purchase(s), the total purchase amount for the Purchase
Notice Shares subject to such purchase(s) (as applicable), the applicable Purchase Amount(s) for such Purchase Notice Shares and the net
proceeds that are to be (and, if applicable, have been) received by the Company from the sale of such Purchase Notice Shares. To the extent
not previously disclosed in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Annual Reports on Form&nbsp;10-K&nbsp;the
information described in the immediately preceding sentence relating to all purchase(s) consummated during the relevant fiscal quarter
and shall file such Quarterly Reports and Annual Reports with the Commission within the applicable time period prescribed for such report
under the Exchange Act. In the case of amendments and supplements to any Registration Statement on Form&nbsp;S-1, Form S-3&nbsp;or Prospectus
related thereto that are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this <U>Section&nbsp;3(b)</U>)
by reason of the Company filing a report on Form&nbsp;8-K,&nbsp;Form&nbsp;10-Q&nbsp;or&nbsp;Form&nbsp;10-K&nbsp;or any analogous report
under the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement and Prospectus,
if applicable and if such ability to incorporate such report by reference is available to the Company at such time, or shall file such
amendments or supplements to the Registration Statement or Prospectus with the Commission on the same day on which the Exchange Act report
is filed that created the requirement for the Company to amend or supplement such Registration Statement or Prospectus, for the purpose
of including or incorporating such report into such Registration Statement and Prospectus. The Company consents to the use of the Prospectus
(including, without limitation, any supplement thereto) included in each Registration Statement in accordance with the provisions of the
Securities Act and with the securities or &ldquo;Blue Sky&rdquo; laws of the jurisdictions in which the Registrable Securities may be
sold by the Investor, in connection with the resale of the Registrable Securities and for such period of time thereafter as such Prospectus
(including, without limitation, any supplement thereto) (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities
Act) is required by the Securities Act to be delivered in connection with resales of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
The Company shall (A)&nbsp;permit Legal Counsel an opportunity to review and comment upon (i)&nbsp;each Registration Statement at least
two (2)&nbsp;Business Days prior to its filing with the Commission and (ii)&nbsp;all amendments and supplements to each Registration Statement
(including, without limitation, the Prospectus contained therein) within a reasonable number of days prior to their filing with the Commission,
and (B)&nbsp;shall reasonably consider any comments of the Investor and Legal Counsel on any such Registration Statement or amendment
or supplement thereto or to any Prospectus contained therein; provided, that the Company shall not have any obligation to modify any information
if the Company expects that so doing would cause (i) the Registration Statement to contain an untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) the Prospectus
to contain an untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made,
in light of the circumstances under which they were made, not misleading. The Company shall promptly furnish to Legal Counsel, without
charge, (i)&nbsp;electronic copies of any correspondence from the Commission or the Staff to the Company or its representatives relating
to each Registration Statement (which correspondence shall be redacted to exclude any material&nbsp;nonpublic&nbsp;information regarding
the Company or any of its Subsidiaries), (ii)&nbsp;after the same is prepared and filed with the Commission, one (1)&nbsp;electronic copy
of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation, all documents incorporated
therein by reference, if requested by the Investor, and (iii)&nbsp;upon the effectiveness of each Registration Statement, one (1)&nbsp;electronic
copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto; provided, however, the Company
shall not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to Legal Counsel to the
extent such document is available on Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval System (&ldquo;<B><I><U>EDGAR</U></I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
Without limiting any obligation of the Company under the Purchase Agreement or the Securities Purchase Agreement, the Company shall promptly
furnish to the Investor, without charge, (i)&nbsp;after the same is prepared and filed with the Commission, at least one (1)&nbsp;electronic
copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation, all documents incorporated
therein by reference, if requested by the Investor, (ii)&nbsp;upon the effectiveness of each Registration Statement, one (1)&nbsp;electronic
copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto and (iii)&nbsp;such other documents,
including, without limitation, copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request
from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the Company
shall not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the
extent such document is available on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(e)
The Company shall take such action as is reasonably necessary to (i)&nbsp;register and qualify, unless an exemption from registration
and qualification applies, the resale by the Investor of the Registrable Securities, under such other securities or &ldquo;Blue Sky&rdquo;
laws of all applicable jurisdictions in the United States, (ii)&nbsp;prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii)&nbsp;take such other actions as may be reasonably necessary to maintain
such registrations and qualifications in effect at all times during the Registration Period, and (iv)&nbsp;take all other actions reasonably
necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
the Company shall not be required in connection therewith or as a condition thereto to (x)&nbsp;qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this <U>Section&nbsp;3(e)</U>, (y) subject itself to general taxation in any
such jurisdiction, or (z)&nbsp;file a general consent to service of process in any such jurisdiction. The Company shall promptly notify
Legal Counsel and the Investor of the receipt by the Company of any notification with respect to the suspension of the registration or
qualification of any of the Registrable Securities for sale under the securities or &ldquo;Blue Sky&rdquo; laws of any jurisdiction in
the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(f)
The Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable
after becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (provided, that in no event shall such notice contain
any material nonpublic information regarding the Company or any of its Subsidiaries), and, subject to <U>Section 3(o)</U>, promptly prepare
a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct such untrue statement or omission.
The Company shall also promptly notify Legal Counsel and the Investor in writing (i)&nbsp;when a Prospectus or any Prospectus Supplement
or post-effective amendment has been filed, when a Registration Statement or any post-effective amendment has become effective (notification
of such effectiveness shall be delivered to Legal Counsel and the Investor by facsimile or&nbsp;e-mail&nbsp;(with read receipt) on the
same day of such effectiveness), and when the Company receives written notice from the Commission that a Registration Statement or any
post-effective amendment will be reviewed by the Commission, (ii)&nbsp;of any request by the Commission for amendments or supplements
to a Registration Statement or related Prospectus or related information, (iii)&nbsp;of the Company&rsquo;s reasonable determination that
a post-effective amendment to a Registration Statement would be appropriate and (iv)&nbsp;of the receipt of any request by the Commission
or any other federal or state governmental authority for any additional information relating to the Registration Statement or any amendment
or supplement thereto or any related Prospectus. The Company shall respond as promptly as reasonably practicable to any comments received
from the Commission with respect to a Registration Statement or any amendment thereto. Nothing in this <U>Section&nbsp;3(f)</U> shall
limit any obligation of the Company under the Purchase Agreement or the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(g)
The Company shall (i)&nbsp;use its commercially reasonable best efforts to prevent the issuance of any stop order or other suspension
of effectiveness of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or
the loss of an exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or
suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii)&nbsp;notify Legal Counsel
and the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat
of any proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(h)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i)&nbsp;disclosure of such information is necessary to comply with federal or state securities laws, (ii)&nbsp;the disclosure of such
information is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed
in such Registration Statement pursuant to the Securities Act, (iii)&nbsp;the release of such information is ordered pursuant to a subpoena
or other final,&nbsp;non-appealable&nbsp;order from a court or governmental body of competent jurisdiction, or (iv)&nbsp;such information
has been made generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document.
The Company agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court
or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor,
at the Investor&rsquo;s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(i)
Without limiting any obligation of the Company under the Purchase Agreement or the Securities Purchase Agreement, the Company shall use
its commercially reasonable best efforts either to (i)&nbsp;cause all of the Registrable Securities covered by each Registration Statement
to be listed on the Principal Market, or (ii)&nbsp;secure designation and quotation of all of the Registrable Securities covered by each
Registration Statement on another Principal Market. The Company shall pay all fees and expenses in connection with satisfying its obligation
under this <U>Section&nbsp;3(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(j)
The Company shall cooperate with the Investor and, to the extent applicable, use its commercially reasonable best efforts to facilitate
the timely preparation and delivery of Registrable Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and
enable such DWAC Shares to be in such denominations or amounts (as the case may be) as the Investor may reasonably request from time to
time. Investor hereby agrees that it shall cooperate with the Company, its counsel and Transfer Agent in connection with any issuances
of DWAC Shares, and hereby represents, warrants and covenants to the Company that that it will resell such DWAC Shares only pursuant to
the Registration Statement in which such DWAC Shares are included, in a manner described under the caption &ldquo;Plan of Distribution&rdquo;
in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations,
including, without limitation, any applicable prospectus delivery requirements of the Securities Act. At the time such DWAC Shares are
offered and sold pursuant to the Registration Statement, such DWAC Shares shall be free from all restrictive legends (except as otherwise
required by applicable federal laws) and may be transmitted by the transfer agent to the Investor by crediting an account at DTC as directed
in writing by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(k)
Upon the written request of the Investor, the Company shall, as soon as reasonably practicable after receipt of notice from the Investor,
and subject to <U>Section&nbsp;3(o)</U> hereof, (i)&nbsp;incorporate in a Prospectus Supplement or post-effective amendment such information
as the Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including,
without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid
therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii)&nbsp;make all required filings
of such Prospectus Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement
or post-effective amendment; and (iii)&nbsp;supplement or make amendments to any Registration Statement or Prospectus contained therein
if reasonably requested by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(l)
<I>[Reserved]</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(m)
The Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90)&nbsp;days after the close of the period covered thereby, an earnings statement (in
form complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period
beginning not later than the first day of the Company&rsquo;s fiscal quarter next following the applicable Effective Date of each Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(n)
The Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(o)
Notwithstanding anything to the contrary contained herein (but subject to the last sentence of this <U>Section 3(o)</U>), at any time,
the Company may, upon written notice to Investor, delay the filing or effectiveness of any Registration Statement, or suspend Investor&rsquo;s
use of any Prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable
Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of Registrable
Securities) if the Company determines that in order for such Registration Statement or Prospectus not to contain a material misstatement
or omission, (i) an amendment or supplement thereto would be needed to include information at that time, (ii) the negotiation or consummation
of a transaction by the Company or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event the
Company&rsquo;s board of directors reasonably believes would require additional disclosure by the Company in such Registration Statement
or Prospectus of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure
of which in such Registration Statement or Prospectus would be expected, in the reasonable determination of the Company&rsquo;s board
of directors, to cause such Registration Statement or Prospectus to fail to comply with applicable disclosure requirements of the Commission,
or (iii) in the good faith judgment of the majority of the members of the Company&rsquo;s board of directors, such filing or effectiveness
or use of such Registration Statement or Prospectus, as applicable, would be materially detrimental to the Company and, as a result, that
it is essential to defer such filing, effectiveness or use (each, an &ldquo;<B><I><U>Allowable Grace Period</U></I></B><U>&rdquo;);</U>
<I>provided, however</I>, that in no event shall the Company delay or suspend the filing, effectiveness, or use of any Registration Statement
or Prospectus for a period that exceeds 45 consecutive Business Days or an aggregate of 90 total Business Days in any 365-day period;
and <I>provided, further</I>, the Company shall not effect any such suspension during the applicable valuation period following the applicable
purchase notice date for any Purchase Notice Shares. Upon disclosure of such information or the termination of the condition described
above, the Company shall provide prompt notice, but in any event within one Business Day of such disclosure or termination, to the Investor
and shall promptly terminate any suspension or delay it has put into effect and shall take such other reasonable actions to permit registered
sales of Registrable Securities as contemplated in this Agreement (including as set forth in the first sentence of <U>Section 3(f)</U>
with respect to the information giving rise thereto unless such material nonpublic information is no longer applicable). Notwithstanding
anything to the contrary contained in this <U>Section 3(o)</U>, the Company shall cause its transfer agent to deliver DWAC Shares to a
transferee of the Investor in accordance with the terms of the Purchase Agreement or Securities Purchase Agreement, as applicable, in
connection with any sale of Registrable Securities with respect to which (i) the Company has made a sale to Investor and (ii) the Investor
has entered into a contract for sale, and delivered a copy of the Prospectus included as part of the particular Registration Statement
to the extent applicable, in each case prior to the Investor&rsquo;s receipt of the notice of an Allowable Grace Period and for which
the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(p)
The Company shall at all times maintain the services of the Registrar and Depositary with respect to the administration of its Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%; text-align: right"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><B><U>Obligations of the
                                            Investor</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
At least five (5)&nbsp;Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period
to which the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor
with respect to such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration
pursuant to this Agreement with respect to the Registrable Securities of the Investor that the Investor shall furnish to the Company such
information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities
held by it, as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities
and shall execute such documents in connection with such registration as the Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
The Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company in
writing of the Investor&rsquo;s election to exclude all of the Investor&rsquo;s Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in <U>Section&nbsp;3(o)</U>
or the first sentence of <U>3(f)</U>, the Investor shall (i) immediately discontinue disposition of Registrable Securities pursuant to
any Registration Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of the supplemented
or amended Prospectus contemplated by <U>Section&nbsp;3(o) </U>or the first sentence of <U>Section&nbsp;3(f)</U> or receipt of notice
that no supplement or amendment is required and (ii) maintain the confidentiality of any information included in such notice delivered
by the Company unless otherwise required by law or subpoena. Notwithstanding anything to the contrary in this <U>Section&nbsp;4(c)</U>,
the Company shall cause its transfer agent to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the
Purchase Agreement or the Securities Purchase Agreement, as applicable, in connection with any sale of Registrable Securities with respect
to which the Investor has entered into a contract for sale prior to the Investor&rsquo;s receipt of a notice from the Company of the happening
of any event of the kind described in <U>Section&nbsp;3(o)</U> or the first sentence of <U>Section&nbsp;3(f)</U> and for which the Investor
has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
The Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B><U>Expenses of Registration</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
reasonable expenses of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses
of, the Investor, incurred in connection with registrations, filings or qualifications pursuant to <U>Sections 2</U> and <U>3</U>, including,
without limitation, all registration, listing and qualifications fees, printers and accounting fees incurred by the Company, and fees
and disbursements of counsel for the Company, shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>6.</B></TD><TD STYLE="text-align: justify"><B><U>Indemnification</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each of its
directors, officers, shareholders, members, partners, employees, agents, representatives (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls
the Investor within the meaning of the Securities Act or the Exchange Act and each of the directors, officers, shareholders, members,
partners, employees, agents, representatives (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B><I><U>Investor Party</U></I></B>&rdquo;
and collectively, the &ldquo;<B><I><U>Investor Partie</U></I></B><U>s</U>&rdquo;), against any losses, obligations, claims, damages, liabilities,
contingencies, judgments, fines, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys&rsquo; fees,
costs of defense and investigation), amounts paid in settlement or expenses, joint or several (collectively, &ldquo;<B><I><U>Claims</U></I></B>&rdquo;)
reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken
from the foregoing by or before any court or governmental, administrative or other regulatory agency, body or the Commission, whether
pending or threatened, whether or not an Investor Party is or may be a party thereto (&ldquo;<B><I><U>Indemnified Damages</U></I></B>&rdquo;),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i)&nbsp;any untrue statement or alleged untrue statement of a material fact in a Registration
Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the
securities or other &ldquo;Blue Sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered (&ldquo;<B><I><U>Blue
Sky Filing</U></I></B>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein not misleading or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained
in any Prospectus (as amended or supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any
material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were made,
not misleading (the matters in the foregoing clauses (i)&nbsp;and (ii) being, collectively, &ldquo;<B><I><U>Violations</U></I></B>&rdquo;).
Subject to <U>Section&nbsp;6(c)</U>, the Company shall reimburse the Investor Parties, promptly as such expenses are incurred and are
due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending
any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <U>Section&nbsp;6(a)</U>:
(i) shall not apply to a Claim by an Investor Party arising out of or based upon a Violation which occurs (A) as a result of the Investor
Party&rsquo;s affirmatively adjudicated fraud, bad faith, negligence or misconduct, or (B) in reliance upon and in conformity with information
furnished in writing to the Company by such Investor Party for such Investor Party expressly for use in connection with the preparation
of such Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby
acknowledged and agreed that only written information expressly confirmed and consented to in writing by the Investor as furnished by
the Investor for use in any Registration Statement, Prospectus or Prospectus Supplement shall be utilized by the Company for such purposes);
(ii) shall not be available to the Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to be
delivered the Prospectus (as amended or supplemented) made available by the Company (to the extent applicable), including, without limitation,
a corrected Prospectus, if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available by the Company
pursuant to <U>Section&nbsp;3(d)</U> and then only if, and to the extent that, following the receipt of the corrected Prospectus no grounds
for such Claim would have existed; and (iii)&nbsp;shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of the Investor Party and shall survive the transfer of
any of the Registrable Securities by the Investor pursuant to <U>Section&nbsp;9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in <U>Section&nbsp;6(a)</U>, the Company,
each of its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within
the meaning of the Securities Act or the Exchange Act (each, an &ldquo;<B><I><U>Company Party</U></I></B>&rdquo;), against any Claim or
Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such
Claim or Indemnified Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such
Violation occurs in reliance upon and in conformity with written information relating to the Investor furnished to the Company by the
Investor expressly for use in connection with such Registration Statement, the Prospectus included therein or any Prospectus Supplement
thereto (it being hereby acknowledged and agreed that only written information expressly confirmed and consented to in writing by the
Investor as furnished by the Investor for use in any Registration Statement, Prospectus or Prospectus Supplement shall be utilized by
the Company for such purposes); and, subject to <U>Section&nbsp;6(c)</U> and the below provisos in this <U>Section&nbsp;6(b)</U>, the
Investor shall reimburse a Company Party any legal or other expenses reasonably incurred by such Company Party in connection with investigating
or defending any such Claim;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, the indemnity agreement contained in this <U>Section&nbsp;6(b)</U>
and the agreement with respect to contribution contained in <U>Section&nbsp;7</U> shall not apply to amounts paid in settlement of any
Claim if such settlement is effected without the prior written consent of the Investor, which consent shall not be unreasonably withheld
or delayed; and&nbsp;<U>provided,</U>&nbsp;<U>further</U>&nbsp;that the Investor shall be liable under this <U>Section&nbsp;6(b)</U> for
only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the applicable sale
of Registrable Securities by the Investor pursuant to such Registration Statement, Prospectus or Prospectus Supplement. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of such Company Party and shall survive the
transfer of any of the Registrable Securities by the Investor pursuant to <U>Section&nbsp;9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
Promptly after receipt by an Investor Party or Company Party (as the case may be) under this <U>Section&nbsp;6</U> of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this <U>Section&nbsp;6</U>,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate
in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control
of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company Party (as the
case may be);&nbsp;<U>provided</U>, <U>however</U>, an Investor Party or Company Party (as the case may be) shall have the right to retain
its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i)&nbsp;the indemnifying party has
agreed in writing to pay such fees and expenses; (ii)&nbsp;the indemnifying party shall have failed promptly to assume the defense of
such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any such Claim;
or (iii)&nbsp;the named parties to any such Claim (including, without limitation, any impleaded parties) include both such Investor Party
or Company Party (as the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the case may be) shall
have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Investor Party
or such Company Party and the indemnifying party (in which case, if such Investor Party or such Company Party (as the case may be) notifies
the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then the indemnifying
party shall not have the right to assume the defense thereof on behalf of the indemnified party and such counsel shall be at the expense
of the indemnifying party),&nbsp;<U>provided</U>&nbsp;<U>further</U>&nbsp;that in the case of clause (iii)&nbsp;above the indemnifying
party shall not be responsible for the reasonable fees and expenses of more than one (1)&nbsp;separate legal counsel for all Investor
Parties or Company Parties (as the case may be). The Company Party or Investor Party (as the case may be) shall reasonably cooperate with
the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish
to the indemnifying party all information reasonably available to the Company Party or Investor Party (as the case may be) which relates
to such action or Claim. The indemnifying party shall keep the Company Party or Investor Party (as the case may be) reasonably apprised
at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable
for any settlement of any action, claim or proceeding effected without its prior written consent;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Company Party
or Investor Party (as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall
not include any admission as to fault on the part of the Company Party. For the avoidance of doubt, the immediately preceding sentence
shall apply to <U>Sections 6(a</U>) and <U>6(b)</U> hereof. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Company Party or Investor Party (as the case may be) with respect to all third parties, firms
or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Investor Party or Company Party (as the case may be) under this <U>Section&nbsp;6</U>, except to the extent that the indemnifying party
is materially and adversely prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
No Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(e)
The indemnification required by this Section&nbsp;6 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred;&nbsp;<U>provided</U>&nbsp;that any Person
receiving any payment pursuant to this Section&nbsp;6 shall promptly reimburse the Person making such payment for the amount of such payment
to the extent a court of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(f)
The indemnity and contribution agreements contained herein shall be in addition to (i)&nbsp;any cause of action or similar right of the
Company Party or Investor Party against the indemnifying party or others, and (ii)&nbsp;any liabilities the indemnifying party may be
subject to pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>7.</B></TD><TD STYLE="text-align: justify"><B><U>Contribution</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section&nbsp;6 to the fullest extent permitted by
law;&nbsp;<U>provided</U>,&nbsp;<U>however</U>: (i)&nbsp;no contribution shall be made under circumstances where the maker would not have
been liable for indemnification under the fault standards set forth in Section&nbsp;6 of this Agreement, (ii)&nbsp;no Person involved
in the sale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)
of the Securities Act) in connection with such sale shall be entitled to contribution from any Person involved in such sale of Registrable
Securities who was not guilty of fraudulent misrepresentation; and (iii)&nbsp;contribution by any seller of Registrable Securities shall
be limited in amount to the amount of net proceeds received by such seller from the applicable sale of such Registrable Securities pursuant
to such Registration Statement. Notwithstanding the provisions of this <U>Section&nbsp;7</U>, the Investor shall not be required to contribute,
in the aggregate, any amount in excess of the amount by which the net proceeds actually received by the Investor from the applicable sale
of the Registrable Securities subject to the Claim exceeds the amount of any damages that the Investor has otherwise been required to
pay, or would otherwise be required to pay under <U>Section&nbsp;6(b)</U>, by reason of such untrue or alleged untrue statement or omission
or alleged omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>8.</B></TD><TD STYLE="text-align: justify"><B><U>Reports Under the Exchange Act</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
use its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule
144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
use its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood
that nothing herein shall limit any of the Company&rsquo;s obligations under the Purchase Agreement or the Securities Purchase Agreement)
and the filing of such reports and other documents is required for the applicable provisions of Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
furnish to the Investor, so long as the Investor owns Registrable Securities, promptly upon request, (i)&nbsp;a written statement by the
Company, if true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the Exchange Act, (ii)&nbsp;a
copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the
Commission if such reports are not publicly available via EDGAR, and (iii)&nbsp;such other information as may be reasonably requested
to permit the Investor to sell such securities pursuant to Rule 144 without registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant
to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to
the Company&rsquo;s Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with
Investor and Investor&rsquo;s broker to effect such sale of securities pursuant to Rule 144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>9.</B></TD><TD STYLE="text-align: justify"><B><U>Assignment of Registration Rights</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Neither
the Company nor the Investor shall assign this Agreement or any of their respective rights or obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>10.</B></TD><TD STYLE="text-align: justify"><B><U>Amendment or Waiver</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">No
provision of this Agreement may be (i)&nbsp;amended other than by a written instrument signed by both parties hereto or (ii)&nbsp;waived
other than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise
any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a
waiver thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>11.</B></TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed
to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(b)
Any notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with <U>Section&nbsp;10.17</U> of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or
remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity
of showing economic loss and without any bond or other security being required), this being in addition to any other remedy to which either
party may be entitled by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(d)
All questions concerning the governing law, construction, validity, enforcement, arbitration, dispute resolution and interpretation of
this Agreement shall be under the same terms as set forth under <U>Article X</U> of the Purchase Agreement, including, without limitation,
<U>Sections 10.1</U>, <U>10.2</U>, <U>10.11</U>, <U>10.12</U>, and <U>10.16</U> thereunder. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT
IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING
OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(e)
The Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to the subject
matter hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without
implication that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner
whatsoever (i)&nbsp;the conditions precedent to a purchase contained in <U>Article VII</U> of the Purchase Agreement or (ii)&nbsp;any
of the Company&rsquo;s obligations under the Purchase Agreement or the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(f)
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is
not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in <U>Sections 6</U> and <U>7</U> hereof (and in such case, solely for the purposes set forth therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(g)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall
be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo;
&ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(h)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by&nbsp;e-mail&nbsp;in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(i)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(j)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><B>12.</B></TD><TD STYLE="text-align: justify"><B><U>Termination</U>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
Agreement shall terminate in its entirety upon the date on which the Investor shall no longer hold any Registrable Securities; <I>provided</I>,
that the provisions of <U>Sections 6</U>, <U>7</U>, <U>9</U>, <U>10</U> and <U>11</U> shall remain in full force and effect for the longest
period under applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">[S<I>ignature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>IN
WITNESS WHEREOF</B>, the Investor and the Company have caused their respective signature page to this Registration Rights Agreement to
be duly executed as of the Execution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY</U>:</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Actelis Networks Inc</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia Barlev</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INVESTOR</U>:</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHITE LION CAPITAL LLC</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nathan Yee</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea025980401ex10-3_actelis.htm
<DESCRIPTION>FORM OF PIPE PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 10.3</B></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES PURCHASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) is dated as of September 27, 2025, between <B>Actelis Networks, Inc.</B>, a Delaware
corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and <B>White Lion Capital LLC</B>, a Nevada limited liability company (the &ldquo;<B><U>Purchaser</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
Company and the Purchaser are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded
by the provisions of Section 4(a)(2) the Securities Act (as defined below), and/or Regulation D (&ldquo;<B><U>Regulation D</U></B>&rdquo;)
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Purchaser,
as provided herein, and the Purchaser, in the aggregate, shall purchase securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Company and the Purchaser agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.05pt">ARTICLE
I. <BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>1.1 <U>Definitions</U></B>.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings
given to such terms in the Prefunded Warrants , and (b) the following terms have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Acquiring Person</U></B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 4.7</U>. &ldquo;<B><U>Action</U></B>&rdquo; shall have the meaning ascribed
to such term in <U>Section 3.1(j)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Affiliate</U></B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Approved
Equity Plan</U></B>&rdquo; means any employee benefit plan or agreement which has been approved by the board of directors of the Company
prior to or subsequent to the date hereof pursuant to which shares of Common Stock, Options, or other securities of the Company may be
issued to any employee, officer, consultant, or director for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Board of Directors</U></B>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Business
Day</U></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York, New
York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall
not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non- essential employee&rdquo; or any other similar orders or restrictions or the closure of
any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems
(including for wire transfers) of commercial banks in the City of New York, New York are generally are open for use by customers on
such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Closing</U></B>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Closing
Date</U></B>&rdquo; means the first (1<SUP>st</SUP>) Business Day after the Trading Day on which all of the Transaction Documents have
been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchaser&rsquo;s obligations to
pay the Subscription Amount and (ii)the Company&rsquo;s obligations to deliver the Securities to be issued and sold, in each case, have
been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Common
Stock</U></B>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Convertible
Securities</U></B>&rdquo; means any stock, shares, or other security (other than Options) that is at any time and under any circumstances,
directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire,
any shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Disclosure
Schedules</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Disclosure
Time</U></B>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York, New York
time) and before midnight (New York, New York time) on any Trading Day, 9:01 a.m. (New York, New York time) on the Trading Day
immediately following the date hereof, and (ii) if this Agreement is signed between midnight (New York, New York time) and 9:00 a.m.
(New York, New York time) on any Trading Day, no later than 9:01</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">a.m. (New York, New York time) on the
date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>ELOC</U></B>&rdquo; means
that certain Common Stock Purchase Agreement by and between the Company and the Purchaser, to be effective as of October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>ELOC Issuance</U></B>&rdquo; means
any issuance of shares of Common Stock pursuant to the ELOC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Evaluation Date</U></B>&rdquo; shall have the meaning ascribed
to such term in <U>Section 3.1(s)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>FCPA</U></B>&rdquo; means the Foreign Corrupt
Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>GAAP</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Indebtedness</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(bb)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(p)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Legend Removal Date</U></B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 4.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Liens</U></B>&rdquo; means a lien, charge, pledge,
security interest, encumbrance, right of first refusal, preemptive right, or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Material Adverse Effect</U></B>&rdquo;
shall have the meaning assigned to such term in <U>Section 3.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Material Permits</U></B>&rdquo; shall have the meaning
ascribed to such term in <U>Section 3.1(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Options</U></B>&rdquo; means any rights, warrants, or options to subscribe
for, purchase, or otherwise acquire shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Other Investor</U></B>&rdquo; shall have the
meaning ascribed to such term in <U>Section 4.19</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Per
Share Purchase Price</U></B>&rdquo; equals $0.2125 per Share, subject to adjustment for reverse and forward share splits, share dividends,
share combinations and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase
price per Prefunded Warrant shall be the Purchase Price minus $0.0001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Person</U></B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Prefunded
Warrant</U></B>&rdquo; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchaser at the Closing in
accordance with Section 2.2(a) hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full,
in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Prefunded
Warrant Shares</U></B>&rdquo; means the shares of Common Stock issuable upon exercise of the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Principal Market</U></B>&rdquo; means the Nasdaq
Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Public Information Failure</U></B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 4.3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Public Information Failure Payments</U></B>&rdquo;
shall have the meaning ascribed to such term in Section 4.3(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Purchaser Party</U></B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 4.10(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Registration Rights Agreement</U></B>&rdquo;
means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchaser, in the form of <U>Exhibit
B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Required Approvals</U></B>&rdquo; shall have
the meaning ascribed to such term in <U>Section 3.1(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Required
Minimum</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Resale Registration
Statement</U></B>&rdquo; means a registration statement covering the resale of the Shares and Warrant Shares by the Purchaser,
including, without limitation, a registration statement meeting the requirements as set forth and as provided for in the
Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Reserve Depletion
Date</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Rule 144</U></B>&rdquo;
means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Rule
424</U></B>&rdquo; means Rule 424 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from
time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>SEC</U></B>&rdquo; means the United States Securities
and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>SEC
Reports</U></B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Securities</U></B>&rdquo;
means the Shares, the Prefunded Warrants, and the Prefunded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Securities Act</U></B>&rdquo; means
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Share
Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire,
at any time, shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Shares</U></B>&rdquo;
means the shares of Common Stock issued or issuable to the Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Short
Sales</U></B>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not
be deemed to include locating and/or borrowing shares of Common Stock or other Share Equivalents).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Subscription
Amount</U></B>&rdquo; means Eight Hundred and Fifty Thousand Dollars ($850,000), representing the aggregate amount to be paid for the
Shares and Prefunded Warrants purchased hereunder, in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Subsidiary</U></B>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Trading Day</U></B>&rdquo; means a day on which
the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&ldquo;<B><U>Trading
Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New
York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transaction
Documents</U></B>&rdquo; means this Agreement, the Prefunded Warrants, the Registration Rights Agreement, all exhibits and schedules thereto
and hereto, and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transfer
Agent</U></B>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>VWAP</U></B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted, as reported by Bloomberg, (based on a Trading Day from 9:30
a.m. (New York, N.Y. time) to 4:02 p.m. (New York, N.Y. time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Purchaser and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Warrants</U></B>&rdquo; means the Prefunded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Warrant Shares</U></B>&rdquo; means the shares
of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE II. PURCHASE AND SALE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>2.1 <U>Closing</U></B>.
On the Closing Date, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, upon the
terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchaser agrees to purchase, $850,000
(the &ldquo;<B><U>Subscription Amount</U></B>&rdquo;) of Shares; provided, however, that, to the extent that the Purchaser
determines, in its sole discretion, that the Purchaser (together with the Purchaser&rsquo;s Affiliates, and any Person acting as a
group together with the Purchaser or any of the Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial
Ownership Limitation (as defined below), or as the Purchaser may otherwise choose, in lieu of purchasing Shares, the Purchaser shall
purchase Prefunded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such
Purchaser to the Company. The &ldquo;<B><U>Beneficial Ownership Limitation</U></B>&rdquo; shall be 4.99% of the number of shares of
Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. The Company shall
deliver to the Purchaser the Securities as determined pursuant to <U>Section 2.2(a)</U>, and the Company and the Purchaser shall
deliver the other items set forth in <U>Section 2.2</U> deliverable at the Closing. Upon satisfaction of the covenants and
conditions set forth in <U>Sections 2.2</U> and <U>2.3</U>, the Closing shall take place remotely by electronic transfer of the
Closing documentation. Unless otherwise directed by the Purchaser, settlement of the Shares (and Prefunded Warrants, if applicable)
shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<B><U>DVP</U></B>&rdquo;) (i.e., on the Closing Date, the Company
shall issue the Shares (and Prefunded Warrants, if applicable) registered in the Purchaser&rsquo;s names and addresses and released
by the Transfer Agent directly to the Purchaser; upon receipt of such Shares (and Prefunded Warrants, if applicable), payment
therefor shall be made by the Purchaser by wire transfer to the Company), and the Purchaser&rsquo;s Subscription Amount shall be
made available for DVP settlement with the Company or its designee.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>2.2
<U>Deliveries</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) On or prior to the Closing Date (except
as indicated below), the Company shall deliver or cause to be delivered the following to the Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">(i)
on the date hereof, this Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(ii)  a
number of Shares equal to the Subscription Amount divided by the Per Share Purchase Price, registered in uncertificated, book-entry form
in the name of the Purchaser (minus the number of Prefunded Warrant Shares issuable upon exercise of the Purchaser&rsquo;s Prefunded Warrants,
if applicable);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iii)
if the Purchaser is acquiring Prefunded Warrants pursuant to Section 2.1, a Prefunded Warrant registered in the name of the Purchaser
to purchase up to a number of Prefunded Warrant Shares equal to the portion of the Subscription Amount applicable to Prefunded Warrant
divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">(iv)
the Registration Rights Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(v)  an
officer&rsquo;s certificate certifying that the representations and warranties of the Company in this Agreement are true and correct as
of the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company shall have performed, satisfied, and complied in all material
respects with the covenants, agreements, and conditions required to be performed, satisfied, or complied with by the Company at or prior
to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(vi)  a
certified copy of the certificate of incorporation (or such equivalent organizational document) of the Company certified by the Secretary
of State (or comparable office) of its jurisdiction of incorporation, dated within 10 days of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(vii)  a
certificate evidencing the company status of the Company in its jurisdiction of formation issued by the Secretary of State (or comparable
office) of such jurisdiction of formation as of a date within 10 days of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(viii)
an officer&rsquo;s certificate, in the form reasonably acceptable to the Purchaser, executed by an officer of the Company and dated
as of the Closing Date, as to (i) the resolutions adopted by the Company&rsquo;s board of directors authorizing the transactions
contemplated hereby in a form reasonably acceptable to the Purchaser, (ii) the certificate of incorporation (or such equivalent
organizational document) and the organizational documents of the Company, as in effect at the Closing Date, and (iii) the bylaws of
the Company, as in effect at the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(ix)  a
letter or other certification from the Transfer Agent certifying the number of shares of Common Stock outstanding on the Trading Day immediately
preceding the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(x)  subject
to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent in the form attached hereto as <U>Exhibit C</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(xi)  the
Company&rsquo;s wire instructions, on Company letterhead and executed by the Company&rsquo;s Chief Executive Officer or Chief Financial
Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(xii)  a
flow of funds memorandum in form and substance mutually agreed to by the Company and the Purchaser (a &ldquo;<B><U>Flow of Funds Memorandum</U></B>&rdquo;)
duly executed by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(xiii)  such
other documents, instruments, or certificates relating to the transactions contemplated by this Agreement as the Purchaser or its counsel
may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) On or prior to the Closing Date, the
Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(i)
on the date hereof, this Agreement duly executed by the Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(ii)
the Registration Rights Agreement duly executed by the Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iii)
the Flow of Funds Memorandum duly executed by the Purchaser;and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iv)
the Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company, which shall be made
available for DVP settlement with the Company or its designee.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>2.3
<U>Closing Conditions</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) The obligations of the Company hereunder
in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(i)  the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchaser contained herein (unless as of a specific
date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified
by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(ii)  all
obligations, covenants, and agreements of the Purchaser required to be performed at or prior to the Closing Date shall have been performed
in all material respects; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iii)
the delivery by the Purchaser of the items set forth in <U>Section 2.2(b) </U>of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) The obligations of the Purchaser hereunder
in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(i)  the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(ii)  all
obligations, covenants, and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed
in all material respects in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iii)
the delivery by the Company of the items set forth in <U>Section 2.2(a) </U>of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(v)  from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the SEC or the Company&rsquo;s principal
Trading Market and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Purchaser,
makes it impracticable or inadvisable to purchase the Securities at each applicable Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 1in; text-align: justify">(vi)  no
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated, or endorsed by
any court or governmental entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated hereby.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 79.05pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 79.05pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 79.05pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE III.
<BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>3.1 <U>Representations
and Warranties of the Company</U></B>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a
part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to the
Purchaser which representations shall be true and correct on the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non- assessable, and free of preemptive and similar
rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of
them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing, and, if applicable under the laws of the jurisdiction in which they are formed, in good standing (or active status) under
the laws of the jurisdiction of its incorporation or organization (if the concept of good standing or active status exists in such
jurisdiction), with the requisite power and authority to own and use its properties and assets and to carry on its business as
currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective
certificate or articles of incorporation, bylaws, or other organizational or charter documents. Each of the Company and the
Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where
the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in (i) a
material adverse effect on the legality, validity, or enforceability of any Transaction Document, (ii) a material adverse effect on
the results of operations, assets, business, prospects, or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely
basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<B><U>Material Adverse
Effect</U></B>&rdquo;) and no Action has been instituted in any such jurisdiction revoking, limiting, or curtailing or seeking to
revoke, limit, or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors, or the Company&rsquo;s shareholders in
connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company, assuming due authorization
by the other parties thereto, and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (iii) insofar as indemnification and contribution provisions may be
limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(d) <U>No Conflicts</U>.
The execution, delivery, and performance by the Company of this Agreement and the other Transaction Documents to which it is a party,
the issuance and sale of the Securities, and the consummation by it of the transactions contemplated hereby and thereby do not and will
not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws, or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration, or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt, or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree, or other restriction of any court or governmental authority to which
the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(e) <U>Filings, Consents,
and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization, or order of, give any notice to, or make
any filing or registration with, any court or other federal, state, local, or other governmental authority or other Person in connection
with the execution, delivery, and performance by the Company of the Transaction Documents, other than (i) the filings required pursuant
to <U>Section 4.6</U> of this Agreement, (ii) the filing(s) with the SEC pursuant to the Registration Rights Agreement, (iii) if applicable,
the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Shares and Warrant Shares for trading
thereon in the time and manner required thereby, and (iv) if applicable, the filing of Form D with the SEC and such filings as are required
to be made under applicable state securities laws (collectively, the &rdquo;<B><U>Required Approvals</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(f) <U>Issuance of
the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid, and nonassessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents or by law. The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid, and nonassessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents or by law. The Company has reserved from its duly authorized shares of Common Stock
a number of shares of Common Stock for the issuance of Shares pursuant to this Agreement and of Warrant Shares pursuant to the Warrants
at least equal to the Required Minimum on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(g) <U>Capitalization</U>. The
capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date
hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other
than pursuant to the exercise of employee stock options under an Approved Equity Plan, the issuance of shares of Common Stock to
employees pursuant to an Approved Equity Plan, and pursuant to the conversion and/or exercise of Share Equivalents outstanding as of
the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities or as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding
options, warrants, scrip rights to subscribe to, calls, or commitments of any character whatsoever relating to, or securities,
rights, or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or
acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings, or
arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Share
Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any
Subsidiary to issue shares of capital stock or other securities to any Person (other than the Purchaser). There are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange, or
reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings, or arrangements by which the Company or any Subsidiary is or may become bound to redeem a
security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo;
plans or agreements or any similar plan or agreement. All of the outstanding shares of Common Stock and other shares of capital
stock of the Company are duly authorized, validly issued, fully paid, and nonassessable, have been issued in compliance with all
applicable securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights
to subscribe for or purchase securities. No approval or authorization of any shareholder, the Board of Directors, or others is
required for the issuance and sale of the Securities. There are no shareholders agreements, voting agreements, or other similar
agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company,
between or among any of the Company&rsquo;s shareholders other than as disclosed in <U>Schedule 3.1(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(h) <U>SEC
Reports; Financial Statements</U>. During the two (2) years prior to the date hereof, the Company has timely filed all reports,
schedules, forms, statements, and other documents required to be filed by the Company under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the &ldquo;<B><U>SEC Reports</U></B>&rdquo;) on a timely
basis or has received or obtained a valid extension of such time of filing and has filed any such SEC Reports prior to the
expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the
requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of
the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(&ldquo;<B><U>GAAP</U></B>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(i) <U>Material Changes;
Undisclosed Events, Liabilities, or Developments</U>. Since the date of the latest audited financial statements included within the SEC
Reports, (i) there has been no event, occurrence, or development that has had or that could reasonably be expected to result in a Material
Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued
expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in
the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the SEC, (iii) the Company has not altered
its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders
or purchased, redeemed (except in the de minimis amount), or made any agreements to purchase or redeem any shares of its share capital,
except as otherwise publicly disclosed in the SEC Reports, and (v) the Company has not issued any equity securities to any officer, director,
or Affiliate, except pursuant to an Approved Equity Plan. The Company does not have pending before the SEC any request for confidential
treatment of information. Except for the transactions contemplated by this Agreement and the other Transaction Documents or as set forth
on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence, or development has occurred or exists or is reasonably
expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets, or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation
is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(j) <U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding, or investigation (however any governmental or administrative agency
may define the matter) pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary, or any
of their respective properties before or by any court, arbitrator, governmental, or administrative agency or regulatory authority (federal,
state, county, local or foreign) (any, an &ldquo;<B><U>Action</U></B>&rdquo;) that (i) adversely affects or challenges the legality, validity,
or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or
reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof,
is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim
of breach of fiduciary duty which could result in a Material Adverse Effect. There has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the SEC involving the Company or any current or former director or officer
of the Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed
by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which would
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure, or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local, and foreign
laws and regulations relating to employment and employment practices, terms and conditions of employment, and wages and hours, except
where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(I) <U>Compliance</U>.
Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan, or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator, or other governmental
authority, or (iii) is or has been in violation of any statute, rule, ordinance, or regulation of any governmental authority, including
without limitation all foreign, federal, state, and local laws relating to taxes, environmental protection, occupational health and safety,
product quality and safety, and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(m)<FONT STYLE="font-size: 10pt">  </FONT><U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local, and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface, or subsurface strata),
including laws relating to emissions, discharges, releases, or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<B><U>Hazardous Materials</U></B>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans, or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<B><U>Environmental Laws</U></B>&rdquo;),
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses, and (iii) are in compliance with all terms and conditions of any such permit, license, or approval where, in each clause (i),
(ii), and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations, and permits issued by the appropriate federal,
state, local, or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<B><U>Material
Permits</U></B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state,
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting, and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses, and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;). None of, and
neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has
expired, terminated, or been abandoned, or is expected to expire or terminate or be abandoned, within two years from the date of this
Agreement, except as would not have or reasonably expected to not have a Material Adverse Effect. Neither the Company nor any Subsidiary
has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or
otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not
have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and, to the knowledge of the Company, there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality, and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but
not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a
significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(r) <U>Transactions
with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party
to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any
contract, agreement, or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, providing for the borrowing of money from or lending of money to, or otherwise requiring payments to
or from any officer, director, or such employee or, to the knowledge of the Company, any entity in which any officer, director, or
any such employee has a substantial interest or is an officer, director, trustee, stockholder, member, or partner, in each case in
excess of $120,000, other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses
incurred on behalf of the Company, and (iii) other employee benefits, including stock option agreements under any stock option plan
(including any Approved Equity Plan) of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the SEC thereunder that are effective as of the date hereof and as of each Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&rsquo;s rules and
forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<B><U>Evaluation Date</U></B>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to
materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(t) <U>Certain
Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiaries to any
broker, financial advisor or consultant, finder, placement agent, investment banker, bank, or other Person with respect to the
transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in <U>Section 3.2</U>, no registration under the
Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser as contemplated hereby. The issuance
and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(v) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(w)<FONT STYLE="font-size: 10pt">  </FONT><U>Registration
Rights</U>. Other than the Purchaser, no Person has any right to cause the Company or any Subsidiary to effect the registration under
the Securities Act of any securities of the Company or any Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(x) <U>Listing and
Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has
taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration. Except
as set forth on Schedule 3.1(x), the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market
on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. Except as set forth on Schedule 3.1(x), the Company is and has no reason to believe that it will
not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current
in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic
transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(y) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement), or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchaser as a result of the Company&rsquo;s issuance of the Securities and
the Purchaser&rsquo;s ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(z) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided the Purchaser or its agents or counsel with any
information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms
that the Purchaser will rely on the foregoing representation in effecting transactions in securities of the Company. All of the
disclosure furnished by or on behalf of the Company to the Purchaser regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in
all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in
order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press
releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company
acknowledges and agrees that the Purchaser does not make and has not made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in <U>Section 3.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(aa)<FONT STYLE="font-size: 10pt"> </FONT><U>No
Integrated Offering</U>. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in <U>Section
3.2</U>, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would
require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of
any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(bb) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of each Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
on its business as now conducted and as proposed to be conducted, including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements, and capital
availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it
to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its
debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <U>Schedule
3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or
for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
&ldquo;<B><U>Indebtedness</U></B>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $100,000 (other
than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or
collection or similar transactions in the ordinary course of business, and (z) the present value of any lease payments in excess of
$100,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default
with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(cc)<FONT STYLE="font-size: 10pt"> </FONT><U>No
Materially Adverse Contracts, Etc</U>. To the Company&rsquo;s knowledge, neither the Company nor any of its Subsidiaries is subject to
any charter, corporate, or other legal restriction, or any judgment, decree, order, rule, or regulation which, in the judgment of the
Company&rsquo;s officers, has or is expected in the future to have a Material Adverse Effect. To the Company&rsquo;s knowledge, neither
the Company nor any of its Subsidiaries is a party to any contract or agreement which in the judgment of the Company&rsquo;s officers
has or is expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(dd)<FONT STYLE="font-size: 10pt"> </FONT><U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect and, if applicable, the Company and its Subsidiaries each (i) has made or filed all United States federal, state, and local
income and all foreign income and franchise tax returns, reports, and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports, and declarations, and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports, or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(ee)<FONT STYLE="font-size: 10pt"> </FONT><U>No
General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchaser and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(ff) <U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly used any funds for unlawful contributions, gifts, entertainment,
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA (if applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(gg)<FONT STYLE="font-size: 10pt"> </FONT><U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth in the SEC Reports and such accounting firm (i) is a registered public accounting firm
as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the fiscal year ending December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(hh) <U>No
Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the
Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to
perform any of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(ii) <U>Acknowledgment
Regarding Purchaser&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that the Purchaser is acting solely in the
capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company
further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by the Purchaser or any of its
representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental
to the Purchaser&rsquo;s purchase of the Securities. The Company further represents to the Purchaser that the Company&rsquo;s decision
to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(jj) <U>Certain
Transaction and Confidentiality</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding, it is understood
and acknowledged by the Company that (i) the Purchaser has not been asked by the Company to agree, nor has the Purchaser agreed, to desist
from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued
by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by the Purchaser,
specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this
or future private placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii)
the Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which the Purchaser is a party, directly or indirectly,
presently may have a &ldquo;short&rdquo; position in the Common Stock, and (iv) the Purchaser shall not be deemed to have any affiliation
with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands
and acknowledges that (y) the Purchaser may engage in hedging activities at various times during the period that the Securities are outstanding,
and (z) such hedging activities (if any) could reduce the value of the existing shareholders&rsquo; equity interests in the Company at
and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities
do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(kk)<FONT STYLE="font-size: 10pt"> </FONT><U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale
or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(ll) <U>Equity
Incentive Plans</U>. Since the listing of the Company&rsquo;s Common Stock on the Nasdaq Stock Market, each award granted by the
Company under the Company&rsquo;s equity incentive plans (including any Approved Equity Plans) was granted (i) in accordance with
the terms of the Company&rsquo;s applicable equity incentive plan (including any Approved Equity Plans), and (ii) with an exercise
price at least equal to the fair market value of the Common Stock, as applicable, on the date such award would be considered granted
under GAAP and applicable law. No award granted under any Company equity incentive plan has been backdated. The Company has not
knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, equity awards prior to, or
otherwise knowingly coordinate the grant of equity awards with, the release or other public announcement of material information
regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(mm) <U>Cybersecurity</U>.
(i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors, and any third party data maintained by or on behalf of it), equipment, or technology (collectively, &ldquo;<B><U>IT Systems and
Data</U></B>&rdquo;), and (y) the Company and the Subsidiaries have not been notified of, and have no knowledge of, any event or condition
that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and
the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules, and regulations of
any court or arbitrator or governmental or regulatory authority, internal policies, and contractual obligations relating to the privacy
and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation,
or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries
have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the
integrity, continuous operation, redundancy, and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented
backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(nn)<FONT STYLE="font-size: 10pt"> </FONT><U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee, or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(oo) <U>U.S. Real
Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of
Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(pp)<FONT STYLE="font-size: 10pt"> </FONT><U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<B><U>BHCA</U></B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B><U>Federal
Reserve</U></B>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five
percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(qq) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the applicable money laundering statutes and applicable rules and
regulations thereunder (collectively, the &ldquo;<B><U>Money Laundering Laws</U></B>&rdquo;), and no Action by or before any court
or governmental agency, authority, or body or any arbitrator involving the Company or any Subsidiary with respect to the Money
Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(rr) <U>No Off Balance
Sheet Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and
an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed
or that otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 72.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(ss)<FONT STYLE="font-size: 10pt"> </FONT><U>No
Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities
Act, none of the Company, nor to the knowledge of the Company, any of the Company&rsquo;s predecessors, affiliated issuers, directors,
executive officers, other officers of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the
Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined
in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B><U>Issuer Covered
Person</U></B>&rdquo; and, together, &ldquo;<B><U>Issuer Covered Persons</U></B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo;
disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<B><U>Disqualification Event</U></B>&rdquo;),
except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether
any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Purchaser a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(tt) <U>Other Covered
Persons</U>. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or
indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>3.2  <U>Representations
and Warranties of the Purchaser</U></B>. The Purchaser hereby represents and warrants as of the date hereof and the Closing Date to the
Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) <U>Organization;
Authority</U>. The Purchaser is a limited liability company duly formed, validly existing, and in good standing under the laws of
the State of Nevada with full limited liability company power and authority to enter into and to consummate the transactions
contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and
delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary limited liability company actions on the part of the Purchaser. Each Transaction Document
to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms
hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its
terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium, and
other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable remedies, and (iii) insofar as indemnification and
contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) <U>Own Account</U>.
The Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under the Securities
Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or
for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities
law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of
such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
the Purchaser&rsquo;s right to sell the Securities pursuant to the Resale Registration Statement or otherwise in compliance with applicable
federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(c) <U>Purchaser Status</U>.
At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises
any Warrant, in whole or in part, it will be either (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act, or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined
in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(d) <U>Experience
of the Purchaser</U>. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication, and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(e) <U>General Solicitation</U>.
The Purchaser is not, to the Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement, article, notice,
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or
radio or presented at any seminar or, to the knowledge of the Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(f) <U>Access to Information</U>.
The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto)
and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers
from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of
investing in the Securities, (ii) access to publicly available information about the Company and its financial condition, results of operations,
business, properties, management, and prospects sufficient to enable it to evaluate its investment, and (iii) the opportunity to obtain
such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
an informed investment decision with respect to the investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(g) Certain Transactions
and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">The
Company acknowledges and agrees that the representations contained in this <U>Section 3.2</U> shall not modify, amend, or affect the
Purchaser&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE IV.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 4.1 <U>Transfer Restrictions</U><FONT STYLE="font-weight: normal">.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) The Securities
may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than
pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of the Purchaser or in connection with
a pledge as contemplated in <U>Section 4.1(b)</U>, the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration
Rights Agreement and shall have the rights and obligations of the Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) The Purchaser
agrees to the imprinting, so long as is required by this <U>Section 4.1</U>, of a legend on any of the Securities in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">&nbsp;</P>

<P STYLE="margin: 0pt 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">[NEITHER] THIS SECURITY [NOR THE
SECURITIES INTO WHICH THIS SECURITY IS [EXERCISABLE]] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [EXERCISE] OF THIS SECURITY]
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION
THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that the Purchaser may, from time to time, pledge pursuant to a bona fide margin agreement with a registered broker-dealer
or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, the Purchaser may transfer pledged
or secured Securities to the pledgees or secured parties. Such a transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party, or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation as a
pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if
the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the
list of Selling Shareholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(c)
Upon the written request by the Purchaser to the Company if, at the time of such request, the Purchaser covenants and agrees that it
has resold or will resell the Securities only (i) (A) pursuant to a Resale Registration Statement in a manner described under the
caption &ldquo;Plan of Distribution&rdquo; in such Resale Registration Statement, and in a manner in compliance with all applicable
U.S. federal and state securities laws, rules, and regulations, including, without limitation, any applicable prospectus delivery
requirements of the Securities Act, or (B) in compliance with an available exemption under the Securities Act, including, without
limitation, Section 4(a)(1) of the Securities Act and/or Rule 144 promulgated thereunder, and (ii) concurrently with such request,
the Purchaser delivers to the Company, its counsel, and the Transfer Agent a customary written certification that the requirements
set forth in clause (i) are accurate, the Company shall, no later than one (1) Trading Day following the delivery by the Purchaser
to the Transfer Agent of one or more legended certificates or book-entry statements representing any Securities subject to such
request, together with such other documentation from the Purchaser and its designated broker-dealer as the Transfer Agent deem
reasonably necessary and appropriate, authorize the Transfer Agent to remove the Securities Act restrictive legend (and any stop
transfer instructions placed against transfer thereof) contemplated by <U>Section 4.1(b)</U> affixed to the Securities (as
applicable) subject to such request. At the times the Company authorizes the removal of the Securities Act restrictive legends on
the Securities subject to such request (and any stop transfer instructions placed against transfer thereof) pursuant to this <U>Section
4.1(c)</U>, the Company shall, at its sole expense, use its commercially reasonable efforts to cause its legal counsel to issue to
the Transfer Agent a legal opinion or direction letter authorizing the Transfer Agent to remove the Securities Act restrictive
legends contemplated by <U>Section 4.1(b)</U> on the Securities (as applicable) subject to such request (which legal opinion or
direction letter may be delivered to the Transfer Agent in advance setting forth the conditions to the removal of such legends). The
Company shall be responsible for the fees of its Transfer Agent and the Company&rsquo;s legal counsel associated with any such
legend removals. If counsel to the Company fails to provide a legal opinion reasonably satisfactory to the Transfer Agent, in
accordance with this Section, the Investor shall have the right to provide an opinion of counsel selected by the Investor, the cost
of which shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(d)
If the Purchaser has resold Securities in a manner described under the caption &ldquo;Plan of Distribution&rdquo; in a Resale
Registration Statement, the Purchaser shall (i) send a confirmation to the Transfer Agent setting forth the number of such
Securities that have been so resold and the date of such resales (such confirmation, the &ldquo;<B><U>Transfer Agent
Confirmation</U></B>&rdquo;) and (ii) deliver to the Transfer Agent customary documentation reasonably satisfactory to the Transfer
Agent with respect to such resold Securities, including a customary broker&rsquo;s representation letter confirming, among other
things, that the Investor has resold such Securities in a manner described under the caption &ldquo;Plan of Distribution&rdquo; in
such Resale Registration Statement and in compliance any relevant prospectus delivery requirements (collectively, the
&ldquo;<B><U>Transfer Agent Deliverables</U></B>&rdquo;). With respect to the Securities resold by the Purchaser as described in the
preceding sentence and as to which the Purchaser has delivered the Transfer Agent with respect to such resold Securities, the
Company shall (i) pay to the Transfer Agent any necessary fees for the issuance of any such resold Securities, and (ii) instruct the
Transfer Agent to deliver and credit such Securities using the Depository Trust Company Deposit or Withdrawal at Custodian system
(&ldquo;<B><U>DWAC</U></B>&rdquo;) or deliver order (&ldquo;<B><U>DO</U></B>&rdquo;) system maintained by DTC (or any similar
program hereafter adopted by DTC performing substantially the same function) to the account with DTC of the Purchaser&rsquo;s
designated broker-dealer as specified in the Transfer Agent Deliverables with respect to such resold Securities. Concurrently with
such instruction and payment, the Company shall confirm to the Transfer Agent that the Resale Registration Statement was effective
and could be relied upon to sell such Shares as of the relevant date of sale and that the Purchaser is named as a selling
shareholder in the prospectus included in the Resale Registration Statement. Any Securities or so delivered (x) shall only be used
by the Purchaser&rsquo; broker-dealer to deliver such Securities to DTC for the purpose of settling the Investor&rsquo;s share
delivery obligations with respect to the sale of such Securities, which may include delivery to other accounts of such broker-dealer
and inclusion in the number of Securities delivered by that broker-dealer in &ldquo;net settling&rdquo; that broker-dealer&rsquo;s
trading of the Shares, including its positions with the broker-dealers of the respective persons who purchase such Securities from
the Purchaser, and (y) shall remain &ldquo;restricted securities&rdquo; as such term is defined in Rule 144(a)(3) under the
Securities Act until so delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(e) The Company
agrees that, no later than the earlier of (i) two Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined below) following the delivery by the Purchaser to the Company and the Transfer Agent the documentation deliverable
by the Purchaser pursuant to <U>Section 4.1(c)</U> or the Transfer Agent Deliverables pursuant to <U>Section 4.1(d)</U>, as applicable
(such date, the &ldquo;<B><U>Legend Removal Date</U></B>&rdquo;), deliver or cause to be delivered to the Purchaser a certificate representing
such Shares or Warrant Shares, as applicable, that is free from all restrictive and other legends (or provide evidence of issuance in
book entry form). The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this <U>Section 4.1</U>. Certificates for Shares or Warrant Shares subject to legend removal hereunder shall
be transmitted by the Transfer Agent, upon the payment of any share issuance fee by the Company, to deliver and credit such Securities
using the DWAC or deliver order (DO) system maintained by DTC (or any similar program hereafter adopted by DTC performing substantially
the same function) to the account with DTC of the Purchaser&rsquo;s designated broker-dealer as specified by the Purchaser. As used herein,
&ldquo;<B><U>Standard Settlement Period</U></B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on
the Company&rsquo;s Principal Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing
Shares or Warrant Shares, as applicable, issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(f) In addition
to the Purchaser&rsquo;s other available remedies, the Company shall pay to the Purchaser, in cash, (i) as partial liquidated damages
and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are
submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to <U>Section 4.1(c)</U> and <U>Section 4.1(d)</U>,
$10 per Trading Day (increasing to $20 per Trading Day five Trading Days after such damages have begun to accrue) for each Trading Day
after the Legend Removal Date until such certificate is delivered without a legend, provided that the Purchaser, in good faith, cooperates
reasonably with, and takes such customary actions as may be reasonably requested by, the Company in connection with the delivery of such
certificate without a legend, and (ii) if the Company fails to (A) issue and deliver (or cause to be delivered) to the Purchaser by the
Legend Removal Date a certificate representing the Securities so delivered to the Company by the Purchaser that is free from all restrictive
and other legends, and (B) if, after the Legend Removal Date, the Purchaser purchases (in an open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction of a sale by the Purchaser of all or any portion of the number of Shares or Warrant Shares,
or a sale of a number of shares of Common Stock equal to all or any portion of the number of Shares or Warrant Shares that the Purchaser
anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of the Purchaser&rsquo;s total
purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In Price</U></B>&rdquo;) over the product
of (C) such number of shares of Common Stock that the Company was required to deliver to the Purchaser by the Legend Removal Date multiplied
by (D) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by
the Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date of such delivery and
payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>4.2 <U>Acknowledgment
of Dilution</U></B>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations
under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to
the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay, or
reduction, regardless of the effect of any such dilution or any claim the Company may have against the Purchaser and regardless of
the dilutive effect that such issuance may have on the ownership of the other equityholders of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>4.3
<U>Furnishing of Information; Public Information</U></B><FONT STYLE="font-weight: normal">.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(a) Until the
earliest of the time that (i) the Purchaser owns no Securities or (ii) the Purchaser owns no Securities other than the Warrants and all
Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.75in">(b) At any time
during the period commencing from the six month anniversary of the date hereof, and ending at such time that all of the Securities may
be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144 (i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;<B><U>Public Information Failure</U></B>&rdquo;) then, in addition to the Purchaser&rsquo;s
other available remedies, the Company shall pay to the Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to one percent (1%) of the aggregate
Subscription Amount of the Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every 30<SUP>th</SUP> day (pro-rated
for periods totaling less than 30 days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b)
such time that such public information is no longer required for the Purchaser to transfer any Shares pursuant to Rule 144. The payments
to which the Purchaser shall be entitled pursuant to this <U>Section 4.3(b)</U> are referred to herein as &ldquo;<B><U>Public Information
Failure Payments</U></B>.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar
month during which such Public Information Failure Payments are incurred and (ii) the third Business Day after the event or failure giving
rise to the Public Information Failure Payments is cured. If the Company fails to make Public Information Failure Payments in a timely
manner, such Public Information Failure Payments shall bear interest at the rate of one and one-half percent (1.5%) per month (prorated
for partial months) until paid in full. Nothing herein shall limit the Purchaser&rsquo;s right to pursue actual damages for the Public
Information Failure, and the Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.4 <U>Integration</U></B>.
The Company shall not sell, offer for sale, solicit offers to buy, or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the
Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to
the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.5  <U>Exercise
Procedures</U></B>. The form of Notice of Exercise included in the Warrants sets forth the totality of the procedures required of the
Purchaser to exercise the Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor
shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required, to exercise any
Warrant. No additional legal opinion, other information, or instructions shall be required of the Purchaser to exercise any Warrant. The
Company shall honor exercises of the Warrants that are exercised in accordance with the terms set forth in the Transaction Documents and
shall deliver Warrant Shares in accordance with the terms, conditions, and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.6  <U>Securities
Laws Disclosure; Publicity</U></B>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms
of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the SEC within the time required by the Exchange Act. From and after the issuance of such press release, the Company shall have publicly
disclosed all material, non-public information delivered to the Purchaser by the Company or any of its Subsidiaries, or any of their respective
officers, directors, employees, or agents in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, or Affiliates on the one hand, and the Purchaser or any of their Affiliates on the other hand, shall terminate. The
Company and the Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated
hereby, and neither the Company nor the Purchaser shall issue any such press release nor otherwise make any such public statement without
the prior consent of the Company, with respect to any press release of the Purchaser, or without the prior consent of the Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of the Purchaser, or include the name
of the Purchaser in any filing with the SEC or any regulatory agency or Trading Market, without the prior written consent of the Purchaser,
except (a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights
Agreement and (ii) the filing of final Transaction Documents with the SEC, and (b) to the extent such disclosure is required by law or
Trading Market regulations, in which case the Company shall provide the Purchaser with prior notice of such disclosure permitted under
this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.7 <U>Shareholder
Rights Plan</U></B>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that
the Purchaser is an &ldquo;<B><U>Acquiring Person</U></B>&rdquo; under any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement), or similar anti-takeover plan or arrangement in effect or hereafter
adopted by the Company, or that the Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue
of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.8  <U>Non-Public
Information</U></B>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to <U>Section 4.6</U>, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf, will provide the Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto the Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that the Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries,
or any of their respective officers, director, agents, employees, or Affiliates delivers any material, non-public information to the Purchaser
without the Purchaser&rsquo;s consent, the Company hereby covenants and agrees that the Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees, or Affiliates, or a duty to
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, or Affiliates not to trade on
the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K.
The Company understands and confirms that the Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.9  <U>Use
of Proceeds</U></B>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital and general
corporate purposes and shall not use such proceeds (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment
of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common Stock
or Share Equivalents, (c) for the settlement of any outstanding litigation, or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.10
<U>Indemnification of the Purchaser</U></B><FONT STYLE="font-weight: normal">.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(a)
Subject to the provisions of this <U>Section 4.10</U>, the Company will indemnify and hold the Purchaser and its directors, officers,
shareholders, members, managers, partners, employees, and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls the Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members,
partners, or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each, a &ldquo;<B><U>Purchaser Party</U></B>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs, and expenses, including all judgments, amounts paid
in settlements, court costs, and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (i) any breach of any of the representations,warranties, covenants, or agreements made by the
Company in this Agreement or in the other Transaction Documents, (ii) any cause of action, Action, proceeding, or claim (any, a &ldquo;<B><U>Claim</U></B>&rdquo;)
instituted by the Company or its Affiliates or representatives or agents against the Purchaser Parties in any capacity, or any of them
or their respective Affiliates, with respect to any of the transactions contemplated by the Transaction Documents (unless such action
is solely based upon a material breach of such Purchaser Party&rsquo;s representations, warranties, or covenants under the Transaction
Documents or any agreements or understandings such Purchaser Party may have with any such shareholder or any violations by such Purchaser
Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute
fraud, gross negligence, or willful misconduct), or (iii) any Claim brought or made against a Purchaser Party by a third party (including
for these purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves such Purchaser
Party that arises out of or results from (A) the execution, delivery, performance, or enforcement of any of the Transaction Documents,
(B) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the
Securities, or (C) the status of the Purchaser or holder of the Securities either as an investor in the Company pursuant to the transactions
contemplated by the Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise
in any Action for injunctive or other equitable relief) (unless such action is solely based upon a material breach of such Purchaser
Party&rsquo;s representations, warranties, or covenants under the Transaction Documents or any agreements or understandings such Purchaser
Party may have with any such shareholder or any violations by such Purchaser Party of state or federal securities laws or any conduct
by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence, or willful misconduct).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(b) If any Action
shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party
shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own
choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such
Action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party
except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has
failed after a reasonable period of time to assume such defense and to employ counsel, or (iii) in such Action there is, in the reasonable
opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party,
in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company
will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s
prior written consent, which shall not be unreasonably withheld or delayed, or (z) to the extent, but only to the extent that a loss,
claim, damage, or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants,
or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this
<U>Section 4.10(b)</U> shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as
and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of Action or
similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.11
<U>Reservation and Listing of Securities</U></B><FONT STYLE="font-weight: normal">.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(a) The Company covenants
that while any Warrant remains outstanding, the Company will reserve from its authorized and unissued Common Stock, the number of shares
of Common Stock, free from pre-emptive rights, that would be issuable upon full, unconditioned exercise of the Warrants calculated on
the basis of the exercise price, respectively, in effect as of the Closing Date, which such reserved amounts shall be increased by the
Company from time to time, and in no event less than every three (3) months, in accordance with its obligations under such Securities
(the &ldquo;<B><U>Required Minimum</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(b)
The Company shall, if applicable (i) in the time and manner required by the principal Trading Market, prepare and file with such
Trading Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required
Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for
listing or quotation on such Trading Market as soon as possible thereafter, (iii) provide to the Purchaser evidence of such listing
or quotation, and (iv) maintain the listing or quotation of such shares of Common Stock on any date at least equal to the Required
Minimum on such date on such Trading Market or another Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.12  <U>Transfer
Agent; Instructions</U></B>. The Company shall maintain the appointment of the Transfer Agent for so long as the Purchaser holds any Securities.
If the Company&rsquo;s agency relationship the Transfer Agent should be terminated for any reason while the Purchaser holds any Securities,
the Company shall immediately appoint a successor transfer agent and shall provide the Transfer Agent with a copy of this Agreement and
the Warrants then outstanding. Failure to adhere to this covenant shall automatically be deemed a material breach of this Agreement and
the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.13 <U>Confidentiality</U></B>.
The Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the
Company pursuant to the initial press release as described in <U>Section 4.6</U>, the Purchaser will maintain the confidentiality of
the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) the
Purchaser makes no representation, warranty, or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the
initial press release as described in <U>Section 4.6</U>, (ii) the Purchaser shall not be restricted or prohibited from effecting
any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in <U>Section
4.6</U>, and (iii) the Purchaser shall have not any duty of confidentiality or duty not to trade in the securities of the Company to
the Company or its Subsidiaries after the issuance of the initial press release as described in <U>Section 4.6</U>. Notwithstanding
the foregoing, if the Purchaser is or becomes a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of the Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of the Purchaser&rsquo;s assets, the covenant set forth above shall only apply with
respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.14  <U>Form
D; Blue Sky Filings</U></B>. If applicable, the Company agrees to timely file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof, promptly upon request of the Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchaser at
each Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States and shall provide evidence
of such actions promptly upon request of the Purchaser.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.15
<U>Capital Changes</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(a) Except for the
reverse split process that has already begun as of the date hereof, from the date hereof until such time as the Purchaser no longer holds
any Securities, the Company shall not, without the Purchaser&rsquo;s prior written consent (which consent shall be provided at the Purchaser&rsquo;s
sole and unfettered discretion) undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written
consent of the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(b) Except for the
reverse split process that has already begun as of the date hereof, if the Company terminates the ELOC on or prior to October 1, 2025,
from the ELOC Termination Date until such time as the Purchaser no longer holds any Securities, the Company shall not, directly or indirectly,
without the Purchaser&rsquo;s prior written consent (which consent shall be provided at the Purchaser&rsquo;s sole and unfettered discretion):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(i)  increase
or decrease the authorized number of shares of Common Stock or any series thereof; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii)  create,
or hold capital stock in, any Subsidiary that is not wholly owned (either directly or through one or more other Subsidiaries) by the Company
(or substantially wholly owned other than de minimis holdings of a second holder required by non-U.S. law), or permit any Subsidiary to
create, or issue or obligate itself to issue, any shares of any class or series of capital stock, or sell, transfer or otherwise dispose
of any capital stock of any direct or indirect Subsidiary of the Company, or permit any direct or indirect subsidiary to sell, lease,
transfer, exclusively license or otherwise dispose (in a single transaction or series of related transactions) of all or substantially
all of the assets of such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(c) For avoidance of
doubt, <U>Section 4.15(b)</U> shall be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.16  <U>Subsequent
Registrations</U></B>. If as result of an SEC staff policy, rule, or regulation or for any other reason, the Company is unable to register
all of the Purchaser&rsquo;s Registrable Securities (as defined in the Registration Rights Agreement), then upon 30 days (or such earlier
time as is permitted by the Staff of the SEC or any rule of the SEC) after any Resale Registration Statement filed pursuant to the Registration
Rights Agreement is declared effective by the SEC, the Company shall file another Resale Registration Statement including all of the remaining
Registrable Securities of the Purchaser and comply with the terms and conditions set forth in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in; text-align: justify">4.17
<U>Restriction on Activities</U><FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(a) From the date hereof
until such time as the Purchaser no longer holds any Securities, the Company shall not, directly or indirectly, without the Purchaser&rsquo;s
prior written consent (which consent shall be provided at the Purchaser&rsquo;s sole and unfettered discretion):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(i)
materially change the nature of its business; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii)  sell,
divest, or change the structure of any material assets other than in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(b) If the Company terminates
the ELOC on or prior to October 1, 2025, from the ELOC Termination Date until such time as the Purchaser no longer holds any Securities,
the Company shall not, directly or indirectly, without the Purchaser&rsquo;s prior written consent (which consent shall be provided at
the Purchaser&rsquo;s sole and unfettered discretion):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(i)
amend the Company's articles of incorporation or bylaws in any manner;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii)
liquidate, dissolve or wind-up the business and affairs of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iii)  merge,
consolidate, or otherwise combine the Company with or into any other entity, or effect any sale, lease, license, assignment (for the benefit
of creditors or otherwise), transfer or other conveyance or disposition of any material portion of the assets of the Company or any of
its Subsidiaries, or any consolidation, merger or share exchange involving the Company or any Subsidiary or any reclassification or other
change of any stock, or any recapitalization, or any dissolution, liquidation or winding up of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iv)  acquire,
by purchase, exchange, merger, consolidation or other business combination, lease, assignment, or other transfer or conveyance, or series
of transfers or conveyances, of, all or substantially all of the properties or assets of any other corporation, entity or business (as
determined in accordance with Rule 11-01(d) of Regulation S-X promulgated by the SEC), or enter into a joint venture or partnership with
any other entity, in each case involving the payment of consideration or contribution by the Company or any Subsidiary in an aggregate
amount or value in excess of $1,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(v)  purchase,
redeem or otherwise acquire for value (or pay into or set aside as a sinking fund for such purpose) any of the capital stock of the Company;
provided, that this provision shall not apply to (i) the repurchase of shares of capital stock pursuant to this Agreement and (ii) the
repurchase of shares of capital stock from directors, officers, employees or consultants or of advisers to the Company or any Subsidiary
pursuant to agreements under which the Company has the option to repurchase such shares upon the occurrence of certain events, including
the termination of employment by or service to the Company or any Subsidiary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(vi)  increase
or decrease the authorized number of directors constituting the Board of Directors, or change the number of votes entitled to be cast
by any director or directors on any matter;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(c)
For avoidance of doubt, <U>Section 4.17(b)</U> shall be waived if the Company does not terminate the ELOC on or prior to October 1,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.18  <U>Corporate
Existence</U></B>. From the date hereof until such time as the Purchaser no longer holds any Securities, the Company shall maintain its
corporate existence and shall not sell all or substantially all of the Company&rsquo;s assets, except in the event of a merger or consolidation
or sale of all or substantially all of the Company&rsquo;s assets, where the surviving or successor entity in such transaction (i) assumes
the Company&rsquo;s obligations hereunder and under the Transaction Documents and (ii) is a publicly traded corporation whose common stock
is listed for trading or quotation on the Principal Market, any tier of the Nasdaq Stock Market, the New York Stock Exchange, or the NYSE
MKT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.19  <U>No
Broker-Dealer Acknowledgement</U></B>. Absent a final adjudication from a court of competent jurisdiction stating otherwise, the Company
shall not, to any Person, institution, governmental, or other entity, state, claim, allege, or in any way assert, that (a) the Purchaser
is currently, or ever has been, a broker or dealer under the Exchange Act, or (b) is currently, or ever has been, required to register
as a broker or dealer under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.20  <U>Notice
of Disqualification Events</U></B>. The Company will notify the Purchaser in writing, prior to the Closing Date of (a) any Disqualification
Event relating to any Issuer Covered Person and (b) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.21  <U>Common
Stock Purchase Agreement</U></B>. The Purchaser and the Company shall negotiate and enter into the ELOC, substantially in the form attached
hereto as <U>Exhibit D</U>, on or before the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.22  <U>Redemption
Upon ELOC Effectiveness</U></B>. Provided the Company does not terminate the ELOC on or prior October 1, 2025, the Company, upon written
notice to the Purchaser, may redeem 488,263 Shares acquired by Purchaser pursuant this Agreement at a redemption price of $0.0001 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.23 <U>Filing
of Registration Statement</U></B>. If the Company terminates the ELOC on or prior to October 1, 2025 (such date, the
&ldquo;<B><U>ELOC Termination Date</U></B>&rdquo;), the Company shall file with the SEC, within five (5) Business Days after the
ELOC Termination Date, a Resale Registration Statement in compliance with the terms of the Registration Rights Agreement, covering
only the resale by the Purchaser of the Securities by the Investor; provided, however, that this deadline shall be tolled by one
Business Day for each Business Day that the SEC is closed due to a shutdown of the United States government. The Resale Registration
Statement shall relate to the transactions contemplated by, and describing the material terms and conditions of, this Agreement and
disclosing all information relating to the transactions contemplated hereby required to be disclosed in the Resale Registration
Statement and the prospectus supplement as of the date of the Resale Registration Statement, including, without limitation,
information required to be disclosed in the section captioned &ldquo;Plan of Distribution&rdquo; in the Resale Registration
Statement. The Company shall permit the Purchaser to review and comment upon the Resale Registration Statement within a reasonable
time prior to their filing with the SEC, the Company shall give reasonable consideration to all such comments, and the Company shall
not file a Current Report on Form 8-K or the Resale Registration Statement with the SEC in a form to which the Purchaser reasonably
objects. The Purchaser shall furnish to the Company such information regarding itself, the Company&rsquo;s securities beneficially
owned by the Purchaser and the intended method of distribution thereof, including any arrangement between the Purchaser and any
other person or relating to the sale or distribution of the Company&rsquo;s securities, as shall be reasonably requested by the
Company in connection with the preparation and filing of a Current Report on Form 8-K and the Resale Registration Statement, and
shall otherwise cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of a
Current Report on Form 8-K and the Resale Registration Statement with the SEC. The Company shall have no knowledge of any untrue
statement (or alleged untrue statement) of a material fact or omission (or alleged omission) of a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not
misleading, in any pre- existing registration statement filed or any new registration statement or prospectus which is a part of the
foregoing. The Company shall promptly give the Purchaser notice of any event (including the passage of time) which makes the final
prospectus not to be in compliance with Section 5(b) or 10 of the Securities Act and shall use its commercially reasonable efforts
thereafter to file with the SEC any Post-Effective Amendment to the Resale Registration Statement, amended prospectus or prospectus
supplement in order to comply with Section 5(b) or 10 of the Securities Act. For avoidance of doubt, this <U>Section 4.23</U> shall
be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.24  <U>Shareholder
Approval</U></B>. If the Company terminates the ELOC on or prior to October 1, 2025, the Company shall file with the SEC the Company shall
take all action necessary to duly call, give notice of, convene, and hold a shareholder meeting (the &ldquo;Shareholder Meeting&rdquo;)
as soon as reasonably practicable, but in no event later than one hundred twenty (120) days after the ELOC Termination Date, for the approval
by the Company&rsquo;s shareholders of the issuance of the Securities pursuant to this Agreement in excess of the Exchange Cap (as defined
in the ELOC) (the &ldquo;<B><U>Shareholder Approval</U></B>&rdquo;). In connection with such Shareholder Meeting, the Company shall provide
each shareholder with a proxy statement and shall use its best efforts to solicit the Shareholder Approval. Notwithstanding the foregoing,
if at any such time, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares
of Common Stock to approve the issuance of the Securities pursuant to this Agreement in excess of the Exchange Cap, the Company may satisfy
this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C. For avoidance
of doubt, this <U>Section 4.24</U> shall be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.25
<U>Registration Failure Payments</U></B>. If the Resale Registration Statement is not declared effective within thirty (30) days of the
ELOC Termination Date (the &ldquo;<B><U>Required Registration Date</U></B>&rdquo;), the Company shall issue and deliver to the Purchaser
a number of shares of Common Stock equal to $250,000 divided by the lowest traded price of the Common Stock between the October 1, 2025
and the Required Registration Date; provided, however, that this deadline shall be tolled by one Business Day for each Business Day that
the SEC is closed due to a shutdown of the United States government; provided, further, that the Required Registration Date shall be
the date that is forty five (45) days after the ELOC Termination Date if the SEC notifies the Company there will be a &ldquo;review&rdquo;
of such Resale Registration Statement. For every thirty (30) days after the Required Registration Date that the Resale Registration Statement
is not declared effective, the Company shall issue and deliver to the Purchaser a number of additional shares of Common Stock equal to
$250,000 divided by the lowest traded price of the Common Stock during such thirty (30) day period. For avoidance of doubt, payments
pursuant to this <U>Section 4.25</U> shall be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.26  <U>Shareholder
Approval Failure Payments</U></B>. If the Shareholder Meeting is not held within one hundred twenty (120) days after the ELOC Termination
Date (the &ldquo;<B><U>Required Shareholder Meeting Date</U></B>&rdquo;), the Company shall issue and deliver to the Purchaser a number
of shares of Common Stock equal to $250,000 divided by the lowest traded price of the Common Stock between October 1, 2025 and the Required
Shareholder Meeting Date. For every thirty (30) days after the Required Shareholder Meeting Date that the Shareholder Meeting is not held,
the Company shall issue and deliver to the Purchaser a number of additional shares of Common Stock equal to $250,000 divided by the lowest
traded price of the Common Stock during such thirty (30) day period. For avoidance of doubt, payments pursuant to this <U>Section 4.26</U>
shall be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.27  <U>Shareholder
Approval Failure</U>.</B> If the Shareholder Approval is not obtained by the first Required Shareholder Meeting Date, the Company shall,
during the period beginning on such date and continuing 360 days thereafter, cause an additional Shareholder Meeting to be held every
ninety (90) days until the Shareholder Approval is obtained. For avoidance of doubt, this <U>Section 4.27</U> shall be waived if the Company
does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>4.28  <U>Restriction
on Subsequent Equity Sales</U></B>. If the Company terminates the ELOC on or prior to October 1, 2025, from the ELOC Termination Date
until such time as the Purchaser no longer holds any Securities, the Company shall not, directly or indirectly, without the Purchaser&rsquo;s
prior written consent (which consent shall be provided at the Purchaser&rsquo;s sole and unfettered discretion) issue additional shares
of Common Stock or Share Equivalents or capital stock of any Subsidiary or other securities. For avoidance of doubt, this <U>Section 4.28</U>
shall be waived if the Company does not terminate the ELOC on or prior to October 1, 2025.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.1pt">ARTICLE V.
<BR>
MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.1  <U>Termination</U></B>.
This Agreement may be terminated by the Purchaser or by the Company, by written notice to the other parties, if the Closing has not been
consummated on or before the first Trading Day following the date hereof, <U>provided</U>, <U>however</U>, that no such termination will
affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.2 <U>Fees
and Expenses</U></B>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants, and other experts, if any, and all other expenses incurred by such party incident to
the negotiation, preparation, execution, delivery, and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any
exercise notice delivered by the Purchaser), stamp taxes, and other taxes and duties levied in connection with the delivery of any
Securities to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.3  <U>Entire
Agreement</U></B>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the
parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.4 <U>Notices</U></B>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a) the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York,
New York time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a
Trading Day or later than 5:30 p.m. (New York, New York time) on any Trading Day, (c) the second Trading Day following the date of
mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.5  <U>Amendments;
Waivers</U></B>. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement of any
such waived provision is sought. No waiver of any default with respect to any provision, condition, or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition,
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any amendment effected in accordance with this <U>Section 5.5</U> shall be binding upon the Purchaser, the holder of
Securities, and the Company. Such amendment provision shall not be construed to mean that the Beneficial Ownership Limitation of any of
the Warrants may be increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.6  <U>Headings</U></B>.
The headings herein are for convenience only, do not constitute a part of this Agreement, and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.7  <U>Successors
and Assigns</U></B>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Purchaser (other
than by merger). The Purchaser may assign any or all of its rights under this Agreement to any Person to whom the Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.8
<U>No Third-Party Beneficiaries</U></B>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in <U>Section 4.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.9  <U>Governing
Law</U></B>. All questions concerning the construction, validity, enforcement, and interpretation of the Transaction Documents shall be
governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.10  <U>Survival</U></B>.
The representations and warranties contained herein shall survive each Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.11  <U>Execution</U></B>.
This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties, all of which together
will constitute one instrument, will be deemed to be an original, and will be enforceable against the parties. This Agreement may be delivered
to the other party hereto by email of a copy of this Agreement bearing the signature of the party so delivering the Agreement. The parties
agree that this Agreement shall be considered signed when the signature of a party is delivered by .PDF, DocuSign, or other generally
accepted electronic signature. Such .PDF, DocuSign, or other generally accepted electronic signature shall be treated in all respects
as having the same effect as an original signature. The signatories to this Agreement each represent and warrant that they are duly authorized
by the parties with the power and authority to bind the parties to the terms and conditions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.12  <U>Severability</U></B>.
If any term, provision, covenant, or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void, or unenforceable, the remainder of the terms, provisions, covenants, and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired, or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant, or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants, and restrictions without including any of such that may be hereafter declared invalid, illegal, void, or
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.13  <U>Rescission
and Withdrawal Right</U></B>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever the Purchaser exercises a right, election, demand, or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then the Purchaser may rescind or
withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand, or election in whole
or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an
exercise of the Warrant, the Purchaser shall be required to return any Shares subject to any such rescinded exercise notice concurrently
with the return to the Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of the Purchaser&rsquo;s
right to acquire such shares pursuant to such Warrant (including issuance of a replacement warrant certificate evidencing such restored
right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.14 <U>Replacement
of Securities</U></B>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen, or destroyed, the
Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of
mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft, or destruction. The applicant for a new certificate or instrument under such
circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such
replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.15  <U>Remedies</U></B>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser and
the Company shall be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.16  <U>Payment
Set Aside</U></B>. To the extent that the Company makes a payment or payments to the Purchaser pursuant to any Transaction Document or
the Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver, or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.17  <U>Liquidated
Damages</U></B>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable
shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.18  <U>Saturdays,
Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any Action or the expiration of any right required or granted
herein shall not be a Business Day, then such Action may be taken, or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>5.19  <U>Construction</U></B>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
Shares or the price thereof in any Transaction Document shall be subject to adjustment for reverse and forward share splits, share dividends,
share combinations, and other similar transactions of the Shares that occur after the date of this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: 0in; text-align: justify">5.20
<U>Dispute Resolution</U><FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(a) <U>Disputes Regarding Certain Defined
Terms</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(i)  In
the case of a dispute relating to the, Buy-In Price, Exercise Price, or VWAP (as the case may be) (including, without limitation, a dispute
relating to the determination of any of the foregoing) (a &ldquo;<B><U>Certain Defined Term Dispute</U></B>&rdquo;), the Company or the
Purchaser (as the case may be) shall submit the Certain Defined Term Dispute to the other party via facsimile or electronic mail within
five (5) Business Days after the party learned of the circumstances giving rise to such dispute. If the Purchaser and the Company are
unable to promptly resolve such Certain Defined Term Dispute, at any time after the second (2nd) Business Day following such initial notice
by the Company or the Purchaser (as the case may be) of such dispute to the Company or the Purchaser (as the case may be), then the Company
and the Purchaser may select an independent, reputable investment bank as mutually agreed upon to resolve such dispute. If the Parties
cannot agree upon such an investment bank within ten (10) Business Days of the date of the initial notice, the Parties shall submit the
dispute pursuant to <U>Section 5.20(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii)  The
Purchaser and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance
with the above and (B) written documentation supporting its position with respect to such dispute, in each case, no later than 5:00 p.m.
(New York time) by the fifth (5th) Business Day immediately following the date on which such investment bank was selected (the &ldquo;<B><U>Dispute
Submission Deadline</U></B>&rdquo;) (the documents referred to in the immediately preceding clauses (A) and (B) are collectively referred
to herein as the &ldquo;<B><U>Required Dispute Documentation</U></B>&rdquo;) (it being understood and agreed that if either the Purchaser
or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails
to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit
any written documentation or other support to such investment bank with respect to such dispute and such investment bank shall resolve
such dispute based solely on the Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission
Deadline). Unless otherwise agreed to in writing by both the Company and the Purchaser or otherwise requested by such investment bank,
neither the Company nor the Purchaser shall be entitled to deliver or submit any written documentation or other support to such investment
bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iii)  The
Company and the Purchaser shall cause such investment bank to determine the resolution of such dispute and notify the Company and the
Purchaser of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and
expenses of such investment bank shall be borne by the losing party, and such investment bank&rsquo;s resolution of such dispute shall
be final and binding upon all Parties. The terms of this Agreement, each other applicable Transaction Document, and the Required Dispute
Documentation shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment
bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment bank
determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving such dispute
such investment bank shall apply such findings, determinations and the like to the terms of this Agreement and any other applicable Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iv)
Both the Company and the Purchaser expressly acknowledge and agree that (i) this Section 5.20(a) constitutes an agreement to
arbitrate between the Company and the Purchaser (and constitutes an arbitration agreement) under &sect; 7501, et seq. of the New
York Civil Practice Law and Rules (&ldquo;<B><U>CPLR</U></B>&rdquo;) with respect to the dispute described in Section 5.20 and that
both the Company and the Purchaser are authorized to apply for an order to compel arbitration pursuant to CPLR &sect; 7503(a) in
order to compel compliance with this Section 5.20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(b) <U>Jurisdiction;
Waiver of Jury Trial</U>. Subject to Section 5.20(a), each party hereby irrevocably submits that any dispute, controversy, or claim
arising out of or relating to this Agreement or any Transaction Document (including whether any such dispute is arbitrable), shall
be submitted to the exclusive jurisdiction of the of the state and federal courts sitting in the City of New York, Borough of
Manhattan in the State of New York. Each party hereby irrevocably waives, and agrees not to assert in any suit, action, or
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action, or proceeding
is brought in an inconvenient forum or that the venue of such suit, action, or proceeding is improper. Each party hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy
thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address for such
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. <B>EACH
PARTY KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY, AND EXPRESSLY WAIVES FOREVER ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY
DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY</B>. The Company
and the Purchaser agree that all dispute resolution proceedings in accordance with this Section 5.20 may be conducted in a virtual
setting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in">(c) <U>Prevailing
Party Attorneys&rsquo; Fees</U>. If any party shall commence an Action to enforce any provisions of the Transaction Documents, then, in
addition to the obligations of the Company under <U>Section 4.10</U>, the prevailing party in such Action shall be reimbursed by the non-
prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation, and
prosecution of such Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Signature Pages Follow)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; text-align: justify; text-indent: 35.95pt">IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.</P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACTELIS NETWORKS, INC.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4039 Clipper Court</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fremont, California</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
  <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia Barlev</FONT></TD>
  <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email</U>:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tuvia.barlev@actelis.com</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><B></B>&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">PURCHASER SIGNATURE PAGE TO SECURITIES
PURCHASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned has
caused this Securities Purchase Agreement to be duly executed by its authorized signatory as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold">WHITE LION CAPITAL LLC</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name:&nbsp;</TD>
    <TD>Nathan Yee</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title:</TD>
    <TD>Managing Director </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Date: </TD>
    <TD>September 27, 2025</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">WHITE LION CAPITAL LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">21031 Ventura Blvd., Suite 920</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Encino, CA 91316</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Attention: Nathan Yee, Managing Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">E-mail: team@whitelioncapital.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Address for Delivery of Securities to Purchaser (if not
same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Subscription Amount:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ea025980401ex10-4_actelis.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR UNDER THE SECURITIES
LAWS OF ANY OTHER JURISDICTIONS. AS A RESULT, THESE SECURITIES MAY NOT BE OFFERED, TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE
ACT OR APPLICABLE STATE SECURITIES LAWS (PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM OR IN A TRANSACTION NOT SUBJECT THERETO).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PREFUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>aCTELIS
nETWORKS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">Warrant Shares: 2,320,722</TD><TD STYLE="text-align: right; width: 50%">Issue Date: September 26, 2025</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PREFUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, White Lion Capital LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
September 26, 2025 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 2,320,722 shares of (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase
price of the one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning specified in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Attribution
Parties</U>&rdquo; shall have the meaning specified in <U>Section 2(e)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning specified in <U>Section 2(e)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bloomberg</U>&rdquo;
means Bloomberg L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States, or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning specified in <U>Section 2(e)(iv)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company</U>&rdquo;
means Actelis Networks, Inc., a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Distribution</U>&rdquo;
shall have the meaning specified in <U>Section 3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>DWAC</U>&rdquo;
shall have the meaning specified in <U>Section 2(e)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exercise
Price</U>&rdquo; shall have the meaning specified in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning specified in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
means White Lion Capital LLC, a Nevada limited liability company, or its assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Exercise Date</U>&rdquo; means September 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Notice
of Exercise</U>&rdquo; shall have the meaning specified in <U>Section 2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchase
Rights</U>&rdquo; shall have the meaning specified in <U>Section 3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Standard
Settlement Period</U>&rdquo; shall have the meaning specified in <U>Section 2(e)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning specified in <U>Section 3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Termination
Date</U>&rdquo; means the date this Warrant is exercised in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading; provided, however, that if the Common Stock is not
listed or quoted on the Trading Market, then Trading Day shall mean any day except Saturday, Sunday, and any day which shall be a legal
holiday or a day on which banking institutions in the State of New York or State of Delaware are authorized or required by law or other
government action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB, or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means the current transfer agent of the Company and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of the Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant</U>&rdquo;
means this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; shall have the meaning specified in the preamble of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Register</U>&rdquo; shall have the meaning specified in <U>Section 4(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Share Delivery Date</U>&rdquo; shall have the meaning specified in <U>Section 2(e)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights for Warrant Shares represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office
or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the
books of the Company) of a duly executed notice of exercise in the form annexed hereto as Exhibit A (a &ldquo;<U>Notice of Exercise</U>&rdquo;),
which may be delivered in a .PDF format via electronic mail pursuant to the notice provisions set forth in <U>Section 5(i)</U>. Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in <U>Section
2(e)(i)</U> herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant
Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the
cashless exercise procedure specified in <U>Section 2(c)</U> below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise form be required. The Company shall be entitled to conclusively assume the genuineness of any signature on any Notice of Exercise
delivered to the Company pursuant to this <U>Section 2(a)</U>, the legal capacity and competency of all natural persons signing any Notice
of Exercise so delivered, the authenticity of any Notice of Exercise so delivered, the conformity to an authentic original of any Notice
of Exercise so delivered as certified, authenticated, conformed, photostatic, facsimile, or electronic and the authenticity of the original
of such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within two (2) Business Days of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(A) = </TD><TD STYLE="text-align: justify">as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise
is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
Day;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(B) = </TD><TD STYLE="text-align: justify">the Exercise
Price of this Warrant, as adjusted hereunder; and</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">(X) = </TD><TD STYLE="text-align: justify">the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Assuming (i) the
Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Section 4(a)(1) of the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;) and/or Rule 144 promulgated thereunder (&ldquo;<U>Rule 144</U>&rdquo;) with respect
to Holder and the Warrant Shares are met, in the case of such a cashless exercise, the Company agrees that the Company will either (A)
cause the Transfer Agent to issue such Warrant Shares without any restrictive legend in accordance with <U>Section 2(d)(ii)</U> below,
or (B) if such Warrant Shares are issued with a restrictive legend, use its best efforts to cause the removal of the legend from such
Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Transfer Agent at its own expense to ensure the
foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the exercise of the
Warrant prior to removing the legend. The Company expressly acknowledges that Rule 144(d)(3)(ii), as currently in effect, provides that
Warrant Shares issued solely upon a cashless exercise shall be deemed to have been acquired at the same time as the Warrant. The Company
agrees not to take any position contrary to this <U>Section 2(c)</U>. The Company shall pay all costs associated with any required opinions
of counsel, and counsel to the Company shall provide all opinions with respect to any resales pursuant to Section 4(a)(1) of the Securities
Act and/or Rule 144 promulgated thereunder or otherwise at the sole cost of the Company, and the Company shall provide confirmation to
the Transfer Agent that all such opinions are acceptable. If counsel to the Company fails to provide a legal opinion reasonably satisfactory
to the Company in accordance with this Section, the Holder shall have the right to provide an opinion of counsel selected by the Holder,
the cost of which shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Restrictive
Legend; Legend Removal</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Restrictive
Legend</U>. The Holder acknowledges that, unless the conditions of the issuance of unrestricted Warrant Shares have been satisfied, the
Warrant Shares acquired upon the exercise of this Warrant will have restrictions upon resale imposed by state and federal securities laws.
The certificate(s) or book-entry statement(s) representing any Warrant Shares issued hereunder, except as set forth below, shall bear
a restrictive legend in substantially the following form (and stop transfer instructions may be placed against transfer of any such Securities):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.25in; text-align: justify; text-indent: 0in">THE SHARES UNDERLYING
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR UNDER
THE SECURITIES LAWS OF ANY OTHER JURISDICTIONS. AS A RESULT THESE SECURITIES MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER
THE ACT OR APPLICABLE STATE SECURITIES LAWS (PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Legend
Removal</U>. Upon the written request by the Holder to the Company if, at the time of such request, the Holder covenants and agrees that
it has resold or will resell the Warrant Shares only (A)(i) pursuant to&nbsp;an effective registration statement registering the issuance
of the Warrant Shares to or resale of Warrant Shares by the Holder under the Securities Act, in a manner described under the caption &ldquo;Plan
of Distribution&rdquo; in such registration statement, in a manner in compliance with all applicable U.S. federal and state securities
laws, rules, and regulations, including, without limitation, any applicable prospectus delivery requirements of the Securities Act, or
(ii)&nbsp;in compliance with an available exemption under the Securities Act, and (B)&nbsp;concurrently with such request, the Holder
delivers to the Company, its counsel, and the Transfer Agent a customary written certification that the requirements set forth in clause
(A)&nbsp;are accurate, and if the Holder resold the Warrant Shares under (A)(ii), to the extent the Company&rsquo;s counsel or the Transfer
Agent requires, additional customary requirements to qualify for the applicable exemption under the Securities Act, the Company shall,
no later than two (2)&nbsp;Trading Days following the delivery by the Holder to the Transfer Agent of one or more legended certificates
or book-entry statements representing any Securities subject to such request, together with such other documentation from the Holder and
its designated broker-dealer as the Transfer Agent deem reasonably necessary and appropriate, authorize the Transfer Agent to remove the
Securities Act restrictive legend (and any stop transfer instructions placed against transfer thereof) contemplated by <U>Section&nbsp;2(d)(i)</U>
affixed to the Warrant Shares subject to such request. At the times the Company authorizes the removal of the Securities Act restrictive
legends on the Warrant Shares subject to such request (and any stop transfer instructions placed against transfer thereof) pursuant to
this <U>Section&nbsp;2(d)(ii)</U>), the Company shall, at its sole expense, use its commercially reasonable efforts to cause its legal
counsel to issue to the Transfer Agent a legal opinion or direction letter authorizing the Transfer Agent to remove the Securities Act
restrictive legends contemplated by <U>Section&nbsp;2(d)(i)</U> on the Warrant Shares subject to such request (which legal opinion or
direction letter may be delivered to the Transfer Agent in advance setting forth the conditions to the removal of such legends). The Company
shall be responsible for the fees of its Transfer Agent and the Company&rsquo;s legal counsel associated with any such legend removals.
If counsel to the Company fails to provide a legal opinion reasonably satisfactory to the Transfer Agent in accordance with this Section,
the Holder shall have the right to provide an opinion of counsel selected by the Holder, the cost of which shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. Upon the delivery by the Holder of a Notice of Exercise in accordance with <U>Section 2(a)</U>, the
Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through the deliver order (DO) system
maintained by DTC (or any similar program hereafter adopted by DTC performing substantially the same function) or its Deposit or Withdrawal
at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) the legend has been
properly removed from the Warrant in accordance with <U>Section 2(d)(ii</U>) or (B) there is an effective registration statement permitting
the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise. In any case, delivery
will be made by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and
(ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the Warrant
Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by
the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the VWAP of the Shares on the date of the applicable Notice of Exercise), $10 per
Trading Day (increasing to $20 per Trading Day on the fourth Trading Day after the Warrant Share Delivery Date) for each Trading Day after
such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the DTC/FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Shares as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Holder fails to make payment of the aggregate Exercise Price of the Warrant Shares pursuant to a Notice of Exercise
within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company by wire transfer or cashier&rsquo;s check
drawn on a United States bank, then the Company will have the right to rescind such exercise. If the Company fails to cause the Transfer
Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(e)(i)</U> by the Warrant Share Delivery Date, then the Holder
will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of <U>Section
2(e)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Shares
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Shares so purchased exceeds (y) the amount obtained by multiplying
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times
(2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such
exercise shall be deemed rescinded) or deliver to the Holder the number of Shares that would have been issued had the Company timely complied
with its exercise and delivery obligations hereunder. For example, if the Holder purchases Shares having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Shares upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional Shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes, and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such
Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that if Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall
be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto,
the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all fees charged by the
Transfer Agent and the Depository Trust Company (or other established clearing corporation) required for processing of any Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Holder&rsquo;s
Exercise Limitations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. The
Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant,
pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the
applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together
with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;), would &ldquo;beneficially
own&rdquo; (as defined for purposes of Section 13(d) of the 1934 Act) in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of calculating &ldquo;beneficial ownership&rdquo; under this <U>Section 2(f)</U>, the number of Shares beneficially owned
by the Holder and its Affiliates and Attribution Parties shall include the number of Shares issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of Shares which would be issuable upon (i) exercise of
the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
(ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this
<U>Section 2(f)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is
in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this <U>Section 2(f)</U> applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are in non-compliance with the Beneficial Ownership Limitation, it being
understood that the Company has the right to confirm that any exercise does not result in &ldquo;holdings&rdquo; of the Holder exceeding
the Beneficial Ownership Limitation. In addition, a determination as to any group status as contemplated above shall be determined in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <U>Section
2(f)</U>, in determining the number of outstanding Shares and Shares, a Holder may rely on the number of outstanding Shares and Shares
as reflected in (A) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form
8-K, or other public filings filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C)
a more recent written notice by the Company or the Transfer Agent setting forth the number of Shares outstanding. Upon the written request
of a Holder (which, for clarity, includes electronic mail), the Company shall within one Trading Day confirm orally and in writing to
the Holder the number of Shares then outstanding. In any case, the number of outstanding Shares shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as
of which such number of outstanding Shares was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the
number of Shares outstanding immediately after giving effect to the issuance of Shares issuable upon exercise of this Warrant. The Holder,
upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Shares outstanding immediately after giving effect
to the issuance of Shares upon exercise of this Warrant held by the Holder and the provisions of this <U>Section 2(f)</U> shall continue
to apply. Any change in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this <U>Section 2(f)</U> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the
intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. To
the extent the exercise of any portion of this Warrant requires the Company to receive the approval of the Company&rsquo;s shareholders
pursuant to applicable Trading Market, the Company shall not effect such exercise of this Warrant, and a Holder shall not have the right
to exercise any such portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, unless and until such approval has been received
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Share
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes
a distribution or distributions on Shares or any other equity or equity equivalent securities payable in Shares (which, for avoidance
of doubt, shall not include any Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Shares into a
larger number of Shares, (iii) combines (including by way of reverse share split) outstanding Shares into a smaller number of Shares,
or (iv) issues by reclassification of Shares or any shares of capital stock of the Company, then in each case the Exercise Price shall
be multiplied by a fraction of which the numerator shall be the number of Shares (excluding treasury Shares, if any) outstanding immediately
before such event (including those representing Shares) and of which the denominator shall be the number of Shares outstanding immediately
after such event, and the number of Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective
immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision, combination, or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, during such time as this Warrant is outstanding,
if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Shares
are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or &ldquo;holding&rdquo; or &ldquo;beneficial
ownership&rdquo; of such Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of Shares, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Shares acquirable upon complete exercise of this Warrant (without regard to
any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of
which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Shares are to
be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that the Holder's right
to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall
not be entitled to participate in such Distribution to such extent (or in the &ldquo;holding&rdquo; or &ldquo;beneficial ownership&rdquo;
of any Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person (other than for the purpose of changing the jurisdiction
of incorporation of the Company or a holding company for the Company), (ii) the Company, directly or indirectly, effects any sale, lease,
license, assignment, transfer, conveyance, or other disposition of all or substantially all of its assets (on a consolidated basis) in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer, or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Shares are permitted to sell, tender or exchange their shares for
other securities, cash, or property and has been accepted by the holders of greater than 50% of the voting power of the outstanding securities
of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization,
or recapitalization of the Shares or any compulsory share exchange pursuant to which the Shares are effectively converted into or exchanged
for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger, or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires greater than 50%
of the outstanding Shares or greater than 50% of the voting power of the outstanding securities of the Company (not including any Shares
held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such
share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
<U>Section 2(f)</U> on the exercise of this Warrant), the number of Shares or other capital stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in <U>Section 2(f)</U> on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one Share in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Shares are given any choice as to the securities, cash, or property to be received in a
Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which
the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company
under this Warrant in accordance with the provisions of this <U>Section 3(d)</U> pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the Shares acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the Shares
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to
each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and
such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Calculations</U>.
All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this <U>Section 3</U>, the number of Shares deemed to be issued and outstanding as of a given date shall be the sum of
the number of Shares (excluding treasury Shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the Company shall promptly
deliver via electronic mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Shares,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Shares, (C) the Company shall authorize the
granting to all holders of the Shares rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Shares, any
consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all
of its assets, or any compulsory share exchange whereby the Shares are converted into other securities, cash, or property, or (E) the
Company shall authorize the voluntary or involuntary dissolution, liquidation, or winding up of the affairs of the Company, then, in each
case, the Company shall cause to be delivered via electronic mail to the Holder at its last address as it shall appear upon the Warrant
Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights, or warrants, or if a
record is not to be taken, the date as of which the holders of Shares of record to be entitled to such dividend, distributions, redemption,
rights, or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer, or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Shares of record shall
be entitled to exchange their Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
sale, transfer, or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this
Warrant constitutes, or contains, material, non-public information regarding the Company or any of its Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the provisions below, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto as
Exhibit B duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee
of this Warrant, as the case may be, to provide to the Company and the Transfer Agent an opinion of counsel selected by the transferor
and reasonably acceptable to the Company and the Transfer Agent, the cost of which shall be borne by the Company and the form and substance
of which opinion shall be reasonably satisfactory to the Company and the Transfer Agent, to the effect that such transfer does not require
registration of such transferred Warrants or Warrant Shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act; provided, however, that the Investor reserves the right to dispose of the Warrant
Shares at any time in accordance with federal and state securities laws and the applicable securities laws of any jurisdiction relevant
to such disposition and subject to compliance with the terms of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends,
or other rights as a shareholder of the Company prior to the exercise hereof as set forth in <U>Section 2(a)</U>, except as expressly
set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive cash payments pursuant to <U>Section 2(e)(i)</U> and
<U>Section 2(e)(iv)</U> herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Loss,
Theft, Destruction, or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft, or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or Share certificate, if mutilated, the Company will make
and deliver a new Warrant or Share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Shares a sufficient number of Shares to provide for the deposit of Shares for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this
Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Shares may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith,
be duly authorized, validly issued, fully paid, and nonassessable and free from all taxes, liens, and charges created by the Company in
respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Transfer
Agent Instructions</U>. The Company covenants and agrees that it will, at all times during the period the Warrant is outstanding, maintain
a duly qualified independent Transfer Agent. Subject to <U>Section 5(g)</U>, the Company warrants that it will not direct its Transfer
Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring (or issuing and delivering) (electronically or
in certificated form) any certificate or book-entry statement for Warrant Shares to be issued to the Holder upon exercise of or otherwise
pursuant to this Warrant as and when required by this Warrant (provided, however, that the Transfer Agent shall not be required to remove
restrictive legends from the Warrant Shares if it has not received customary and reasonable documentation with respect to such removal
to its satisfaction and in accordance with this Warrant). Nothing in this Section shall affect in any way the Holder&rsquo;s obligations
to comply with all applicable prospectus delivery requirements, if any, upon resale of the Warrant Shares. As a condition to any resale
of the Warrant Shares, (x) the Company or the Transfer Agent may require an opinion of the Company&rsquo;s legal counsel, the form and
substance of which opinion shall be reasonably satisfactory to the Company, its legal counsel, and the Transfer Agent to the effect that
such resale has been registered under the Securities Act or does not require registration under the Securities Act pursuant to an available
exemption therefrom, and (y) the Investor shall provide to the Company, its legal counsel, and the Transfer Agent such representations
by the Investor and/or the broker executing such resale or other documentation required by the Company, its legal counsel, and the Transfer
Agent in support of such opinion. If the Company fails to cause its legal counsel to provide the legal opinion described in the immediately
preceding sentence in connection with a resale effected pursuant to an exemption from registration under the Securities Act (including
Section 4(a)(1) of the Securities Act and/or Rule 144 promulgated thereunder) and if permitted by the Transfer Agent, the Investor shall
have the right to provide an opinion of a legal counsel selected by the Investor and reasonably acceptable to the Company, which opinion
shall be in form and substance satisfactory to the Company (together with any representations by the Investor and/or the broker executing
such resale or other documentation required by the Company, and the Transfer Agent in support of such opinion), the cost of which shall
be borne by the Company. The Company shall also pay all costs associated with any opinions delivered by its legal counsel. If the Company
or a Holder provides such an opinion and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of
the Warrant Shares, promptly instruct its Transfer Agent to issue and deliver one or more certificates or book-entry statements, free
from restrictive legend, in such name and in such denominations as specified by the Holder with respect to such Warrant Shares. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating the intent and purpose
of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this <U>Section 5(e)</U> may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this Section, that the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any breach
and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits that any dispute, controversy, or claim arising out of or relating to this Warrant
shall be submitted to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan
in the State of New York. Each party hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for
such notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. The Company and the Holder agree that
all dispute resolution proceedings in accordance with this <U>Section 5(f)</U> may be conducted in a virtual setting. If either party
shall commence an action, suit, or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or
proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with
the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers, or remedies, notwithstanding that all rights hereunder
terminate on the Termination Date. If the Company fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally or by e-mail, addressed to the Company, at Actelis Networks Inc., 4039 Clipper
Court Fremont, California, Attention: Yoav Efron, Chief Financial Officer and Deputy Chief Executive Officer, email address: yoave@actelis.com
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other
communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent
by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
prior to 4:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 4:30 p.m. (New
York City time) on any Trading Day, or (iii) upon actual receipt by the party to whom such notice is required to be given. To the extent
that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant, without the necessity of showing economic loss and without any bond or other security being
required. The Company agrees that monetary damages may not be adequate compensation for any loss incurred by reason of a breach by it
of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that
a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <U>Severability</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>Actelis networks, inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 5%">Name:&nbsp;</TD>
  <TD STYLE="width: 31%">Tuvia Barlev</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: actelis
networks, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0pt">&#9744; &nbsp;&nbsp;&nbsp;in lawful
money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 112.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.25in">&#9744;  &nbsp;&nbsp;&nbsp;if permitted,
the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ___________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ____________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase Warrant Shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print) </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:_______________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT>________________</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>asns-20250927.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K4ps7xRiXgOn8uBan0sSaqIScP9wZ1yWZkxvW97bRm6zyorc7L5qi3WsX42oc8A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ASNS="http://actelis.com/20250927" elementFormDefault="qualified" targetNamespace="http://actelis.com/20250927">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://actelis.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="asns-20250927_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="asns-20250927_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>asns-20250927_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>asns-20250927_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="asns-20250927.xsd#Cover" roleURI="http://actelis.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://actelis.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Actelis Networks, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2160309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4039 Clipper Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">545-1045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASNS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0259804-8k_actelis.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://actelis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asns-20250927.xsd</File>
    <File>asns-20250927_lab.xml</File>
    <File>asns-20250927_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0259804-8k_actelis.htm">ea0259804-8k_actelis.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0259804-8k_actelis.htm": {
   "nsprefix": "ASNS",
   "nsuri": "http://actelis.com/20250927",
   "dts": {
    "schema": {
     "local": [
      "asns-20250927.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "asns-20250927_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asns-20250927_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0259804-8k_actelis.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://actelis.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0259804-8k_actelis.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0259804-8k_actelis.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-25-095449-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-095449-xbrl.zip
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M8"SM,811 1Y!.4Q$,\<*6 I5!FKC.LA6\PC+C=#4M4*X\&_] @N1PI0D(YF
M:JUZ4^\5Q2%FZIJ+\ J/8$QU'N\QI&1$<& !!<48*S-C,H((5XOE<PH9XWJ<
M]4IE%F.+(J+GM3!HD^EO6W"*?^C$@3GH?=H8P?C<2ZYO! N0H&NEQR6M7"W
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M%P]D9L_']4 FP2&]IB T'"CYYC.DHP3E*DDL+KWY<\,$[89"46D.GB/""T!
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M#!5ANN@<Z;JQ!]S;:8MOW"_W!E9[Y']02P,$%     @ S(-"6X;?@ODU'P
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MLEV)&OH(/E)!6IA3 !?"AMGC5N'"-UCIG(ZX08RKYIFN>6-<N/);(?%@8#D
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M-*F[DM0B"KU@(]W%#)V'"8!L2E]_,AWO9OLOHTZ?; *JU>4(.+EV8;\MLD*
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MDUM6_H #$ OS9? +1AG@ZR^54MY^-CX^^^M,@T[ R^#R;@GO.2C )IF^#,Y
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M@/9[WAJ ,41B+46LK>P'@BC3T] IUD/ +G4_O37ZFU'PA.)'QP.!S^2Z1 S
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MAQG%JO)+^/^CLS<OR<."]3X#K^O7T>7/P>G@UXNUEF&,C7?O6"7")LR+)4Z
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MA\]>?!\^.WQ!' $M/].^UT1=LJI<[Z)UY =!=ZPCJ(4ZJIJA!,8[>%;ZO+M
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M>M:9R'&T!/U:?]0)MUN:R2L7]H)?C)O'LQCZ8H191J4J(4H4.J8ME(LC_Z'
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MUD/&7SU8WQ1.,'C2;=[O[3T6V,\K+>@[B>Z<,&-2:4&6MUZA\0S]EZ""6N>
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MRZTBF\19C%XMTR9@D[^&]K.)G(HX ?N]10R"2H[5S)$HMDUQWUKER'@<TPK
MD*LW'F#=TB5C,?*BL:$Y4U=X#S5XH.YW)*I6HU*=&;>E;]L5PS-EI@U'V'+T
M-BG1:>O:^;:AJ\U,3G,F:8P;X8$@*K<9.@'+[SWVAI&[=NB>A+<I""P&I&8B
M7E5?*SDMX8_AC+NBE)S_Y7XW=6U)-JG[8_VP]J-^KTYF&VS@LOUL%+;<MM)2
MV(:*<46;6QNT=A$E,#F"A&_0MNJX+B_<4XG'82AKC*36V$AJZAU,\26BG)C>
MQ]VH?D4LE[37+*%E!--X9?B*]F4,W#'4]3-TD#PM"EML&'4FLTA,_@58U2W6
MF)(TWS/LB$LJ1BSX<@TCF'&B>5D]LO;M0+EJ5"=U[NX%\Z<ZJ^&OC6,Q./3)
MU%<%PX7W>OF_@;?T38ST/H6'3W991\TZ/MEE';_!'?7%X@]/!?+Q=G3)R-R+
MGP=C%]DQRFJ6N/)--^ >G8UL0Y^ZAAJ(":F2ID$2S[=GB\P[V*2ME+TQWL7"
M$TT,-4':L[TGA_N!']6;@S.>WYI&"7HF9!JC[SX-"/C%>.&F?0VO%F2KQ80K
MMCH2?RTQ4B?D0+]IA$AB;!SM\+R9C)V3*B#.-,^*=/,)[[#W$Y)25#@YIE<:
M'>-J0C3ITB4"X5)'-09K()WBTL#BN0+%%0\^=:&Q0C M8AOLO#(.3' .[DM1
M7B?+X-1XT YUF4J#_WL-C8.T1$N2&_]JZP]*<R]-IOKO8V("F+OC>&G'E<83
MN09M0S;@)+ZCB9J3S^N^:@U 2)XG[>BHY  O,QP(X;UAP_LD,R<IS(Y[KI_,
M@.9RE5&"K:V:A%H83:1MA6F<YN>\FHN#M3!L6GN3T5RNM4NEK00P/C2]YLGL
MVIS6]5RHA--F3N8\Z^#KS+A:(,NUHY!.H+CREC#=G1WG.D?$$)1VAS??&^SC
MVQ)51<)\.?[/DQ+#5Q$6/[%JK"BX82;$6+;P0W#'"CS2N)6;H?O&ZSTE(YS@
M;0K5R+=C>%H^.'L9_,:H'2S/(\H>AZ3#.]VH+^MMC#+\@[0-^,=/;Y.,NIV2
M[I$CCDJL7^W[/CJ=%HNEY Y8F"BVV"IO>N1LT>TSFN0W+3->KVGJ8$<Z\-]Q
M O;<58%$F8^F>9H7/Z $5W"&O];-'MWDR4R'-,M7$_0>,"K0@(S7%0B3JL=1
M09Q(G4UF3?RFQKOK'@FZ-;A"AM$85R:$9X,S[/,Q_0Y':K>B_&T$9U83=>+)
M76]0"]:KB67U+%UCX_B5LIG.4$M2.)V#Y'J'A]1 F(TL'_PE/)97QAA\U7!?
MONJ MV^Z[)J3_=YS["'FO S6G8 Y^?/YZ<EP' S>O1N?_S(X)6-GHRYI"V]4
M1/V9*JN:'_FA?@G8V!5,-@I_F(B'M,G,9#^A>J%LBE4UBSBF"(YGJMF7<*Y\
MRU=N]PYJSM&Q4^9Y5HL$+K'*09M0"98E4[[!U&I?3"!=@QJB*-@M?'F'<!(P
M<F=K<WE&<=HZ4#_BV-H+4U5,7>4XIX??!-D[:SK- -+#&^<7SB,9Z_UF6!T5
M+W;*K;F:B]>6?I#D'J?E2G= C#K'"_YP.@*UQ*SJ:7HI).3)<T:A;[C1. =;
M0NP(?!,X<6#C->E%A1!:B'3Q6R7#D\)8C:K^GA=.*8@]0''L'3W$VT]93D?2
M6\2?2U3\]\2JH!*49SF_X[M8+!VSY4TLT(^9JTNS1GA<5;2[YWEK-@H9;49.
M'L;+=FN)>G#T]'AWJGRE4^4Y<PZ</7KW_M7IZ#@8G;T^'[_UN"OD30^VL%(_
MMF6525=]7 F8DDD:$]#F@%OZ4O(:(J#- $@IRZ0@A'Y/DQKN/D%41!8I,XX+
M;+--L6PQY^:N6 2"5=58-^IL5RP"9&[NBN5TP@K5*K1LGN94;.N<%=JE:>^2
MI1XK4ATD?&_RJ[U!VQ27J@A.P&LK ;F>P$W+RL0!W!<Q\SIKIOG@YQ_B>"G:
MVOV56X[7V<]+Q:VKG9>3!F42:45_&2=5E]_KYP7:>NN&7L%E>SQ(1RO!-\:Y
M;VI<5G<$+$B"9I77J796U3HV,U]3MU2WS(^ELL?QKOC JY5#UG/QH4M-=;&:
ME,DLB0RI;F1: ?@M3(5?S)"-Y/A/WA!A@"HAOXOU%@Z+B:3,$ \?&^0[]UQ$
M4]5K_MHUM6'@L96WS4,1(_[=5,7RB:U5<VETZXDAQB,L&Q3>L=LEC3]=Q[^Z
M\F2GND-[_HFV?O%-DJ]*,K@_58>_SZG+#H(!FO1MS89;([:45S8]9S!UNLJ4
M/[^E7X P1=L7,K-2OXZ?Y4!4ZV\M[6N=5^I4!A;=XDZ5+*2_YYK6>9DL5BDH
MR9B64?*]M%/L>[,PF*EUG^U9>QXAP1J ]W9Z6FA^/H6BOD?C1?1V(FF<(,0*
MH$HJIG5;Q#.RO+U5]2QO,UL=6RWQRR#D3MMI?:-;G3:4K/69U+M5Z3/%FZVW
M,#B&/7"''4<87N7%#X>'0;0@T_&WO/@0'*-38P*M&6R,P(,Q[RN67Q?6Q2'2
MQ&S6MJ8L8!G5 58ETPA@EY/D/ZMD1JIL%BTB9=ND[L?$[;>$-4]AL!$VF+6Q
M5JZ:P9P8^O,@-V!J9YZ3,I.G>N7X+EM]?<KQN4*WS504$N5CE:*WZYR0VG,(
MP+)S?C[3@-N&N@Z\\'0'7E#PPM,=>&&WO_YL<('Z-S(3V?!_WH\N?PM.1V=#
M9+PXNQ@<8XS!P"&VB5J;6>'_;/S%:SCJVBP]R1^3K;>&A,CF;=P#P++7;G:R
MC+4"ARX5JF%P@?)R)->$1\Z$O$E"MXC(A',,ZQT4BIYS(ZDJ(A\KM3S$KKE_
M:\AXI>$#<^!B>N<FG[+!3'WIT 0P:277#*(&)6YQ*)[[]0(DBII*QI1X9]4
M6W"M)G_34H@<B"7'*6KQ_G4@3HNHU@J06N#F>2O=$MLV-,W;IC1=>]6AM^[W
ME*NZ>@1W>B3OICR1NBXU='1U7>2KJVN"[6.^+:9"PR+_ $>!4 \[;,17$CWV
MC$'/?!;) @/'&)<N3-RE\*7)['RJ1\2-/Z64C=2O(?H!T:#,P@S'5G(3T49Q
M1(-D2]C*VW_*RWY#3L;]Y*(5US^)N2M?RLM:QO$'T^CEAAMY)?'<]+NI!8K
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M4Z^M7J/?6[\_-YP%;4__R"-AJ_KJ+W$DN!Q ]D[W.1*Z9N6>BDCJZ%INY!P
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M-+]-BA2!FV$$BY5(HEA6A62V-T;$3XP[&CJE00U&"+_5F2=4'!5N&X)P'/
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M_"O>^?HNI+><'(%EBO-FUX7]P(T5_H&Z-BY+_!?F;]7XB&S@(*KU?'>H7^N
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MPPT9^<W;4+KJS6A&_Q96T)U,;2M3SW 2+X?CMZ.S>O\%]Y0C\+?PZ<1U?>%
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MZ2CIO>RF<3K<\:CH>F6W.1R&MZG5.@W]+_4!JM5-T_<EFR_:G=[P Q$QYX/
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M5/3QO*R<M?Q[5:.@P#FB3P%<[AEH^*NTNL%%P<M#PFU+%@L$RY8G4L-!Z @
M'8YWD45M'6PCV#.S=)X5=+)U#&$<WZN)OX>R\'(#)78&ZUYE308#^P(JK/?I
M_=H,K@65 I?.4-^4_&PX_A8UJ[?5Y#=X5R6.\.JS#-^\'@Y$J->\.?RP7UE&
M__G=4U9N<,.:!!G_Y9P*@3=^>] A]?O#P;(JKV"SPAM=EM<I[$!\Y80'@W>"
MQ<==@Y^Y0YFE^.:P7^K EZ.FO$CAD\JL>FO_'\SG8$W!8M=@\>$;XQ2_!>\%
M-0*(3'&!0I"@ZB;EWG7#"/X?_E3FN.<YX^BZ7.4H.@7L]&D&&@1^=EV@H*8?
MIVEM5LJ9P!?Z^NC-=0$CO,R68#*"1B$5Y\UJ2)7T+CQ(&;Y"[8DNGITEOO)U
M!E=/+\NR3FE/Y5FZPK>5TPPGRBQQ[,Z-=VZZAWF5SF$'PRC?)U65%(TO'_@F
MP\%6KV*/SPP*/ZU7TTO0-Z .*I0M^'25-^JF=0+'OSFMO7-ZDL([@J@FV0QW
M/]U)OZ'(J38$>"?"%>W7 ]F!R9B@4*?5-*N324Z'QX;3$]Y$H&.V7>]]'.2]
M4MOW\"0YM$\26*%ZA4L@J\U*MYSS<J^U.=AGQ8U"3FOX<->G1V#QA@-+3=-U
MH*J+V0J$TWD.>L1DUJ2V47.+!W:8/<.!.8-(<EE[NX,@#3E-JR:!B:ELY[]B
MYY\N $E>6J>5"A+@EK#&8\LVJ"+8B.,(E4*=-CC+<!_^]'/[MYUB\GLZN7V#
M>/[N!RO.].YSQMYNMY]^CXFZ]<A.WKP'(^ <M_N/;TZ/8M*O--K6WI8#NDJ7
M(,%P?_H41G?-2CK#D4[+J[0@C4]VA=I*-=X*=X469J4^[ UJ[?5-=RA>ACJ'
MCNOHHBQG]-%5DJ]H0SEO$,OXIVFV;.2XFJ-YD193LF)@6N#XRF"7X2#1W)U^
M*,KK/)U=H)T&*BP%RQ*4&6Q=.,QR.#/1D)G@U$;\$]=N]<WB2-T7WP -CWF9
MY^5U_?V=B07_[]YC6OCU$O) 7;KI 75^\.+U4?3RZ/7KMP>'A\<GK_[YU<.O
MZ&\P.EZJO^4=KK-9<XDO\?!O^]&V+_2@*9?T4OJ#2=DTY4(^ZQ;J\U/U?#@!
MFFR:Y&H.X(Z8#GE^?NB-\.'?OL*$R^$/@:\XI/9HS_\^,+E*'QVBWF8/!#72
M'F]\_/G7YZ?X/SB)]T<-W$,;1"+"V;_3V7# -L>J=I5'43:6E>X>E6)]7R97
MJ>QY.G(Q6KY(DP*V<!V9@[0SZA#00L-!^[*]Z$"&1W?*:M^&X%U.BH->Q1N=
M^5H-[N[TP9]4/D;)>#C8*'/B3[9,,2C?&I[/QAQY+;@T2A3@A$L6>'[0F6<O
MZ+V:A?NX,)/6PJ!PTV'\JDK ;'\+3RYGG[I*H&7/.+S%D_#-J!R+KKU'LW$/
M%T@/YC\>/(A^S-)\]GWT-KE(]^&)_UJ!)93"P*('#P2.\/SP^!<U:OM<?O0X
M<# _HX.YK,#@TI^]R&$DT:.]I_ "=9EG,QB"-P]%62V2?*/I"#D'&Y@+_-K/
MOX:7";S7!';[AP>3%$X#>/DE389]TV>!F^+[VV]RZX$9$7&&9ZW.U[@\O"+W
M1(;NH5B/IK[>>9&OX.#^< /3F(,JN6N%\PR.H)W"V61E9JV56=48O:ZCP\3'
M!M ZU!15GJDH+$:YB^@L:585? 8#A6?@=Q)\IDOH@T(<N&FY6&"8$73*)"D^
M4! 4W_?7LOH0([B _QDA@"%9-9=EA78FWK "%9@AQ )\M#RYYG#I J,YT[P$
M V^WV.L6._47^V6>9(M6?/L/O/N^)*IH-!\'TJMUW<Z%# >\DW!VW^V=[=F!
M%/1JCCZ"$U-<,+"![Z!V%$P\9F0X>)LU-SNA7R?T%RVA#P*?[M@5V:W+NG6Y
M]-?E2(/F OBWR.P8S(2;Y&JR7.;9E%P8!]%WUL!E%"? W, $<^*S=)HG>( 8
M>!X<)7"3X<!LM-W"K5NXS%^X8_CEHLCF&4SM8;( @_C/=*3\P5;GM_;JP,$"
MUE9X=]SU0CW>+=2&"_6AO5!!D.SN8/J=%R;O6ICH;5(U+;L!#;;NR[-/TX7U
M<+#3AI^PE@M_+5]C6A#LZE51I_G=*[_);ETV6I?"7Q=Z]N]T0DUWB[31(I4!
MSTDC*N_BE IDZ^[5#-S'15GZB\+8T.Y0W9*QHSIB$,.M&#.:1 7&[4 ?\C5Q
MU%0PJ#2-[=*A.%K".2;XSEB7_=@?#@>=Q4!RSSA:@3BHNU(\[P($Y-_RA(D*
M.H*XE--,/IUGU2*.?BLS<.*N8/"K"D9V45ZE58&R N,&5X/0(94*%>X"(NLE
MZ%\M":I*RL"O6J:*<;J7^AJU>><E;>1IOIH9A&>'"][VU;6S/QR@MZ_P2^'?
MQXC&J5?P:_H3'M>JCF'\^TUDWB4ZTS^(99R4Y,<(0CE=,?+)EDDJL*O2>5IA
MH@TO_)P0OC^//%7=\F2M08^",I>;-58 3.M>\RR'E7>*OB0VJJ5A.%#B8$-C
M3U<@<$\>/P'K+$+H<N6#UPZF&XI(M).0VTA(W9*0=24FMS(GJG2*N*2:96?G
M]&ZS1(V_1(R03G4T(E8K$[PJG;6N:_G%-N;:7V[:5+ANR7#@8+,Y5,L[;UFE
M8'60&""RE#+'45FD>/XORJKK]*@9";^ LR?!;1NJN (-0#>UU,9PP'KCT5.-
M-., L@;<ZC RF2Y8>X02&1X$[ $)-D>[6//F8KGRQ3(,R \?+DX!F$9&H]",
MLC&_;6)7P\(*MNME#?[9*7^-X1[9V*RG745)W\F7=@G2*+L:RZ$6KJ&!2^ *
MA4U&!<@)=/M%A@,IRP6AQW^I:AT'R>P7A@30DV7K%.R"<(^N,A[4E'&?4<WC
M$)--P:D#PPI55(2KB>.NF?3G,#A]PX'Z6J/-G;%:AWM,@RI7#3LRXFF,'BEY
MP-(Z*<*"]Z.,*XE/#=H#YH/_F&587E+,8CQR%!B6;S4<I"IYBW5F\ S0&%%Z
M)5-N,+$TLX_EL:9HT1EWY$\QENDPC*)5]LZ$#P6BJFD5S$ 8==_SB*255?:?
MU%%4Z3\STH^DBKPTF5X.!U-<[!7<-I<3&\TSLN?AC]J(WS3%"QF\WU%V8XMU
M.ZPSWX5U[@IC^'@_>K,DB/SW.#*9Z/WHER1?X==_0@BB-1MJ'O:C\YLEO.X!
M"&(VW8].DD7*<W52X@P\=H" ZE?XS0[0^.?>0W!,=]@E9/5]+A3U+NNSV>I<
M]ZY.9V9!0A)N<6BM@U@$00Q]4_OG-$<J*-3 K!N>IZ&\)A5L@+,UR148Q:K@
MGW<<A':PHFW.P!MT9U.05$#.WNU?$VOOX70&-4C6%Q?I]47E[(&B\)NH"DT1
MC04#R1Q*@?=%ZW$7;_E4^?_8DG_T9!\]>1*6>/4M1N(6J_Q"S;P79>L.G6F)
MPANY0C(<!(3"00<K&QG-96V&TIU8$E>Y=KB] 1$&#!^7-'0_#OPA_8;'NX'.
M/!&'6.:FMV7%.UFN)GDVU9O*W@@[L5LG=C=!L7ORZ&F/V&%XY0\F=LPN@"J-
MBIOG<U;DMFRA#IZE>7*#(X&+L, Z*U;EJH;IJ[-Z)TOK9.G?OBQM0U"TBQ[_
MW@6?K8K/3G:EW=K\WC6?K:)/, ;G\QVLYHL5P[6JX7[)2CYM_@"XZ3OGL @S
ML/Q5J2Q@-AY;E!0;,5J<.HFU':7%[2@+C!R^^^%G<&T3\!QNAH/@Y$;G/N=F
M'!5E!)M8543.L;ID]'0<V?64M4TV 7=P&9]C<HJ# (>D0!QP'XX?;<X?RVK!
MKW#VX!'_8]0J&T/8SGB+" 2IG>1CME@MHF*%I).4^>F(T">*/V.B/+&&M13\
MK;%"[.P3OV R!6=_9M*R%D+(>GTTR^O8LLJI3 ZG!%YA6:7"=A2--/NB8LIL
MKDMO!995QHQDG']83:P".TXICZ.Z)-[!TG8F98;\+"^,=#BP)L"?0?9>M*O3
MY<P(0@J=B_0JX<PV"/F'M&&R/Z0<$UJ5>?81X7?TZ3C :PGB*R4?KO#:<2\D
MXO*8N$FD^VM%9&F%+0I<' N<,TOK:95-E#PM<"?@G03$CH,WS)_=;+;;4$O-
MLAH+?U5L*2M0M'G(58IRPEQ01(Q7@<.93(5V%%\@72QS<C@;87W2U<4LK')S
MB_96O^O:;*(LQUF:TSI2KNRRS&'E+6R$-@'>Y@EYF8<XX]F$]($^_ODL%Z;(
M2=T@E1?16BD$7HU;!AQ2'N@U3AD\TI-"RL91V@7?#EX??TD?PKV04E,62U*U
M-2)$BQZ\U?;@*LE JHPV<W?R.&2-$/=!*^!$5 ,0#=J,J!#H+ULGT%+2&/;:
M"AHY@**,R,Y4 7J.JY[494'Z9@)3A9".LFIJPI%IJVO-KN@L*W0T."C&DO^K
MGXF(%A1*UG?NT<"JB*+'%!@-+,-^!+N]152+&SLVY9$R!YKVM9S ,:GFJU0Z
MN8_KD.5_.%@S"Y(+1O'#/S41L-:$\U559/4ETTUJ275Y2EFW6CN9)4<XL3'(
MLL*4L@XC!\F4V\%M(9&UZ=>M14"YP[4/'$?&G(Z>_#6+VC?)%G^S2PR[B>%O
M=HGA/X7PPYDF#R<_RZL=$U\ S#_#<.[[WT_QLHAU>)"#VK#@(0DMV:5ICC=#
M7"-Q6()^HP<RW\E5!B^).A'+(&HLU8"]D2)A-[H(#5:ZPWV) ?C&58(N)BRK
MVQ$<&NO(-R9;;]UF@V>@D#+\AX-7.9AK5?0^S7*0GN)#]%-YG52SZ+](N49_
M3Q;+?8P.+K.JC,##CR4*?ZG 6_+&B9SIR1S]*C Q8<GL+(&:R]!QCQ,['(!3
M9DX\GL%L,8&9\,B!Y^(G\8S/4[$NTH_+%$:BS1%G+O#P7%7<\R?(Z-]C=;+1
MN8N5K2>.LC?@F6*$;8:#$_)%B5"=P6FG%A19N>G'<R<WB'+1Y;B"^8+>%7+D
M5K:$]1H]DL7NQZ6QW1!YT,+V=2E?9Z,$8P737#,.V,U%.1SD)1A?E;%#0[U!
MMC&#_78'(.'@1R<5XU/).09+%'X5<][-'FJ7\QE'TV1%^$>X*WR/5ET'$H&,
M6,W>P>X(^$>T3AL9W>3*P8N"(K#FA-W_SEB+#2A/9NRQ=LX\^.6D_, 0G0<F
M&\9O,(^LD?ZU@AU!5!F*CAUG@U"8_9&=Z.S!-VT6(/:@4)TT9:R2H-T0=+D7
MG%G6S2036E_"FC^@&W:)F>EBL,%H'UF!%-I6C&B>^\Z&$S_9>@]JI&F$0-/8
M=K1L[VK4)!\TTSV:^:N"%<.RK#-)]#)6I\;L2"#M.UJ;0QD' <]$5Z/IS\BI
MI2=0UP4),)&0&&'KVCNX@AR>Z/;-^UWDUFN-HQ%-GC<"9[)A@:Q*O.AV==OC
M3_7)"<7!NL.,N/OQ9O.[W?ANX85K=)*:[QU?T#9G^,PYPT]*#"5,\U4MZ(HW
M9/(9%;!/:[C"Z'OT#H,Y&"K *_#3VCK;"PRY,[*>I<F%RG-@@V3-0F8TFK.P
M2P/1'KKIDBK[J&^=\ZA16TE1'2)$NGLX_)5L:=L3]R@9EBA68OC2MIVFV96Z
M&B<!SF"Z":E9MZU/;.+:(K,]M4@AO:'BOZK-CD6N+YV,LD8WBC'!431J"J41
M5F:U["(PK3%J"8C6[8"HTN'A 7/\."O\"E_3MT"@@9Z]8C-&6ID%)(^4;B76
MQ6Z0%TTJBB*G^CK. /1D/W:J8#T!)8\*VR6C,G@CX"G'8C='I!A(UND&'N\'
MSLQ4O/,=V"U"OBS :<', $&CPV&-7U;EDL29#U=3U"@1[4YC9\9M]DSPG]2'
M9=2IQ ]9G6 BLB=K'2U29-1YW(J-9@DF$@N%B]PW<D/@YUW0#===P$X;)EAO
M;Z6^!2(76W< *K23UAE<-OP!/1HK)M/,[6K'.G^;AWEIR/Y'1B->*]':B7;M
MV4IL:V\=%DAJI3%PD<#6G_8/J$H7E+\A'88R/":_"PXW\D'HL.K(PM9.YA54
MEI]SM40YA*QL%669I55VI+WY:,;KTK9:NTS5L/E%#0JY&P.>'!CIK)-LMH?%
M@#BWF.!2>[=1J0(7\&7U$82'5C>QWE;#P06?E_Q =:$$8!A'+@D^R>EE8'7.
ML <>&8%PWLX8R(FM9*;B/7<)^JP4;\4VX3NV\=K)F!/F%(^7=@:Y6YYMF&D4
M0)FJ"@13Q\Q)Y@=;)IE#802\2"5.P)U*<Z\1D4OF2<Y5W_X./ %1P<L&5F:$
M/G]F67L6S.+)=Q'85E4]UH,A8PE$:58EUTD>K,JV5Z:=ROSVV\X\YAX:G60R
M7(D-QE%64$'T/EG1M52MX.LRJ9*+*EE>LFK[-+^(@QEVX*+;+ZJ#7F-6H,G7
ME?QRCXF0WNB)K%&$FR(XMN;M&AR:FMC.3?TF$.=1FLF<@FG(%"0"<11S\>LJ
MFE4_<GRO[*-[:+)MDO][LLO_N?F_)[O\WU]TNXSFX^'@P#+H+66HE+M=Z*Y]
MX]#UVHGF4RU-JCQ#Q2]'K Y5?6_X+ BXDW2>=A19;44'G#&RG4)NQGKB;#_P
MV'W;2VR/23>#O4S6RBRKV>GBGKWZ>*1[F =UF)>>'M\G.@YK#KI'PAT$<]L@
M7HJK2"?HG$[>L]6DSL VK"@BQ7P>/F,!GC#T-F'0WS2KIJL%FK13AM%P!-CX
MHW#DFJ"$BX[3)7G=@,$*X> ,B2)B$7]TRN $<<[4"4@01M_D&0[P02I*=57F
MJP4;$M25^$$Y?T _ _NT 7M0]964RSDPHH%;.JEAU=61SQ4DX*'T*1EA6'6'
M>$X;PF=N:H$H8:@84RNM/[/QZ/'8!G_=*XUP'Y44MD10T=BH-QBK>K;NW66X
MU8F]?+EP:V1%6Q%]^+N&6W?U&'^8>HQOMJ_'X+CQ&X.UI !G]/O797QAM=3Y
M^!_EF)BMG+"!%TUB'HU/13%0^W$)"5VF+MA@36 X  FEN!'U&H85A@/XLB0+
MAJT9SB0W"N^5($6446$J2P\OK?0,U6VU./H#;RP^L6/WV6#>75/239J2_MA;
M?M,3@V+JP501#X:1(QL =90P$, \$*-'/3$6O"##_#8,ZO3'_B5P8Z>Q!:7
MC*F=6R"VX\"?L/_\O'U7GF]-TM[.U'-XGN[&9_!>9 $Q#X*-3>M-=0G: YTO
M\R%-EWWI2FOLHW:P*A2J\L-48U=0= #W$^+$K>#PEL%@S))QR1$BZM#\HPW,
ML4#CGM(XM#L:QK^$(+#D1ZU-U2EH$%$U]\:3C3N(=^.(L=QZIOBFJ53,.0=Z
M"I+TKR[=(R+P$TQ(&#Y0^S'2NLKN.0_OC7F$KA<>4?7.W$I?QP%4$6=BMB/3
M,ZG([29D(^)(8O8Q8QZ+FXI>-.60/HW[3]5D(.<?W]1X O+A%9?&>8767K&L
M)NH*U<-UIJ2\!)2UG]O)*LI=U*R6M*JEFIU:N?I=S9)%6P>S+RFX-IP:;&*[
M6(O@%O;V!/'(4QL0RIR,72G/-85M!&E$H">?.2[_4ZT,G'$@0A^ZM70-V/+>
MJI5[L.JGMVZ1H852NPA3":JK6J4&;TH9U<24+LZ3*7-V4@EHR1>V+O#J!NDB
MK=DI?V]0LW#)(OG &J"V<QY\#(Q4J1519L)@[ Q'S.A++!*0O=D17X*O;J+K
M%,-#R0QV'KXV6"AYFLSHD&RC\*@(5N=+C4$C7&']@#E/C?B%9Q$\MRH$0E3H
M"@:::63^RJ8KQ)YV>LY248"O$H >R+/X$PQ7PA/FJZKA(H*%E!(6&SUK).EO
MFGP&THYC@FQS8G'.L"@WU;D-!3316TO&#,M729K6SF_ !>&@W9-GC[H3E??*
M]+Z'WL F::VGN[26F]9ZNDMK_46WRP@YA'K*W+3-LDDH8VOGT7>^AX.0]\T(
M=F-!K#-FEF7=/+"\3/W+<=OX*->C4SU[I\M,6><"JV(Z%XEJ@_Y#Q?<VA=YP
MT,N8)R4BCE%B'-J^XVM+KQ;,&$GOD%7:=G$=0]6*B04L=$Y>]<T:A=KD)G3A
M4F*'E'>ZL43&M;X#F;5@$8<5WD/;I1ONXO%*NN8A5@'JVI:^N>Z V 381^QG
M6_XTYVVM%*MC1UC3X<4R:S^8Z8<9T&))R1IJ+M= */>B]_:^4^M[ <92E6"3
M,-U# ,^&BY*VJCUY.%E%HMR!!'6*6)(ZPB!A-_ E2R+4?W[V[NT/!;AT^%^7
M?<>!^SEU'L-!"ZZV23"/!@7#["E"4?P[7<I&^S4QC\-5E)V1Q@ZC<!T/!\]U
MAO4]ULYEY=)66"(D'&UJ9>A[7GB#EY5P@"RBU,[9];*172Y+X1Z"07O-(R@)
MKJEF7"H)T/_4IV%%QPO!(_.<AP1_,]N0[K#!Z3SO]A(MI$3B8B%@"HR?DH:F
M;48 4/1IRE6=W_"N@].JI(8([8(%@];NJ>"R*8.ZUW,X.&#W5)["3XU=(F=^
M.467H4HH7=Q#]Q X1B[=+.!I8X5B;\/"NP\=D@BE:&RRIA"?KXIXV"5]GF]D
M43QY+T)I7#=+BP'.6$'RYUD%=L7H$:F(NME.140OA6J(4P48D6M)XS5%J$LX
M>?# F:5YQKK>[\ZBD0J=<8REW#ED/74I!2=O:W,SH>6FQ6Y;ZI[@::B&-U+8
MX*;$AB+J8]CQ5%ZIL" =+7147$RK%.NVY(U;\4-^C 67,3%'>A;^1-L(X18S
M.BI5I V5?$S3=";'">H15H,C,B2\@*L^4<=2E=46/J8;QI/(9@D+CV0O.K<K
MCY"EP-$B/=Q35 _25?_1EA5U)[P16MP'1;&B\VQ)MK7#&??HX8/_UA%S%XLC
MY%YF0/W >8=^B])HUL)J;0IWLXP^^$EZE9".JJ<PQ'^MDHHP_88YB@2?IO5_
M^,O\1K\)7N6]7$BOX6?R"I8L*=YP-#2Q292\JY8G5JVVBK.UH@:%JZA=7Q2S
M[ .[E!Z%7ZSKOL76J9Q=K<O3^%0UDNR%)-MN@Q^D7N<IK6,.^4;Z7H^EA692
MEX5O" M.)I'9=%_VNP?_'?._''G\'_7>@>_^6\\)Z_XD+R\PN=6_6*%-0KO;
MZ3I@K;K;@8"JQ_O,'UQPBRD.MI&M2>CK3'2#:I3++%SJX3W/KBTGRK-U;)X!
M)E-Q=PQL(R.4)-:.3+:\KC/;B+"T39@O0?3> D/ -VZJSYY[O329ZN5)$CL%
M>1$Q7H<D9)()9_R]J^$,/M9W!'E&MXAL.5,NZ+2>T&ZDK,26"^]&V05$IJ=:
M:@-=S3X<K,V^$/&#:9"J,B)V645?5KH#S-+RAYUJ:,6ZIR^WT7V50B^_R%=P
MN'W0B.4\N=8&WF]P>3W+#)&AD8X.-Y9#%,-!"%L;9'QCT5$G;\^=*8*DU+IH
M?/P%M0DP3$.JL<!=K,Z(373BS6AL(JB"30*O+(U1K=]BKY]NLW_,U<E>1:;G
MZC&-I39" ].FD 2[@N;/F49XMDLCN&F$9[LTPE]TNXR0^;Z=?QX=2!Q(2FE]
M='94+O$07A5B+EDL>)+D9;I1'13L.P7!XLC!0$4TQG5I.G!VD$1GW*I*-=KR
M;1\WC+4.PK FB[#NA%D7<!\K]R:QDRFF*G[FO!G\**MZWBUFUVOTPK0HI7)[
M'8A!JR8C=@0R<52RW07*!]#V OA?8[?I>:3^.>V#55B\UA&"[$>&(+<%33"P
M$'(!J C((0M<E#,0\H@+'+0[3$:]?1]D"9Q*[2J6Q\]*FM-R!>8+ Q]'T@VX
M&QA@@"DM7$K4#4LA2)'@4HC8=F-DRE; %!="@C_5S8]M$^E6KX%+V0NP,:.T
M2:Q#PT602$R@[1Z<#!M5(:A,O %41@."A<T8A^*(MX5N L^GNDAC2RUA^+DJ
MBVP*\[249!'OG@HC;"6J43@)=2S)]K(J"^GB>7]H83:UZ7"=8(R[UE$86I@^
ME<@4=OXH-(\_B% R%4J)]*.I\U'+Q"]7E 67<4E(WRGENDBJF:*SMH=-_VD7
MW(UM_*8!&)&+B;7SG ^>Z81P,(X>$W9:=W9V)Y]33[WGA"1WM"(:M1+#1,>F
M0/T;0.=,]T,[VB <WUGAN/L4@Q3H49OP5"=0U"1INNT6(*GG'3MG"-.4RYNV
MC[HQ=XIJ7[X>T&<K:&$P=V(TX 5J+3UQ0UMJ"^(JZ13'R"HY<P>O,NN2 %>/
MQ5?9>WOX8\3R.F[M:,U/+SQ1]-[Z>4Y4!N; R)^F7#\RDG>8-$GT*L$ADJ0<
M%$E^0V!LF)W3M 'AOX(GG]W HB_:5+Q'AZ\.3H-HU7MEYMU'RW,&EF<K&^V=
M^%[$TKC?MT5!!ZP-=8 ,!]8)XFYM7<#HGQ^WUX3*Z%V_X?_ *G'TQ]>&OEJW
M.+%-SP.T<'HGUC4N6OE^M8SAO+1>/8'#:DL^W#4AT&C3L=/ A,,PMZI[\' T
M/:&Z\KIH+_*]/"V<6=KJL"!]OM/=ZUD#0U&#!CT SJ1P3#,1TD8MHHY_H[6H
MHD2C?<!LS#<Q*/L<502Q4J>@H?&&)-EVN2B[Q,+@/.5M3MD=!17I;Z/556+'
M!XVUUS>)L0\'*LA.JL7DF%KQ=GSTNR)#G4DZJ;959:NPD7Z *6/G/G$?O)*!
M0I^&KVPU;:FCUES77?C%!;B<Z':R?^$J?8FYKP$8QK;6-9+%RZ$@2>;I74)F
M!K+9^V#&ABN3MP!#*N/_RAZN@3(9OCLUQN' #!*=KME55JLLHFR /DVLB4/4
M,>=(QKYNFJ=T)%%)ZD]U6R+X,$1UYJMJ-T]!JT<F#4,/$\.38O+>L+D_RESH
MU\$H3#1103W!2-D#!Z'%WQ.M+45J<" &V.2='NJ^6,[%:<1@&CP5'LW1S5BC
M6\"Y37/RV07X")KK8Z+XXOC0\F>5<KBC?\M+T;Y,],\5)P7NFK2ZPB024N@@
MH,6\:NN6O=$,S$7-82 M7HR@'B,,S+)I$>BPO4'W4MHQA!ZJ5S5VU;!, +<D
MO](D^5-ME\O]-Y%28[9OE:KTY2-2ZL11G2;6PE. /P1S(<E5.D\&R<T:&QVY
MH1QW81&^"OY(=1%7^"?,2^\,@CO(NGV[R[JY6;=O=UFWO^AV(4ZZMO)GG=^F
M0G)5OM6J3U3;)=B:CBHC3JB8Z1GD/.DL9P0+FH(81/) (9AKM#X57M+<RFZ5
M8P C'<YW%S^W<F(+8VBIJ$1*34FWR;74MZP!WB33H@,>ZZI\-\]>1",O\Y6U
M"+QHRN7<DL0-3HJ51])!_2@8S_>S$-WA?$+5UJ$"LDC5CL4MMA48C)WYL[."
MZ\H0-!GANFX!E/28BJ/>E@9:>F;L"NVA)$<V;->*VF)'^;2-'LZW*T9#*='.
M(@NW89+0 W2WZUE3G\)W\QA91K:-QT3D#FDCV=PZ?^0 X==,#IB4L*.H(Q'R
MWD@H[@'X59)F&HE%F<R4#386!"*8T1J"&!J05)U<^SSR@NBN->>;[(A0%HXA
MMOUS.1QT3J;JG\$ AA GN^V::WIIKC]O,V[.[1WAXSHIZ]<W5 4?=H5.?>KT
M8+5\8S=&KG,<%N! %6A(%IWXG).>FJ">4;)C-DFYQ_&RRCC1;3N_GDNR;LYH
MZY":(E]YGL[(I<*I(\U^@>5Y!3X</DU6S65)G*&J/:#5(*FOW73_7ML$VL O
MX2]0R(>3E.UFQZ^"3&BXABIG4&'<-ES>]M[6:9%6I1>QJ#@\_FV?><Z5P\)R
M1A&DSYV8V7E8FS"$!H!:.L&R?06W[M8"LK4B!++L5=#[2\D7Z(HU$R+@/+V?
MQND3Q,8@K->A@W1[Q79(PHE Q!24P(_S4@;0BA/[/]@J9A&(3T6J$(D#KX6>
M(@P7Z=%F-<TG&7G8ZI3 -_C$0 L$/<?6[WUJ:5#3U-#1T)28\RADWIC:=S](
M9"^S]7C=GBX%_WEEXGCE_%-"*TS=XX15=GM\W1Z_#.YQ)"23(.P\8R20XH$C
MQX7R9UQ6MF+/S3X)X5=3.$!;I+LZ?^9!ESCM@MA'$3+WUGX[>&IT:OM27-W/
M!U7K,+?B?QCE\TGAVH]RJ][\9R57929]5MAG2-#="CH+:D-W:ZFL#E31*M"^
MJO\C+%N?F^-69K7Y'NRDQB47V4F16FAF:8=ZI6+H@4V695HD9*V(V80IY5CC
MOAY@1""AK*8JRL*M3FH1 _:KBE[9L:TFY8RT(RY@2JG2=OQ;&WG^8)$,59P<
M(H:2R#A:/GZ%E+BO5IYWXL@O3/!55N:6G>&4QCG6XKFI3X\.):?KN84V1T$F
M?G;,Z&0BPN*- 5^ND?.N?90A7]0*PP,<6,"Z>)YA6IXMIEB4)]Y,7F^1)ICH
MNT#[G$U)WR7RD]T";"BO720&' J-\XEV$Z2?-AU69,5Q[LJV[J<*?*ML!F>F
M5/=>.>D2'&@C/H5('4)!_/G<'0;K#H/LGN"C5EB7M[%IF6:\KZWTOG27WI1)
M%'=0+RJ?57*>$>:H5#"1K)AF2]AC/Q-C:JP@T:*N\"FI[E>O"@5@"S0FH;7M
M #M)&^GNO(/]<05S?LD-/;S=XSY$1@ /J^<WY,!AA$'+@JFO#?ITV5@Z.MXC
M$;^'NVZ31-9WNT26F\CZ;I?(^HMNE]%O08]E6B+E"AH/&OMJ6RBQ,EL$DF<3
M>VS=9T^C&3D<@%ZRSE<832\1[YONREK*3!V^/W@IE""QF/XE-L1MF>#=28[A
M(.61DL5CW= TWF$(8EJ4*B;+R06B3:F#K*<;0C\C&_D)\P'_V'-);B9A@SBT
M8K*DL2R'20^0T0V3 F:#%+'[AQ0WJ^5H0TV1 &=B\28R&%TA@_#.I*HTM9@A
M&O/\4ZD9L]I?XPU4[LR>[[) 03#+Q@+278IOB+N=VR25Z5 ;<VZ3^S!9)"S&
M\)HF'($2;,O;/"'CXA"?F4THO*+A@FLZ[$:JQ;9Z7J!GDX<T?+=WMJ>];LJX
MA=WN:I6+K5&E%ROVM3: ,9,_99ZV-($\O;\LOH@.-K^]Z(!]$9+3T'2CQ/"F
MHU? \(?O5G=-6>MV.N<U!ZD7!YAEAEMG@9>2IR#',]AXZ<=I"IHQL0(!R.D2
M[%BN)AGGD^&3 D0DRC3I^"O)CD9MF.0B-:]@9]BF\ !EX!,EQ(KK8@_/7^)P
M9AE&-R3ZH%*5N[Z96YY5'^"L>J?J$)0?K31GJYU4RQ&*-Z"&9BB%%2_U,Y>V
M1TX)\?4$KHJA0OM3-C=-5G213T5]&>EV^,8_8-J'2ZM;M\K9^[DVBI_3H6LI
MO;Z#=QUNV0[#A."+:]N,3U(&Q[!2P6@DZ)18HE'B U,O#;ERF62JXF6N@BHZ
MYH2Y5*W:Z)X6%*>WK7@M@5P.OLLO[3Z)"X4;UDJ'J\%KD]'??JT5O ='R2@!
MIA_%X<*DPI?6RAK&)37.[?$.^^V:&7N@_)(F2;Z&@:OJS1=1Y7=;5MMU*COU
MN$X]YMB"\/B'_SU-$<.<SOX/2QIWT[9NVA9!#XB$O",(CO9TK;NP@D[ '3AR
MBILXRI.Q&,.]-/F5K0K;A4MCISV$.IC@Y$*0/.:+K#[M!6PC>/[H'P]5G@?)
M*$Q!([,4BIX08B85 &O8>H\IZ<HQ]-K":(UP7^(X)1FD^"RT1<NJAVQ:G8;"
MV]&C'/(K)E]Z^ETG&^;8=-!-HN8ZS:_2!PL0!T4FA2UN8<4+T7[V#.#-F(%4
M$$HA&(U+?A@5(!L>#:EE%+8YBUN!3*OW[VYOK=M;17!OF2S=NF"!W>[,2DMZ
M3E/0&6J3X9+Q'?)TG5J)7<_;C5>W'!/][+8MG51K'JN/D[HZQX)JS7FJ<H<!
M9.N8"K IG(#\C&X5%.A@21"VDVW&/P"/-[D1'9(+!TL;%=-IV,0&]C%K9>6&
M@S!<AL,>M33/Z7\ ]2[B0\4@?;P^;YC(XR9T::2)YSPSUN$>W)1SW*8*9TO,
M[4!!:\>(Y[1I\E20(IIOEW+((2H\>S3CR&/]T434:J8*DX'<G)62C@F;.,>
MKVUP 2??+9#HF'QW;7:'@80:/UFDZ4Q1##*!BW.T2XB+V4,UM4^17I06TJ9%
M@Y[8A.V!;NID>5@P<"(L2 M%(82G^96"&)=3:A8Q4V77UK-CY\DD^$K"-%^^
M/D G95))/U8,8I25XSQ/TCQ+">I+$R-^CXWJM)+-W@OUA\]H?6PD[=RLHSW5
M+0ZJ2ZIUF,##(X3;F))%*08C:<+^'#AK"I-#30DTG759/###M@CJUV!'/&97
M)2I,9B7!1P:-=$![.VP86@(:AEZ#V+0 W7Q$%&[/\M9Q:HY2:[%"@4"'RXP3
MM-E8O=5%B5U%$KSC;ZO9A:K]8%OQ-T;]JK]3=/C]SAX](A?;74E;FIK&LK)0
M.)N1USI\Z+%9+R5F3(U?90+^\ F",0]BE=7$ LS.2,/#J$2HL&X6^3;L-XC]
MDX:'/T)KDXQRGZ8FW'O5YJV!BQ1US3Y^3KY@B]H!K^XL7G%5,9Z.UA%G#DIO
M\'%D)K_[-/-W,X5EE%M"X\'@+;+'/WG*Y;C81Q@,<9=%D)5<<G&!!3-LH?_C
MH7#ENU<*7.R;9T\?H'? 3]KGJ)TS,]+<3LU,J)A:%92K(F +[6G5E5O;Z"K)
M5SP!2]5L)^QQ# <Z?B4V"O6P4^#X+K)[BH*NP3L)7"2@7DR]MTZ P+Q,RJNN
MALTX4PJ_Q,-D"T#FF&5(F!*1\<7I_Z#&9@^WLH<5^P%UFZ%> _#5#U)9!H,N
MKD18,S[WEBOAEM:K-FO16W @T%+#JL(?05+,F*DX+7!NUG#ZHA9P#*9 TU)#
MBNUW^S%>K&WX.C8OX_FE>8P7.[67_"*[PB=4Z%HI@T58..BUUQ2A9=3L,2^+
M"TQUF$X1K<:M5-*V:>?68%U:6\SX+*.:P%:V19)3?C(V ;-?KDVM!D.F*"S$
MS>U$?\,HJS4(*^_8H+9< :]2<6=WR(R_EFQ@*%9+VY8A6SKA^UD>C(:2>WL'
M?T)("EH#2G;SZDP;C8Z/[9PZINFB=7Q,N+'$9:$@S[K>G[HS;P BX+2BL=E3
MV^A&*Q/#AIF"K<,I$#X3(T5(3A/J=J^1?J9-=),VXKC,=F[^'2"J_K%#5+F(
MJG_L$%5_T>TR6@9CG@X9D>(TXFPK$\ZT0C>LX ]3(G?#HS5T^B<S,(HLHA>N
M%$<WC2/5Y?3#9U=PW9K#;I^E1W%^\.+U4?3RZ/7KMP>'A\<GK_[YU<.OZ.^S
MMP<OU=^W'&FWC-/>N<YFS27>[^'?8'CGI^HQ< I2HD6]&]PE^+)?H5MU?JA^
M)K=[^#?WX@K)!E!QGA_^$+@:!8@FY\D>3XQ[6?"QS\G!>Z/!PJ:Q2+3%_ZES
M4)#$\FQXI:_/3_'?N#+W9R?=Q\V=P.8^4,R?<RK<?]I/=V_,^Z0 &<N6Y"%(
M(&/6E67RVC^RUWE94@I+Y<6TT:@-,G1%T$X==SBRBI6LAXK$C:RUFJ[6;21,
MVRWI[5]ZW!A(ETT]QCW/+'A5V1)VNV\1Q:]2H<!T"05[VG*%5&A_TUG#0GF9
M!$/P'N>LGO-6[9NA^&#ZLKCOZ9<I]^G)&AV4]+K*<GAL0^I/\ KT#1D&99C(
M'>B%*IFS?&?GL&HE2/SI;X7@_($8=SS]B#&>U"7T#-=,^,Q_"DYK97P"()*=
M:;])#_)S!S5'(E*CYYPNFZ0P-<*=H&M!(Y<]$&0/<-?"^&BJV8Y&5#X87(6!
M^Q6GSN1J*M*0+\AP*C<M 2K-U8KMJKL\U55UFL#?U!^UKN^J5D=EVJ<N[Y6X
MW$<)GGH2;*/C)0GL$9D$N&@4UR+^&>;B4M]^R"AN8O7N[()]4L"[,[:G8GIQ
MZ$C!()#=#M3.\GHJOT.N'-!\=U">FX<*^J:O"SKW3M\D0F.(LLFWT0E4#*,J
M;AV7(<=/-8<F-,*YZIO/, %*&8#R8D0HP3!V)P^6W0A.Q]B<4]!.&DI6RVMH
MTR8R5^%]%7.COIZV_(F."I2PPX5Y<LW)&"X<;T5DNW$772PQ3V#K=#+(WB88
M&WU:+'8XN'7):RL@&T3Y;!&/]6QKY\A8%UK=/*"9;*R*-!?'+751M/W6<:*H
M@0CS+HIZBVX9SD%E"J0(GAXNZC))>H%6MNIU\,<JG;6N<L?=*23E6;#^:UW"
M:Y-:.BT2]V0%/*'HB68_>K@+9[OA[$</=_'L+R"C7RA4^O!SADK[XZ+NK?)T
MWE#L\^FVD=(CQ<!@Z3!43[O(YRV'=(!,@C8RVYI@RW2);5H@.46J:%*5'](*
M-]M4 \BD<[2BS "_9@*'BCF]5,'R7+5FXQNKYZ))Y#I/5(9&B,=P8V:K;T2L
MRK)P<%[_"/MH,]91'3W69A&Z;^R[K:M[XTHP\^"82$_87&\UKL"I0,)>C/-5
M8A1P(2DQVJ=$)R(OZ+H.L9Y*#J_US:7[.QT&Q((Y[ZYW:=+],5)$]T_O/=M6
M[QW#=EX46JIVZNY3$CWGDKU9Y3F15C"2A?%AC?;+W5P+$AHX! FSDBMD>5UN
M8F8#!+=Y(=V19@0/]2@?8XYL<CYW.+!PL.4<%C<E1"SZWE)^%BM(;4R9H(+^
MA5&5\B;E*"U3-/@-34=N:>Q;^!WJ(G::X<V+*:.XP0M![^(*-#IB>ZJ2?>E$
M?D$OI8-(3=:@XB^\$ 47>( )K%($=)W+!T<?<3D^30#?GD@[26%=7S*N'P90
M>]@>P1\RO#@IK.BMYP2)$CSZ.(5#"LZD TETJ!G'+[>8\.'@\\]XM,F$#P>?
M,./J"IE<BJ^KL77#DO7DOX4IN FTT>0#"?96SFFC7(H$>V^4I1ZPN<:_%;H9
MIS;)BIKQN,@>B]-M90OC:)HGV0+^.TL6L PU'KO@U^2<L2"T'IZIX,%0!D.!
MU<DL*.@0!L<\Y_0&=XS$?Y2UVZ*KHT\@,C/2M;&#+X43IBK2FUH"07S:XU!J
M/J))!]2I%%CB9,CKX/L*L0P=TAA/I)B+"I IBPA>I,RD;@6AWN!'CMR)]R?]
M)4U3J/FI9>K=.&:5-32< D[,""2?U9@BN4N$=9+6 N'[&36*P!#%36R1RL;N
MZY)P$O<EP74+BT4;O<B+4I@ST*HDOU+(MP.$F+&#CB$V0QTIH3+!$L,G* 8P
M(&9VU.:1+@NZODSQ)[#)39F-ZCTDK0#HEO QAL1@C[A[@DE 55DPUWW=:'!N
MJQVM/K]AN@]9>D/K$UL12A,P7,ACJ+6 [I55U.4\H4Y?M,%YT0E5H$#/3"8K
MZU&;=V)*\RDS+M@O39P1*E+*]!:@LPEVC!N"B8>1=F>2U$BNLRSA(#8]5RG8
MW6X+ 3HOO2 NGO4-1%H=2JRRW+4-&-3L2V":&GJ2PB.D;4<.LM4_BS *BCU"
M5S</!VZ++!:X[1MER>)V <XKPVO5DB%\"DS'AYOH1WJMH  I62^M;NAJ ?1G
M=]"=A00UU%E>7>RU6'%8'^]"4C0@G;++7CTF4G6IE)13[Y?.QI9X=')V;#Z#
MZG4IS>V.<%TG&Q;+YE;=;$(S;OK;D,7@-+@AZTDX151M@E:[H,I7Z/);.UFR
M8T1.$D?]Q\TOBA0XJ-+V0&2[R72>J6Q5 -@$+[4@?]=-UK E4<=.#P?N8:)B
M%\(,QJ<;V658[3=;\3&\3&XXH:2J<:SS/"?&=G+*K5.E'1WQ//9%2+LX9ZIS
MD'+NUJCM+=)^?KEU+!@BQSWDK(,N^.VJVU!+D- 2?$_4XE9U%&84F,V;1TE$
M6ZUS$(\'>C]]0)C# 7ZIA4-DEZI70=0.QG[K*C<713?7V;4$;'7*P*($PO$/
MIAV^*@+NJF0%)]<DD1+%&.MA81]Q(JS"38!8M-54F&=?C/F4$ZXV'F6A:=Q+
M] %OU/I9-$P"!^-Y5"@2#QLVD37U9D@7.7N?@S#!VV-5]5PJ[=;#9 S?4%?U
MNMNCIE/#:0'TCD]>PD"!]"AKA*N('6"0X>F'HKS.T]F%VF4H=5+U1QQ_JDS?
M3J";MZ9L>[60'TNK3E5ZW<6FAE)CU@*'X7QKS61?B?\FDZ1C:*L&CMM_MZ)S
MK6:4]7@?MY"SA] V]'G6O0;8*OY@U ':EKR): MA::\4 _H_5SE[_HNS^W1T
M@[8SK:3<TI_>LY%KDO2(O3<>==7^C-=UL,>^1M(+P$&)F+8=6YS>H1M%UP@=
M9([1WI=P<:3M//G,Y,D;[']%@IS-.?;COC]CD=P2T!9L)C#4HHPX.%43&X^]
M\ERK?)E<X4.(2+M-VA50T#V.)%NA(E<RU];W6-),IC0:4FKA6.D@W$'M8-5(
MU\\*L%)7WSIRORHL7Q/O3%!55=69SO9@LU%I*QU=C3GU%]1<#UX# W2XRZ2O
MAF!7&6^;6T0>KJ-)J\^>)'(MI'#7>6OOR-FE,:OUJKI"9X+0*PH:4\[YH.ZG
MD/,55)]X_6/']7U'E6F/'NUR^5XN_]$NE_\7W3"$]SX.P^/6T2J[>+Y:*H"Q
MG(7.<M?VTIAPB43F-[KC$04I<\)ZKTV):&8 :D.IK E#04<?"P]=0F0X3F5]
MEP?C.)%@<EBI%COP;W^LD@"4@, >%+6CZMLLXNO3%U[:"-TX-E*WSUYT!^C5
M_;OB\UXTG8]_]*L"@<AHPY!CW,GU%[>'KKQG1+S&?K!R.% #BD+CZ8\XTBBU
M6^E6G7L$]@(P*-A*LC\G'X6'8CQ4\4TW]0]#WHU/N6L<$^VSM)U&"B_J*S=R
M"WM=0,_@;_$"*Q*2,(%LE\,7_9[^GC4?GL/G3>OG]?=<#'7 X8NZNS6[ 2Y=
M[C5)L0D4DVF6=4]49F)TFC4;?F@LB1Q5P+DS"F+I^)4.6H5R/RIFX=YE732+
M,/]N7L@X,?MR0K[39#ST(OI335FD-+9Q ;:+6TVD($--;=)9#TBZ61%>.[?V
M[_JMZ;"ZI8^EE%J_DQ5M[&,9R,"V3I:L#GE9)*&M!8DI\:H^U4Q)ZK.NFDCJ
M[D3^3T]+([4NN%U@)*1\J1<T32"'\OO5?TW@"F9H(O(H&DL!)H"DL^J6>@W$
M$BW:)@2L4>3L%B[<IP;;?#=W.+#]W.C.W=S ;@ZZN89C1]U_Y^9^@1JWMSJ)
MX70H"(;:X1_NP@8[TO1M32X:F5M\.QRDXGRP\+G-K3R_FT->"Y/ '[I]P0-W
MP0C\59E?,37T2X4C: 7(28UM\,+2!"(SBL7DL750.U-<^AP<M&QC[:]P@P%\
MS+HIC'5XU;!UM6Z2^"RU@=E6PXNM:O#6C:39;"+A*6*A($(S[:EA'T":_58'
MIZY;EM1RK]+H$DT9J?%#H5_!2N=)E:M:2WY:4M>K1:K<'Y(?0EH)\$4M -U>
M 587*^Q6G-\(GWHR)<Q&SUSZG9/UAK#M,T=&A@-;2#ILDL@W1VZ[Z;K6""QI
MCF:BKWE=Z G0N9UV;T&#V.)+66QM(&]@@K*Y!<3HN.8R01PQV^QN$@L;'3*+
MI3^:?:\1<+]X8J8".W)I;C\M';9$8%C5"GE+7)TA=OJM+;/&EY%0+FVS51(O
MP3)5#=NI><<B01]%$6](%PQKP)LHP0Q9+)*9N<]8TPE/2N6_W4[==6L*UB(=
MTQ.P"[HE&6L!KU)N&YS,P%-A3T&+)-ESY-"!B446%Z';$4T+.C///J2\^I3#
M4&S0%-71&P#!"K1!!$;9.24=!DV'-!IR;8X'*&O\]A,B7 ("2PWM/6LO29D?
MT0C4EEC7G,$U[Z^ZR?,^,RPM[36E+)3_)8-3;2[3MNX);#V=XO43(YEEAQN5
MZ^@AP^[B#%TK_/;8QW%0ZZ[Q.U0MMG3?9G"*O4>)T72#&2$6E'H);E-&C<'D
MM+#@'$'ENT#P(=6Y(.7IZ)'N5"LKR-ZU77J!#W21"P(2LZ4K2\,=!-W&LUHZ
M/7GM.70L3>DR=?0);"A2[)&8&W5M@06T.:<1(3TGMD.DHXDC0Q?G+O6W]4JM
M[/FM9HHU @7G:".7P=?AI>@\XI!:_/9#L-]IN<0(YXR:?QOVN$2[M0CN6ND2
M++T0@MHP<05KQ7SB40[B(;"H^X6T.\]I:._FCA\@>%_/'6@%-=#,"08UMHD)
M=<JMV=KML ?U#=/DUH9^BKN0T!AZ)R-N!V:8+:8[^[W5^L?Z)G@H@*FLV24,
MIWK%) 1"0>"L!C<U: 2]BP86ALA9K'6P1%D8& PI8([T+"#H.JT66OWCX(13
M6'8PK6XB#<MRY,3(YG-M;#DO3$/91.(IT@-[+L4/=8-'!=F_<;RTTC:PX+:(
MZ;_0]M2L%5$3*\5Y:Q36F0)H)L**3P$A/E%LGEOGC?:B'^5L2*[*;*;8D6;E
M:B+1=)NUA0G-J$9#"!=42$?'"NWZPF>CA!J;J!)#'1[CM<!G*_Q("\57FRY,
MN$$MXJ/P#E$#F5#.IBHO$HFOTSF!=D&+<FT[->J%59E</JNTE8N5%M6">?M5
MRSJ:!3\OPEA4BXG"?W?DHB#S$_UU5LP*!V7AGMI]8+K, JDB2NSCG_J<AKSR
MP)%G=$_%G3$4,7M+G<B/C9SSJ*P8_EU&<^)(FJ.VH4F=0I+5=BL$RN3,8#9K
MD6X"5TI9"+)8F->0@C9K7G9!OKO LCS>85D\+,OC'9;E+[IAB% 'I$#J(3E4
MG%K0D'ZVI\L2(Q 7JRQG54SX\!756H)I8!=MPLU'X=I21\L^>C2:C[63Z_<X
M[$K-TS#U88R,8LBFQ*EN]Z!CPP@/@?8+FUN5G<VVU"OCT;39:^]T]CH13(73
MR5\KF[F-CF3W/#8+KI)S3.F;33'"ZO W23)4&>16MQDL>=0!(8SK>T64X@TR
M.QH<QM<8'H(C.N>R%TH@73%P.HRM,:4Q8:?,"L48L<3"4;RQRO;+^T0M3M[@
MC.B L%O2(Q)OMU%5]U7!&I,TMK]N-:%0A:)S\HY2^M IO/,[T#'DG)]OWLP9
MPK6PH=F;U[Y@MXW6;:.YNXTD*N1@,31DPVXA+3 EO9O0;I>^<Q$!DZPR0JYY
M0)M;QW(D326!4+61UCD\*B78$7M0[G<=:^Y(,PBK#+WK]VS/8^)#0X7<O8,5
M_=<[;I8OS\WR[;;<+"\M@=X1L]QR2.<EA_TT&/BF=?HR)B(4SZ8XR64VR1H^
M^"@;YQ&YA,+.&LZLJW,7R<=LL5HPEX364JVX!X::! ]FA3 :*=\Q5*\^8,H[
M'9NU1#3# ;S %L%3*PM<>+ WUSCA\;@UQM>7E)2C:?B T15Z&Y5<PH;=::'>
M9UY6K04R\&".NU$U:U+-//BV-PFE= .VB%^-=BU:C@!5!FWD"63FB+_?+H&S
M3'?B#RC;9;.7;I68.0.:W$@L&H2TZIEP"<F2R//VPW-;[-S2L^8<,)^V6148
M59ZE&4(\*-^:7@3Z8#6)GJZF%7[9-<?^[3[WP<C;MYT4WSKO:'@4]&1B7;Y(
MEFYT&5NZA)#L'Z=6 P;Y'*;%U&HX,P=&#^-H["ETAM4UAUI\NU;3;>#-@7G5
MRM-=2WR#F2HE:"%'J66QI1#3PIX=#,_>4&5V0'7:LX@0%=8OW4CIB2KEUP(B
M1!)E'[6$:1;-3.8>U</.)/OR)MEWVYIDI^D23ILZ>J=/)+LX96>DW7)([PE5
MD$17&3R2S28*"'17N%/!0Y'.N=8J.H43*'KTY(E+]Z'ML._OU=O>PP4@^D)%
MX4\IJVJ:R0%@2$KF<Q)^9=?BX4[8A4!K6+UT,;?>P3;JS-Z/@2)2N+"0TGUS
MELY5V00NY'  *WF_YN<>+ME&":!O=@D@+P'TS2X!]!?=,%3,O(6.FV>YVYE*
M04 HW:\I0;B8F/!R;!L8[FG3HTQ;G'[4L*OR54-1G>+7FKMM^]W,N.3'L:VE
M YK5X,&471KMJWO;,">4$Q\E9\NNWY&G:>XDN]^>>8U;-F49FVH[TZQ+7J)[
M6NW..SJR;_P1U^-2-L+]DLK[N%&P?LAK4VB*!CT9U"99>5UTM2VS*-6DP1;U
M<XNMB+M&W!@'2A7L:DX8A'N#CQ5K-#2Z@-3R)!.HH.!P46 (10\;0N.VD*"M
M9#)UO_&)DHS@IK.C1@G&[TS?\P7<CSQD"BP6*RZ._=<JP;:;I%=P)#XR2L/.
M% N<D6\CV37KGQ8WE'I+FA:MD/RM4E'G<['+'+#K599$1X>O#DYC/S9C#<DQ
MY&K%11IJR$>1$(XK>@9Z2<$6%78)-H+1TZX0DC;U/<6.[M6VN(\[%3$-2'LK
MT*F9AF5*UBH1'=G=2M%>L53@:Z&%[ GI.&$QXXFMJ681J!WY>4I0I,!\F17"
MR\S05OP7A@<H()P243*8G2L^>IA$ 8:U$F!D4SK5]?J\.E=EJ0?4F:Q?L"6^
MA4 ^U(#XWQ9A7&&'E3#6W@;*.Q>W>GMQFPNK?:H3AUVS:W9MNN]I4.D?VP:5
M#FHDB%$ 42>D?$K8VEU<Z99#.DFSALBX[2.T$$/1B[ GM I>RDA3W],1GE4J
M68>U[@KW7#F6L,92[_;G/=V?CQYNO4$UE2DL]OLDDYSH;DO>9DMB:D;Y9>T<
MK3J3C6>@^#H;W29J8M? \]'/M1LP+#9LJ!16%=H:\G9CR%_C(B*?B;DK>?6]
M=U6U'@;3<WT)1D):$,>&TM]TAM/]B?:L+E>@)O:B'PW9*N/<JD8J63$,@>6.
MY,DSM CUS"*=.80!CDZR*+ 4)0M/BR[$D_MJ])EWY]C**RJ3!8%_PX$,71"$
M.RUV7[78HVVUV,]9/05+/BG2<K4S*3XI4W)6YJGPJ"G*KA#<)+%@(C/\4/4_
M2"+N"M0+,TD+!-\XB%**L3"=(M^/7"[D?X ;52DV3.X#,.Q%QW,O<$C9_5I7
MW'.UF'&F8JF HJ>J'O;2AKZY)J6*9<W#@=.6R$(T-:H^ORLR9 ]'##'X)86)
M*,F7U%G-/ #M4=F#TD@%:0 C 1&:$I@@GNN^N;E74G8?!1_#YP>%XFAQO',^
M,^K8<,-A?'U5Z%Z%)OY=63 TW@P7\%L;XV4U^7:./0UQHA]P=PZO1[@/X0!3
M[]&WBILH')W>K?M=Y!F?[/*,7I[QR2[/^!?=,)0^66?N1[^/M8_E-7WF?N19
M^PYG2(L<RR)J-3RMDHVIN)<('JJ,V5/ .^2^U?A$L&A4$;&560P@(\W[$Z$/
M93/2"M,2@O_T-#]'9]#LP"BQ.D,J_K6>O^$ -]CT$IL$'!.E$-\'YBV_<6AG
M.7#DLUK8X%IR&7^3]HO<^TG]1>GC9<4OBQ7K* GRY)IHJM:^M;B;I34*Q6?%
M[J9^5\I@FW.3\ESFSE('-K))*+A_%%%&HDUTR20!8"H5Y0+F#CLD<@68_(;8
MA,MB9DYW"4W?2$)9G>[CF%^#/_6J:PP#G$B[9H=603J[H,5,-6/MR=2#IS1W
MVF;XSZE_,"ET  )+J0R2 EC::5H5"HG,3(KX%U4QH!VG;.LXNH*'PZJ!RK "
M&^#+5)-,=Z6>9?5RU:16'D;2,""#2Z2FDYYW*.AA&\Z8>^0=B.S:@'X-RCU
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MN#9,P<A3'K\<';T)M8:!BR>*379*/+PF'77OYXL%!/*1>EH1-0$]F_R/59&
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M%QVE![$\)S@+\"U2 I-V]#BD U53R(UEKO;!D]Y.C72C>E#*X8#.3M*QQM[
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M8OY49\VP;@C::DJ:EQ@&J>\JV@LT!@*>%7EG,_?V7 P'=TZ&TZ:-<^8Z!=[
M2"O;L>#^(DX;IVN?>+9R4>+@"5)4XR E!%A+N%^\2?:)G0,/Y9A95Z7=+)L+
M&6I' *X[U0S'(KP9;)%TYA0^B753RC@(/#"C:-R(4@US8N2$J?7*AL]H8QX\
M3AX=/,66CGCKP=,9_S0VILB=R=)9BDYU.A/WW@XKZAL5AM_)D9?X@E.FM2D5
MB81HA&L70Q181%T+;A:A&<@^VEDN3;P@+ X&)\HD@PO0]4P6SNH*G^V'P*E@
M0QD*/4)(46"VM-!2;Q+WK[?"09_F6[;GQ)#EA<;(J+*<MHO)207>/=&A.]"]
MAN:ZM%# I7PC1V'L[']XSY-HQ&47G#!OI:).^'.)#0(N:6>?W.TA+@;/^X=W
MN1D.CB1(#=,'AE#M<J-V+4PRP2#2QZS'! FMI)49%F6:KZX)/"P/"B;#)84+
M_J2) 8LH*,J(OZY6H30GF0PJPB7U8JDX/_BA(\RH,><Q5F%FGNH(%S2T#+NS
M!E(8=9VV,2 V+>>$XO/L'9*-H+O2NB&^Y^=L,+Z=.;O&G&VXL XV0H)NTPL3
MM7@%JKDJWW%XMJ3)A[UE">Q2UL/4%X,K$L@,05",M& 45KZ[ZMIL]>IPP&^,
MG95.9M=9S4P>XI8EZ-/S: C[/A5>L<N4&V\CA0@GRY*"'H;_=:( DCCKX.M"
MQK,/:IGT-0G8%P@I/]V%E#6D_'074M[JW?'0ZG=%ZO=-E5VC/_%&M9FD5(_
MPUPHUU""=<C)U.3Z32\IA^C")<*3E!SW3T,E:Z//TG1$D$R/]PX-E:+'762L
MJ>$@Z">0.<4[ZD*4Z.=$:QIP!>> 1!W-9S"@PU&YW(K;;_#%UFW/"VQ4P; H
M<$ 833CV)+K"% Y;F=-Z_*M2Z@\MMM>" -"S=CB056V'NICWBYTMX0!#_E+-
MF"C8#.EJTAG^ADS!AAKT3=-L*4T0;TU\U5_TV,U:4_A[DG:]0#T1QSZ8JIM&
M?W =P$6:%(YQ:;_3?)4$T Z^?[+/?3061&+O?3J8V5=4IR'%$5ZVFB)1TGV^
M+KM2\-01;).!.RC@ONU[CR_8 K'?WCKGFWO4.9\Y:Z' ,-X>KVT>PM. I($[
M6X8BZ(%J"]=GTS#D8J'W;6$(V]JK$%#JP*%C7)\!W+E4ZX7DO7"K2DP1@T._
M8> T)=(&;7KNT,&+SK#-\.AXQ<6CL$QG0Z?#T80;.AUBAV6-*?CM?0)^*<+2
M<J#2T+O:N)XD& 4 Q7S=-B.8U=9K%Y2@B9 PDE?PM6JM>,)G!<KI3=\30NHB
M-VG53YE2* ,R)99(UX"@@3B#HI"'.RI-S%-0QLO,>VGY]^-V-S!!']+O#PXQ
M0]M<45)\FAIJ2"]S$E*QF!2M;W,0T;4'0?-DPN4)R5$ZJ(X;S@"!-#I+8N;%
M/X:[RJ#QJER$E8@UC*BV4TDTB8&=U(=O6#N+F; QT63> 4EC1)U,-[HX=2K=
M=5>-QN$(#F:IQ[I*O1DW:'>E^Z5>8Z7N#2DLH\0"#KHBD_:^48H0UJHLLBGG
M9.8DU%6YNN2I/4ZI]PZ63UY@.MM7JY+U=0+^5'G%B2ANJ2;MK,/ID_$0:XF3
MQ:8Y2CFDLO;U(X4";#:$<5?Y R?YS01(_ 1F8'<^K#D?;NE\.+(E,,3+=@&*
MF:*<;PP)R9K$<;M;IXO=1G&W.4 E\L[HH(^]YFF,9H!?N0ED)C7BP"OW2J!V
MU-Q!*G9[92PFI%Z) KS,< \OT8 -, =>DP@!*Y@R'(4QC#L[?L+.?M3HS-B>
MQO;LZ,ZU4%$T9WC=;40RK]!3^+#&;<LX5HX7YE&65A&8&Z7U\9^DQ9<4EF3Z
M!K;7;4J\R[\-^ZF'HW=[* >F&MD1W7X_UH56Q&[9NFVW$==LQ/_01CPV&1V)
MNLAYUM70P6.P[.(-H?3A!P61O?.1<KWS#-]!DJ:%6%EC.4C=8';"C/8E9\H$
M:X2'J\ 69H$H"NLJQ<Q5B(LZS0VP!(\5FZ_5TUA.9^Z2TV1(2L8MK,E)L;\T
M\T08PT?<YL'O(.(J-=M.VTPI?3L3ZP5#)P^Y0DNTM!8!DUF&;2BTNR&99.ZB
M( *]S]UQ&U=[>6[!!_(RHJKJ 76U-SZB]RMC&*Y+5<62,^SFM#':OU_".&86
M]F^U(FZL,C$0W-8LQ!I,K3QY$2H\6;BK8R<(B6NXG4";MEJ_1T-0IQNH2Q!+
ME[CM/C&RX_3[I*_R.BEJB?6GZ?F)<D5]3J24&<2B3J44,8QKSMQNPVF.6=%>
M_T!J"YWV.'* XU%Q<U5BOX/2G5\^G#]L@H,+MJ[=JBTAZ5\("W*8&N=4<#DX
MA774H3&,C)+D6+>CB4P3J3!R3AQG)G!^SU0A[T$7;=I<E;:UZ)2RW7<$X\5S
MW(;C^^&B<0\\H(URB]_N<HN:6_QVEUO<[OWQT/9MDMP5KK;1ZE<E8Y@ON8G[
M:TSF@=9E#_2SY"&' YN(;)<TVO8[XIG9FAO[ITYKN-1&:]8LUAH#+1O6GV($
M),F10.E,AAHF>5H'87+N&P [?TIEGLX->)JN;KUK8SGT_(/0Z<ZFL7UD&2AE
MYCM<0*4F-ZO$'2JI-9K>UDJS8HQJN:J0-H<^0OJ#AEF H-\#F0:=@5Q3W.%8
MT-8=]Y^J-,=CAHT[+>5L(TC+IFC<>VXBW0Z/1J5??,)68&_> @,7-DS*@6Z<
MMJ_K4'UHI3&9<($#ME,OIK?B$S]S,(U^L_"NQH/A0G3#]F/)\UYFU-E)(]?*
M?\;)7Y9FDU\VR%6F3G.X.N["!)C.N-1"G2XG433D!%WQ& &$8S$1O(S-7BXN
ME^TK4+? EEXF&4T6<Q*HY=CS#H,^GZ43\:K8=/0:XCKDW6CX%I'3(=>Y<!QQ
MZH1\*>+(#9OOAM]F_0MUWE>%@]6L%Y3"YEZIG(>LD()$0PT:"TRX#XCDNM.9
MUFL$C%WF[ZZ+2E1^\H:"5A6\(*XT1V @@_EYV9.JR:8KB@WJ'5WE+FX[7QF/
MKQ9C7X@%P?LO9H?H>C*GT^0OH)RNDRS7^H+&+9"QC7BU+QGUQ)WG,#LMPH_R
MDDGK32+&R+6[?[1E .608G:8LH9*+O,,ADBNI'!K4%A'VH+R]NJ:2ZK> ?F9
M9DOZ_E5MU2<.-[9M0X,RF.26;V:&!9*#EI0S[Z\57D,+8(D9JLX]T]/!EM(T
M=!U5U,E&F:2W)8=08#ET)7B$0OX_80H(9SM$HS[):K*%YH5TD*6T,];Q,9JU
MYX.' WQ?@&&7])976$EG<J)-%CV+@,\V]'<C=MP["1H0^2X5J&5UF112"T.5
MERH.?HP< ;#5:MEHDTGO-HUV)]3KH,KJ668S/.CX%RG1(EE-ZY=>.67,:,$=
MX %"'BQI%[;S>BJZ4&)7#07^*$.+6ELV(T8C^:?3 B<VG751&K80$%Q_:IGY
MUL,EK@AQMEADC>3]7B@-H&,O!3&RX2!@U[*C"^H9"$4$FOL]6S_NAL !<O$O
M]L:E^EX<G<K=#8/QW1+6?2IAE7)IBHL6PHPF0EP; ;U'MW-L?7$[IH6X7"5B
MGR-C^*R4BE;W/+(G#FS[22YM&NMP+P3K1?<B3,OOS\%'-F9,&#1>7UD6;-L\
MO>O@HMBX5=V3)*>,27V5@H4XDA6$5Z02EFK*L>$4LE^)YX'SG3C2(KTLFTSF
M4!N4\&+-.(M*TJ5\:ZP(-)T4QI?OF'DY*_XS%JU/[I*U14A@B+7$%'>[ C$<
M&(F8K5*7RK$.U:J<6$2MTT,]N2GOF-\M1FH8@VHW=S_L[.QU=O9T>C_G7(FJ
MP"93JJKGPG8 @SQIII(L+CN-/7,$=3K7H6\=]K6S"$-)#G/N-#8 @=1)WE*G
M8-LVK2Q,M[6N5CIDF6M?&[>9#2EP$U#66TUB)OQ K=^*N6>3SP2HV!'&B]Q-
M_K7Y++)+L.$TNNT!-<7>:CLGI*^=G]WNGBA?S92 ;?[#[2<Y^V-'E[_;19<U
MNOS=+KJ\W?OCH0^PV6SS ^PB>3\<G&,;,Y\3:5Z:3EYN/'1#=L=-.WOYY/_#
M0<"@2V1)"(XR\4D?J]A9\TK1K!&UOI'T,]5(YM+^YFU!<6'\9+3W^]JI$4<,
MX_QG;@>VR/GU'#DFKI#RITG>PQ?!&590QR?E:*7J_&DNY Z.!3BY;7MU0;\]
M.=EM'Y^:@U?4&P=YSAW[W^\K1^T8K(L@G:@BP^=ADLTX^>39Q&CDWQ0<C&5H
MKJ4 6)%GS>0"=W^C&VJY$N!I4B,_A\:ERO)=[0#&'!&!M?KWBGI?M$G?7: #
M8J7?B[-FR ! !$BSF3BE_L7,J^",PR^@CW86"86-:YLJ]H&*$NQXFGM^K6 I
M[&@D[DCDN]Z\260+;J,(AC;\ZW+J+2C<,HNU7&JYSS'\T>XA#PGLOPG,,T^*
MR030D+XN8^*AE66:WL_:_T6H3\XYQ41"(W79:\SW5OZK&Z!$MB*QDLPDC:49
MK"!Z#JO-*@2!6_AG962IG6'A(_3W"6K6)JM#O(;WRB!"/Y<4&U/#M%&3U(Z"
MZ]-%$4D$!GQ9ZCE*!C[6-X$SO[Z8"\E0HJ?[![T)JVT0XJV%2\[GE!EZ(4?4
M\[+"H"+23$L_YKL%U(W4%<P(BY?U,<]U!?CH1*:TA_$XF7</,4'KY;[C:2B7
M>(IWYX,Q+LY;8[Y"<")U BCRY&:^$FH*037#I%]F<VIBA/8GRJI$"\T@S7W*
M#R>-ZTF3Z[&/IP2<^[!64^S1"'(Y)7:J!BPA85@:6]22>:2>8#U/L@<WI9<S
MS-:1M^B0/E;JE:X?"B5@A/DA@5F%*R4'9T(!/%?*!H7\W?R-RO(#?\_S6P=E
MKLAP^JX[FR"/R&3D*XDG9@T"UO10<1^)CO@-G+AC_AN88.W&OS"ODKN^'BM%
M_2P\DDWLB^EJU-2 VU\\?W,$][HFY7@;5,OVGH^7EYN?C\*PEQ1='9QL>M-2
MNB&8F(Q=%WC27+7;<7".*KA1FH<G?DD>(9J#2ZF2S+6^F["XS;0=XLI@4 45
M%0-CU'^9%::P)H"==S9O4#2(M'#H"Y8?%05RB?-G6K)3V(SP6TKL"-7H<3HE
M8LWH\4$<'>X?/MU)[#J)O;JBTQ"-M>.L=M@XF1'8RB@M^LODYA84E2GHL4;_
MS+M9;.]W&26DE617(0)QX.TZ*5PRU5PUA^H<#'_P-B=I<X,E@Z%/*V N;YPY
MCY,,OK3B\] 9!Y\7+<BS/,VB-&Q]6B<G'I,'W?"Y0!GKGF&P]N8*&Z>I6&NO
MF_0OD?"2M>K$8=UDE>5*M:P/.T:?AV;T^=LN+JIQT;_MXJ);O3L>^ES TYV,
M%'5JV.X^,S5 ;;RL_@95DO5'.XH_-Z]Y0(.%+6+8*&FN5)J$FDJF)CH$1\3"
M#"-/BTO$DSJE5FU3I%-=;E"8U+AL/J:*8[ZJR#GROJS[<X@X9BHTK6"-=5+$
MS;/9:DIN0N#ZC3B 3"$K+0"5F1BW,]D/\*&1(4N>46N[2^21U'/3*\2S!Q5&
M/BUR^IK=+*G1ZVX^]]&CQ/ZA:<4",J7.313X#((P1D26CJ3ZT1-?4G5=S??4
M[<!.2%%@7C)+I^1)T3A(;S%<*ZB4,I%,>E/W1!BZ!.;DE+U0*F?F+%VFM'\=
MDLZN*DZFW@T+?#J,(+0V@C7\JDR)AU:6__J73S_IKB+.YW._GYA4(Q2WS16#
M^$*9(#Z&.N7685+))H+'V?:*^$-P^RCL+)9,B!2AEN6,.<8<E=2R=RW?MR?1
M6E;&?0GK=QTWEJRS8X_FQ EVXA^Y=0?BU6LX."BX(OM.*#KJ-,]IY'G)D,5O
M&$!588JE#PY/OH-$3N%+D7 .Q--P2#DT;0KU=G['#<1;/@9'C1#'WQ74)65K
MV),QX2,!K&7"?1\$CU$NJ>2/$?ZFR:ZKND*UB2U#W6(ZIP.7=H&B!EQ"37".
M4Q.=)T(=W3L)[CO1;4+CBU0PXVA1B 3Z6&I/2/L52^'PLXRD_N.PD56!B4MJ
MU!EE,(/BS<BGPP.FO4!T#CCDMX\(]#=SUD8";0$W@,"5T:D" UJC=EFQV<?;
M;%;;JF ,RYH*&NLNXB<+ D5>2T*J;R1(G11JRS<;QI6 V=T.@0,GTJ1LAMO>
M ;H4Q"),94%T?M QR<RQED682T-:9H\[5[=J*VPR6]TGGU/3WM(G8N(@]-+_
M.)PP;BN' [B":\G<X? OD4 @1K#*RE5-).6U6VPL9-Z6$<GACD YMDC;F$>$
MZ$.*>'6\:,1D(6/QO:L4["JN!_+J)4SM@E/04\O,8A,[[AC#G5[J($0%'R,S
M8[87$:^;#^CZ_@H9L*5- P/[UYC(]"2.Z>%6QDV98<O7CB</!^TZB"1"+PP9
M<N9_B(#!]L;*WKW;/+I[9B" P\%OM*Y,Y-1VAPP3EW2G\!G+BI*@ZWW,&%(.
MA-7VO;J,5844)SI$:5*O5U8^Q(0@S=QTPD#RD>(Q6ZYRS[0TFMXO*&RQ2$C+
M=CQ5&JEPHA,'7BG%3IU96SEE,:T+IUA&#*VQ,=UGTC@IFPD(<8'I*![?W!8U
M4F,IN:46#LVN=]& .-7#54]JQ&@MAH3\-#5]QRN5$0MO5E\C,6PG_:0=6[#]
MMM;(SG,RLKGA$U;Y8C (&^U@[R<),]CF X8*KML0\6C1Q)%ZE=2SY-_R.R[5
MC!D@A8FV672)F'MC#-LH<3^+DSDZ=*C8RZH.>:6Z>EG5X^@&](*^DI(W+=@[
M&TO,X=-7^6>+53L'L]E8#$YIK,PZV!&H O\V14,)U4!WSU>J413#,*Q0=(VD
MVD.MR7I0D0V?>S3_II8+#[>,NI?I!"D-H^GRXWQWGMQ0&P!_$6T 79>Q>WX<
MUWOZCDHU.K4WES/"+(+VE5<8D))IAJV<'=K\0I^!>>FIY"@8@X#S%SPPU@'2
M=]12+\UTEVX'<WO;M.3*#=&[]!2J8/6>@PO*0$&AA7$ "9(>+ HP*J>FP,2!
MQ!DF)(SY=+$#"4.3ASDTE>Q>CV0X?6J>@I*)>;9!&?;8(NMR!M_O<@::,_A^
MES/X<QG(BP7'P6XG"$QF@U"P#7""80GAA;0 LDK0&([JI52F3F^!??<R#M.2
MO:A\N*5KQ;6*24*LC:4E=/55DTZOBC(O+V\EQK!8KM"!X[9ZR,:1-C=E]8Y*
M<:H90FUBV'KSAO\%1T'B'IYR8"6:K+749]*KG8IZG%ZP]0J/*/SM<'#-)7RV
M-6%SE<%9Q3X\/55;UG73MF5(.XEJ?6E:Q3J?-])2/XS8Q'XOJU-P9OB#&:%X
M#"\+&UK)Z7\[]MW>WKYO)G;(%,<8A9.B<OFS!Y23MJS7$O<T[ O"FJ=%XW="
MXV/?#5DC3>)C^9^.9<#)CRV:@<CP5;9Z7-H 40]3KV^#, <+U@YH?V6\1BNC
M:BDBJ[F*K-:N;FYW!\6:K2JNM:HF&1*:<,K(0[7;$C0DS#50ZM@VI"*3(]/W
M: D76FXNRL#=<>+Q72=3Z<WF>GP=<ZGN+-^G7+"&?;GK#HH1KPKMC<@%_;%T
M8HR11,UV+<2(*#EMBW)F>+1-@2SHE_N78/06F/WHL"&L$W\L7X/G9" *9"Q)
M$;BS=[%,&^UF&HG3@[-.YBD6]3("W_:G9#Z')I6V"\;RFCH)!:\EH8&P,+T.
M+;H02V.T#?LYRTQA+*Q 7T+:][K+B9+9N3V\:.;=FL"9"43<3]^MEEP# 2M9
M2V\,E-M;5UV1=0]_5= -K!XHT J[ L.]-$<\+P+7W6([<0N.Y*+8/&;UFHHI
MB"98T=%'S*XB+8#O@XS&7YF>W&LJ4(DBP_;=UN[9W =M.- 3DZMOG6XH=^!K
M7:ISM[4(7O9V[WP/MERA;6=GBZQ02*3D:'@J(CL3U,7(F0H= 3WK K?R"MYZ
MC,UIN4')R#MG7[\X>MYJ%+D%@KNUT9ZR)%.2IO<LQ6S^&^U&_VN9S[@OM2&R
M[NO78USN(L6<"6<T><VHW;WI<'\ESW3)L3N++ZB'%/WY;]]_IT)@NF:?H1VS
MPE',4FY+\[=OW;8T[6X6G BJ2VWB&:V69=!/Q2&D P^JWHKJCNU5>,OEY@KO
M65*\&PZL/)F60G<KNJ[:>/B3I?/S"0?H&?BZJ.-M+"E/OXT)>2VB$HWP%D^)
M//OU^5&H1-3,<B@'1(49;OU?R#0L;9'<"Z[C!&D%Z8)CFL_YCA?*A0C[HBO;
MK6X_;HK*FZ)V$IO]A(;1G#BD8:].2;<^_2^BN5]09IL_RJ/@P32>02%/\X0Y
M7*[+QA#T9%K_T=S $V\?S2GB)\\/'MV4:%1+V(SL<.(BTE,'S;!&T!0=BPZ+
MUK](P5+<>T+)!'9F5,.RF.&66<T98S+/.?I"R6/.UVNK<@J[B4/ ',SW_SQ"
M.=W]?3O5M49U_?O?=.;]ADQ*P\'+A&+4AKT43S=CO[=9(KNJNZGGA?K==/@Y
MQ'9,G\;Y][8'"T)NW5<W4(L9B$?OTG2I/&.VB7$7A9WS%&:(RLUG!=ZPO=!I
M1^YZP(UMC!B$-%J*BZ8PLC.(A0LAL97$-8H25;"(+!):,5[&N-JTP_R:\<N4
MO2;K5Q,1ULS8H8YKGA7797[=$18/[-4N[&9+$.@S<!,NI=C%,;'O4WS87('U
M Q[6=I"(_H$K! [W=]%^B?8?[N^B_5N].Q[ZM*HJJ1Q#9QELVYQ[K9T3@=T1
MTF1?!MT!32+4@9V!&K67.O1;''H$M8_]@+I*O]88F71R)$@=Z5'LF6>7,%Z?
M;R^P<0+R.2WY;>%@,X;CA/67XGO6MEAX1J<(/=YF:J>6*M!$MX/NA'\2SJN'
M%LVZOA]-Q7%6(VK!]F,\N;:"^WO'R=QB,U=2"(JD(I#8VBK$*RF6%3Q:R!N^
M[21O& Z(;KQ R%>(>]Z :,!#-[6PMS ^:H7"F2;U&6:,BJZ,\U522@H<B>F*
MTE>6DL[LGD[*%28UQC). VI/#9^[2V"-%T_ ^. *?F[[A0\[W/^OP//JX,=S
MO#QQY\0O<Z'$TR1'=N7&<GTSW8OU 9?E#3>JK;3L?5%B0'J4:.%.RL76,QAF
M@?LWDZ5[LO^TEW=CK,4M2FH?* LR*K5R*3&,O?2YA(4;8=+*[?,L63I:(7C2
M-0K9<, HM)"HE0B@E(LYS/-Y3Q 86\LB#OP[1YCD8<^2&7YG6<D=U%G*VSHX
M8_6TRB9<RZW2/IJ-1P=CPBJ6T>B:TBE]LPB+X ^^>WNVS'D46D/'E43==T53
MF0)0Y>[@#BF@@/]ZW,%^K&[US$W:3!-F830L4$H.RXFZSBD/9[AGE.T1L'LF
M116,6:84B8N;XG1)4T>VW9=/<<LS;CX['<<F0&K;@K6I:^#E2\/#9)_MMV63
M[;T-!]/6FDQ-0R83-\X.=G-'H:3&L&^2RL!DA2=DY+1EZA6V,:LR@[8H*\/T
M3R#7D1-M0P6G/XY!RA>K0D(-+K;5X']-=65O29^+[=TU<EPO'NQO/OOY\=YA
M%!%XW.L\P_GVWVWKF;!EC:I"%A^GDHLK_)SR1:>'3=W'9ZX9"H<?W;0+<WIA
MS,L\+V_J:+0J<FF=0+%#+6GBAS9.2S6A04BX ;SF/B;:BP=K%6Q[9KQ[_,-.
M7-;T16)EXK#@PWE\I$$IJTZ"PB<J*0,=H4SNC&0GU;[*F2,-CYEK&.G,(^T@
MUZ:(+LMR%ADCS![BPL O:)E&LK2OTNMDEK!:0,:D-:\GFXQC@8;\SR^=E3 Z
M>G6KQ4*!K6M*7-=U*HT,)>2-H(*H)PB:F"VZ#6O-&TPOGW8TP6(K,_P"2RSR
MC$ -ZRIM&,/ )!_D&K1KJC^F#:M 44CMT[(ZH)K);=!9N7])]+UB1:.)WU(^
M>]%)PNW46\.@I(#+TZG4T>9(HK'Q_-DO"LK_J.^&3&K'15U\\ 87#_,@34WH
MY'/*HAHN LO89R.V;T2791)8-8O?^EXD1X-5FW+?G>0R099]^K[V.*@:G@9B
MH$EH R>UF7/X&F4=)$>&'KJLL(Q]F;=#X[8'!FK46KH;Q4$WC!B=* P_9ZM%
MS$(II.;2)<,0'=KNW4),0QX5?Y_BO9F>L+05<=+S6AZ2*Z&;_U7T*@= )EV'
MW(8SJ.KUL'"V G[9OU8%@R?1=4[G3F#(SA)F&F8&P\80+9R3>4)-JE%?+@IK
M6#,#H\O4YG3JPI+%2>J./Z@@^)H.HB\0)S_8Q<DU3GZPBY-O]>YX\$YT;*;=
M%,JFYK#]V4/,;1[>5_LL01'M2>'5SSM!H "%[?#]]88<3>+2Z6U(%IR#E0 M
MJ-'M9(KQ<4UJNJ.L]>Q*B 2<#:F;PG;LHHRK(#N3Z#J#50 ;0=L=S;!'(ZEG
MIHA MX4!#.03G'O(#0TZLCU&/7M\^LN.T-+=WSD<$&NF]+S2EC;4NTN?ZXU2
M@F3A^!YN+!;#5DJ$U@7'N.F3J'3EB+IH2KG>K4<Q6PN/*7^$<,^[U5OV VGP
MP\$G^3J2J!%1GP0M[QTOE8A.^%RFKH$]R#AJU(T]PE/$-/BC6:ZJ>I58KO,S
MKCL^<SN"GML>Y)7C%'0A^\T'@<@*NH6B_AU?5^\PGFM[!Y%FM#K0Z:P 6LD)
MC_OV_DTO"3>1X-PD6DC3&=X@1X0O@'6G(A'N85]83\6@J#B2*Y$7B6%@-WLN
M(D#E$YN&=EB8PM@M,O&+-?S>1EF;_((3*S\ QWYT@#W-$@Q+\W\?8W@;__&=
M_.)O\M_OY;\'>"5&L/'?C_N#ZTXO6QV@Q)]I$.P=P8X J9ZL;M..H=I4R,&3
M)T<8A=C1D'](WQ&N9G^/?"=I(;#[5E0OB.#$*F))3BG"*NB]V4'<Q4<9*7 '
M=5^7RRN,ZVC=#&Z'U!D+++'MB5JX[7&USTE=4E-*[<[&327GAH%,3I(%/%&"
M'556OS,[4JM\T<7C7;'@8S;<T1S[I$\H]>&R[[N>3=]I']@5 ,.!TK 3EMD4
M?,)R 2XH/D3X!%M#(MBWL7(PT28FFAH(J*=B]_G@3H.S0LD3K((!#9.7=><8
M=[MD3<,)VB6];21"*SH3*I5>YC]G"SAD9&TK-M'"0LE@:$<(@:E0JCLG_C.L
M07()\K'$:U5HT,&WJSRC9))SODWRPD5Z4R^3)>[Q17*9_"?C_:TTCQCJ2 AG
M6)7);$K48X3D3?-4&=O!B,9&XZ7#=BQ 3ZJ,7& 7Q[6002_PIC;CILTRTITP
MW]5Y0BA5J?TEK,&I+=SKE.8V"U3&V;RK1#@CEP@Z FGC2'F5LC_5&W-VR3Z(
MM_TJFZ@*K:7[K6TWRJJ7Y#8 .)GP+2LY(2CI&%$"&I74'16N<+55K5\AM&<V
M#JUEPO0IU"4:?JQOJ#$@UH;&X=D60E! DT_3JM#MQLPH4N#*5<7F%@-,:7LO
M^M4=YPL>C*BW'81+B[ H,>NK;'<:]:2.K$ZMY@13#5T@[HYF]+'ER)@[,'#0
M/+87JU0ST5 LNC_6,E*FU0@Z8:>,9>!&S7J^TB#L"15V! \6N9PPZR53M<QX
MO$%=:LB2BJQYV'E+>W 4$E-(#?.AT[X=SFB4,^;%Y+8C!JIGI8<*9]^EA/SC
M5QN+FPYRY6/MA%K_ 8[C.R*LA[L(JT98#W<1UOM*Y1:E%00.,;H<1T*HZYYF
M H8(&'7WHM<6#V/2P^8<Z$VA.JA$TEXM$ES+<.NROTTY%N5Q<*#-Y02:##&8
MR923VO'?TE?O9C.BI"HM?QVW&,,XASG(B146W!/^O9QFO0QS'4R;Q$D IPTS
MDFO6V5!8!O,RS^"+]'A&]X: DM*U_ ;>V:0%6\-@&XZ9TJ$+MDW+)?-I3O6P
M3*9.&^Y*0]UNZ$Q6.+3'>M:[P)S^M9E[*9O)%F1.-PBU5AXM =5I)I^C14@<
MYM$LTU6H(2Y+)EUF(V J9.))2 Q..>\%G-O9(SZ19VI"T)ETG5ZA'Q'="%*G
MQOIQHM^%+YZ#OBWE(*]J^8=_B5HT_B)9]C<N65>#IOU0@0G8R'++)>@X0*51
MJ.3A^T9*MA4'G>\<*-:]XDB5A\P+!MMV1V P7:>"&J(N>]1]LO,\EW?2FO D
MR/3W#IO6:SB@3^OY<(_.,3 :'5BI3^;MJ2:TEAS)KVTG;?\F+A<H^]:U%>*Y
M@SF:LC &QFUAWO3Z@G[)[<YMEU3I1E [% QUK"S^>)DM.NW4G0[I"6T07U\K
MR8@+)N69+P5)T884(D^UL]%#\B7"*=$Y3^)NU0/,JW/;^,XMK;VEDNLR8R@'
MIGS*U80. Z)L9QP!?YW0L[-4>K2[@1PC^E)R&K%XZ-3S*G* -G%+F+&_KF;#
MP#:KB-Q/"IPI3$?V&AGOW%@H8 G7^(&G(KU&\E_$X-U"]_S"PS?>U:/$7UP^
M=1*-Y)/0@:NO5!&/]P[1P7=8OXFU".LUL-A?N4VD+]1PL";!53F='\+BB'!,
M3AJ-550X1*_C 'YVU04\[7N$/<>[H@W^23]S?HM9AHI_<NP<8O^W*"]/!0@%
M>GO,HEK$W.ON>M&V^";]1+L3K-WY)(+/[L!=<O_IWW]T=G'Z_.5)=/KWS[OQ
M]?T_/?OY]<6O)V?1T2]G)R>_G;RZ.(]>OXC@5]$;'-O).2*9/^/\J!YX]/CI
MWO=/U[E";3?EQ^CAA_67GZ,G>P>H/FA;S;%B0Q ?F=;LM(K;;E)4$#^@M[)(
M\K_\O*<%;B9XL'T!C2W0^9B]O C@, @%).N2*S^75/C)Z)(0"\ Y?\J/"1(@
MR/_O1:=M4X8('G5IO5Y9D:WJ& Y\;U*.=X9$.L"%V@4N:%8VY-TR?7&MU=8*
M^4M..Q@L<ITLV2%( DT*%SM''(CL:#)&X8R]-^-L2CFMU<SPX:R\*2./5C47
M$H7#A@%+/U'*CB*$J$YQDG.NL=.6\?:93$AA.TM.$7.K*3GGT;%:?0L.?J\F
M: ZRK<<P &UD:HH4[&.' V1]K^?)E/@56T\67U(/='6BS9K/RI0K>W1BO!55
M+TDOQ]/0$9%>#-=>="2L+QR!I1669P@YIOO85#TILFP(VE!E2O8(GSN!R;8S
M[)G3[>95+I9F.#AC?+!_&;^,W$VRG_@:<C@<H'U+*O5S[WQM%+YU:P.Y7WX\
M&T%V'^\"RAI0?KP+*&_U[O@$D%TO$PNGH+A_DBU:(,J5JZ+J4OJ7U1YSA,:!
M_".2ST<*%.;I9<H8M,Z.),9'IRH["8(N/JH>[H%GJ6_9^ %TIV\D?_ 8N](#
M__?5R2FZ$?\$S^'T'#/4;\].+_X1_=]7K\_0F1@.Y%?@4$2GKRY>1[__>OK\
MU^!J^/?_/?G?D[/GI^='SUZ>_/.?T:]'Y_B,BW]&STY.7D5G)[^<GE^<G)T<
M1[_#^\A-<1Y\].HX.OG?Y[\>O?KE)'K^^K??3L_/3U^_BG@,SI7#@?O7%W#C
M/V"^CB[ #\.7O#P]>O7\)'K[!OYZ] H>>?+;FPN\],79Z]]D$&='])NWKXY/
MPJ='1\\O\*D'WS]^'$?P!4?@5QW#F$=XG<#\W,' ]98%"SX"_N_Y\]=GQZ>O
M?GGYCSCZ[>@?$<P!3 $\]05]/7S1^>N7]+4G;RZB-V_/SM\>@1,"$XL#AJN>
M7YS^_<0?*WTANGB=HZ9AX(.#AQW]_>CT)2Y', \Q7@O3=13!\U^=P\WX%QSG
M^=MG_P?>#_?'] YO$&<G__/V],SW-/VI@X' .N*3:1)H*6BUC]Z\>7GZG(;"
MB^7<]_+H=V1^]84/GQ,\'];\+3V!%E>E[>2?/!3G[G\.!SCO,.=O7IX<_W)"
M(WK^^M6K$_Y0'E'T[/6KH^C%Z?$)K-+9+S+HMS!Y\G='8I^=O?[_3LX>'9\<
MO83)A\ECQ_OEZR/SM!>GK^!S3X]>PLO.+TXOWN*KAH.+7X\N<'/ A2(]\!9X
MY.D%#>OO)^<7K\\4&@KR=GP"#^(1G[V%;V44ZQI9]<9"?\3QPIYX"WO47KP-
M-MS^EMEP,IX+UT]RHI72C*ZWI3(X9+&DY2C'5PIT4;P\S^L$XZW %L6S5,;*
MSR4;7"HXG.J2256^ TMOEB8Y'ID($:.6,XGE%M<F>GBZU>6"VU+F><?Q1Z^W
M.!@'F6P3:QM K(E1M1MCW<\_0OC.;&X/<WNE<808[.)25[6FV3I\/+=, D5S
MX;MTFK.BJR1L+U=)R\N]Z)S>9Q]IZ.W15W,91:B!4Y*'>5^A.J0T#XQ#G%NX
MB!,_ZEHK/)>'$GOCD+0%_JFL7+]89LF/'I!WCT*R%[W@9I*8/A' )-\]'+BW
MZZ3RN\&;#237=M5B") ?9R (OH23F6.>0\G\3 =*I)%HP6"!& T'\KGAQ-\&
MT1F.99C@@M Q=V6K3-"DK+Q03ZM<P>;M,JV<]VN^G*7UH@3MHI8UKG"L4&5*
M'6N%#4:"& #'H7]9!T6*K6J$="V%P=_ECGER^ 1,Y-&:*@-;KNO4_YARVYZ*
M(95>ZN^ :0Y*CG!&!-NY\6IP.=BYTZB32)N</7[G=(Q9.+\^OIHO$"5XLHL2
M:)3@R2Y*L-6[X^'+UX:#M\K6+] G<RBT6"J"T'8VCUL,<'Q2T?VA.8'PDB)1
M[(5KW64-@GBHX10FH93CB2MG0S5+>0W$:H^.QH&IM[XJ$DT_1,H@59\E>#/J
M?SB8)DNZ12PR[!N)WW3L5)*JOX"V'W[JVC<:NAGSVCN[+,%J8&.'.XLR^UHL
MW0FC">I9[4&IQL8M$E:W.;"[*O">C3L_J'"PXF#-+'A2^XOYVB/&L]+I&:^Q
M)RXJ[#EY)?NNZ2.B0USEEUIIY3 W2A=0!-J;[BH6V*C"&Y3IZO34K50) I/$
M]+2M,4S:\^B2@OW20(U8LF67<;,,+;)Q0!EV\L%X,< QG.F<FAU3:69E&:=\
M(Y*L4C)3,<4EF"TLM,.IN\#:&N+#NG6B<GB[(?P)-SWQWW1\$L)%N;R'R"XY
M%(CMH<QGL1<P*<MWC^ &;G[4B%1Y<$F?7LTU%W%%6!Y9GWB%@K1</C2#Y](
M-ITR%*E*X-;13#WDNGI4!]C^2"SOP/<;>]E"]8741DV]V+(3=3V(3-]%>=W"
MW*'H*AD")D8EI#K2+GH@-4O!C,U3Q9T(*&0)%@;B3H2^QUPD2<EQBVJI,]=)
M-*KO+6FB,S@P2ET._7&X-*:;2^14.M>^SZ:S4HMT+US/[LZ)0'7?\BEZ1N%/
M6O2!<^8[)5[T>SC 69MV9(AETR7,NE67>6H]/-RRK".Z^Z9Q74AMFYGCQ;Y'
MBXA")$<T%$0M]<+7&Y>X$H D_I"G6.QJ%D(W_ <***AF69C-A*L,*XS(T]E
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MO][<SXH^V,UB:^@C_:RUJ2_K9H4:@RJRT$ 7DH XB%UT:+^(E5_8VFV1)MP
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M[48$%L\:7I#Z_3@T[1:YG!AHA86']6;JM"K_P]BV5ZR6VIH],TZ8Y]2297,
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M0D%87!YV&[+A..P6U2/*:.[E!V'I3U*WV\^)<M!\#=$H07+YK1=B*I&NQ=&
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M%6!Z*#;:XV\C^^4VIT#D\.DGQ&&0#[,2H3CZQ_)A\$>^_N7G]TBFD:3-[Z$
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MFAKN%>:UH->;< &ZT\,(>VFSHV2L236P5:V,?3NJ=YW2TUH5+=MYRKBT-=N
MR'/JBQ(2)O:#F654KS0W"C$7?)JIHZ>N?SO ^\G*%FF&@,2$78_0.RQID !>
M51_#NF(?4R[),XC,VC/)"5.NPK?5RCFV$7[/"^K_0*>]1=C"V+E9&[R4ZG$R
MKT$;.B744NFI),1_3PB2ET:@R_X,CK%,(RXP&($OCR.>JAI!7*-I!\A5$"N=
M!WTR +N?*-?#F7[P![>SB/:>'U7.&YR6^0?.\PW!T%.<-X=,HJ#L#VG$<\&M
M@&OGSI*8'*U @.N&/7WS?]!G=^M ]*T8EN%JV@5]\[P1K!JF))HV"E0-LKNT
MJ&61S.FRG$W0]@#[C_U#+-<POB?EOO@L&.3WH,$8>F3S1SP@=R/M^5:$DIJZ
MT)3/>^4OBSE&*X8<":?UA3%'/=3^M #[V0YUT2O:L=,H>K2MB640CH<9!YB?
M'ZYV@(O6@-=!&$2UB3-:]@23@&YW(GT4XV+9<LS5"[<#*3GI)ED1?#?.!2^O
M)FC!<Q#O$]YWG[<)O,Z$]::&\[9#L_&E^X%;C-,1[<\8MRF?[ZA(]W*_ZB1P
MFAQN3I.5LWM+$[B'FP2N)' /-PG<-97E!UM&/\[WQ)>;2 $W20RC6S.S8@I]
MKA_:;"PSC4(#>#P+R1X.= I^)0NIFL>N&D?-QKRW?N@I/.\^*OVZ>('#?3>?
MZM!=,L-(ROOTAV[=.?7/7.Q()GF,S:'[:(KJQ7)%9;N A/23O9CEE[Q_)T34
MEV_IW@AH$F"R(L'"V#[*$;09R$887,AUGV3&!9C;3>&[@Q^9ZM5%V6/N3^TW
MV0X-A](!J&AQSS<;YGDIR/0KV?14]+-H*F0:'A06?[&"70DDRAL9?YB,OV0L
MJN5Z!+A.Y'B1H[:13K/ 5\9#JI_&7Q(H7\SU];VS(,J95CVJZC%.,RK<:;A2
M9HNE3"80Y*OW27 H^>_2]@_:D2^_U:GS!)VH*N:]S]JUN[.W?/]^HT&U+J]/
MCD[;T:\[9DAO+LW0WI]<';5/3UMG[?,/5VLVVC54@8<[5(RA](_7A-O+!$!X
MW^\>7X<R%A4P2 Q_B]KPT?6,O4D*TE>R<QB=!^5?U)M8&C9-AT-\:*T.@PR)
M:RZKI(#CP)BH8B!X#8?,RXIVHK(.\P''-Z51MU%:1KF2ZE5Z&>)VS49"7&-P
MWT(@%PB82,"XA7S2-+7,]]POGFDBW O/F#<&7WU[ _1?+*+[B&1.TY+BUNU/
M8V!U4\<Q-Z8R$N/:BM=HY,.%O;4FY;A@M$:<<DS87$VIXV"SD?( )"LGI#60
MCIZ:+P8QTE&9$SRQ*$"NP_P$S%<D[+@Y$(@F\*O(WC@;84$D;C!B#,(!06UP
MCU >Y =*U1/6?BI\%11OFV.-_LE.(3_-# !S:#8/Z-4NA9 W"15N7PLU6.L&
ML3^X'EN+$:<H]CAQ%NV$)$C),'V&+B#U#!,8&&+'B(T65FF AH&,OXXSLR@^
M\[)%%[!KK&!JO[ *:AMK8(?C:))\2KVEP0_(B9Y2-W*(RO?F@=ED4GG<S89*
MIE:][\W^_K)"GA\W<6") _^XB0-_3[L#3K\#--#:QATLC%LXISPV>+@!5<!-
MBMK-ZJV4:EJY=RZC)C@:,LD14&4!*BD^D^"C%FLB274V7H(-D\LI8LN9^DKX
M4#BL:O]=3@%WG?8(^$5^D")RL[0<\FBDZ$J05H0-2NZUJ!^/IR4]%]E$! ,O
MPTT<AP-!@L&^)$:3'A4,4^C(S6%XQC8Z?;'4/G=$ J7R*%IR;#-30#=UE+N(
MC)V.N.2^)%('/&4S;4#DA>K$1!$Y&VYPI"[6+W?4 QKN#@4O(&@]1!02'MT!
M2KB^A)I 49=H(<+ 6(Q0H#*\&\TY%!M!)E;>A7HTL4W2;-QE200-E 9<>"Z%
MP?A,^KS7*Y!H6K=#XE$!:RNU.P!%7MKB]4AJUR=>6.'P]<%N--X9[D1;PA!C
MMHTEBR$T-  >M0,5(WT"69B??-?*934^=RJ NE7LLZ>="GRMGE2W<1@Z,7ZM
M>A\S0 7@#,U6%)@L(\;^='5INKCYXQ)?%-B>X>4(<&\F+"6>2&P.2=XFH\.[
M^<T(60T1[(+^)C#)9*EEE"06E=XVE469(P!2-^:':3:>B/EK?=/[VWR(RV,K
MW;.R6@B&&X).%9E[2UPJ6U;*L=1NM?MJA84R?IR_4AMMNEB;'J(-8%'^Y4_-
MQD>(-Q;*"386HB.$K7EV$KRA,&4<#?,>X)-ZL:HYA+_@#.;B ,?_E=@(#KEG
M5,1IQI[V8HL+[C(G+*119*!QR&6K1HSBJ'H'&F41^_*;W"3P>!+B%)"@W52H
ME(DC"424X[!N*C((-D_-SL$IHCO;_J5I/X'&AE4K@BI@^ ZQJROE)H>X7^31
ME7EVI0M\P-"N2G02B@<A%"13H99.*L,K71Y"1AJXBL-*H>$B)9L>KT3!1KD<
MD30- ]*$MHJI&M2R'C8RP*,><F>MUU0BRLQ*9P4;F_0KVT065PA_OA.A*6#K
M5NCP#7-Y5Z/O9C_XZ;".99?/*Y5^E ;A+!RH79TAJ51G[D17,#PWIA"_<H<*
M/Z$H#)=VF"8CE[U_8ZL;H_-[(0D_M?$0NV)]"M]\Q$I%8UKRYA1^V]X:Z</U
MY:LZW"$HS3LJ72N]P#4$?.GCB OJ$N;MII*1C'B=1Y#ZZN6XM)8D./4JTS*O
MK-_G5_1V.<:]<(/:=A3$EG^;.E$J>0NNT0JOY8G'X .A?>30;PM[%GCT8W7E
M6],(\$NC>0N;>>#6'[8A@?B&I \R13=92LR4_0UJFE"RB.FZ!S0M\=OJB2!]
M,X@B(B_FT%#J!&PXVUKKJ;K%[3K0=#5G)1%S;E=+NH?$Z@=#$\YQ(N($KY:'
M);QYWL@]ID%K/U:0130CYJZN1W<]&3UV!$[)1#%WFHO3E+S^4KMJ=&AV<C.L
M.!ABD%\C<D0]J#,CU:HV'$_;G/@_C,>2YF_"M@_8HB^QQ,/85&83%KUG%V@K
MV!.PR-+Y^S0K76U_I1]/=5.*5VOW)@L"^.EE13W4]BEM??+[ZL\A,PAWA[;W
M)%[52<7*% X2L;6$>C.U>2=;/F^L4)UX\EF:=QDOM2[+N'9BM4HVX,4F&R#9
M@!>;;,#WM#M Z1(W\<\4#@)VJ=/D7A$1FW,=23F$LZA+ETF.V^968VA?D_60
M%%BYTC';2F8]QT;M6J=E_OGI2JBH'HMRK@RZ9#>)&#E9DP;].Z)Z*0#GA6T*
MI4!UPM1'+A8G5A(1S\B9/2;:[ $#Q,RC^X.L2VVES TE[;!1O4NP0+ML=0/S
MNB(&(&NW2 %;87[$IBLLZSUYL'!0<^:(8WJ9.,U$XYX2KD+ />)YZRPZ+KC#
MXJW/U*SG4A%NJRTPCZ6H+0*$T 8<3@<3V"V(5X&]GB H!9?(K(1PH_B_,]MZ
M ,%@=#84D[\%</%GG'/CS"-DZ,SGRK>&VA071HQM.:0?+@.,5W8#I"RDD^0J
MUB-83B\!036*FJ7);Z&R+S7TV4QL3/.&E'/ &&0W'\\"\;U.FECDN0MKJ[F8
M&?O!)J[XP@K A@=KC%;X/')5M0%/5FC&S-10Q!5:)%2CZCA@Q@B5/OQEY^+X
M;8P*^\I<KCCA;XP=7! -EU'(QHZ%D._ &*M%/LJZ[N8<%EM^GVCA;52AL+$_
M)-*'-(!HSY?(O7&;V$9Y !*RG3U++1%Z;-=V'O+"8F^\F42IMKI+:RT;MYMA
M< AI1EPC*4N^X66Z\8/\7CC$Z&J*D4+,P?N!N*HA?L+-B;2:FB.RZ"N 9QHC
M>&"F6FFZ$PJGP@3'?@#\+ATEW-BR<.#^P';.2JKG *-E:9,&H8-"VRF.,J#Y
M2J :!2#C^+#I2"DH"CX7H%-&/<?SB?*@QENZ 7-06@U9)].\<Y5N"YNH/P66
M'7@H><&V&ZY$*HFLYIXT8<*!]I@#]9STX9=*\)ND(LBL'QV/"GGBRYFL@+YJ
MQ 8@=L3#[-  33WTX"%\CAO%;-(L99X2W/FUYC'V&S,[D E).'A3X0IUN%TM
M$H @#LO$3G3"4H"<GD8@QU.Z%Q74<=4[+;U8JB-M&-OM;K4)-AH@>(D]/ITH
M4 .!APF!F+T^T:$P!>"3^:1SY&%V[#6!C41>H<Q$">Q&&RW11@=2+M2E/!EM
MN(]F<7I%<F].)N0!UCE9GSG(+!K4Y]Y48<?*>#:;=8L,'H6FE04OS1]F3?WH
MYK:7::!#>0X>#$P';*[BQW E3P>4?!@/CND(9_BPF5Q2$MP[D]LF!1_BJ$7J
M)3!F>08S 2!3\#FEK:8CXI;-12K[+,^AHOF8W-8X/8FAWZP,0'H+0H;!JF!Z
M&1Z&)4>NQH@KL #$ JL!_]6] "K%"K:<@5I@#]([,"#H&F^.9.(PFGV;#ZA9
M)0P>,DJRJL8:P1Y!>'\8'">!A6X8%0!&YG]:K6(AD$0OK)A2WE'AI%E6./\8
M5V92,9?JQCMF@)1 X,8'@O+C+ 'E=FD!$#W@8[(A&"%-?ABV1RH1;ULK6.81
MVN[&[GY4;&R.KEYE;1Q,A<N:11(+)-'V@AF!"C?*:N-11$U^]:UT"3)^SE.G
M>28UO1;,OCF2&* @]B;TD*6>,M!/#:#\75L=38,$LQ,'LBD*^<(P\<M-F%C"
MQ"\W8>+O%""Q]YSL%:N*T$QP43:OHAE4J-90>&Q9N)?25WYR%XSGX722#<AW
M&.3E!(ILS,E'48(>V+'YC$]MQWBMN2NP7A<="_*PB.:0F >):Y Y FVK.RZQ
MZ]&9W06].Q@DFA4<5+,^$9L-'B74%TO3NT&63B.+1U>WQYOT 9R6(+/QW(DA
M/E#L\8!#$>@E- &G*=,,X,T&\2,FT")Z5CW Q)XW<T@%W/V)F\(INRL(S!R/
M!V8L(\IJ+ADAVVL$^_29H1D"-BAS*O,:>7[<!/.Z%%;JFF4M]6G7-<)GI+B
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M5Q"C*U39E*:&PEFE@"3Q>+!9I:,<\8.$:,<8$N1#N[H9!<O \[@G)798J(F
MV!0E63]BC:1HK:,EK[@QM</)52!0 2=$' 6S!D/8TW\C*?&!RLP+0QN<Z+[Y
M)(4C#J -8VA[-1TQE  NH33K/$6*Z08)4G"F>03>@G'PH \"H> <EXI8#,)>
MQ TKDF$GNYE2'"<I4FM&E?D SWJ%L.D521\348H<AUK9@3AB=M=Y1@^!$+*A
M9>NN+!L!=@L1SY;A26AAH"O*=B.F4)BA55FSF%IA,R<;S3>MK7FCLQD]D!7J
M<(7)8BBT)(5M_KX'W"&F!8RK-L@@K49_$4?JJ =*B#XQ5EV'V:,\KAE)XWD=
M)@4"1R^"*X1VCZJX?F##\8?2G W2ONR(A^PO17,6.B@6!>E?;8+T$J1_]1T%
MZ==#,)^4%+ R\GT<NG_RV$_\ ^H'8#S;Q=J:XZP< V3R$O2Q@WF^/3^[UF-_
M=I^":?":#X ?H,0$KGGJ\W6M;,(7N,1 T^$FKH2F%MR?]"@MD-CF6-I9 >5A
MN2X%.7MK9F/OX61FVY$Y@BGVY' %/9;*2J_4V)B<LV?FQ+XH$!/1EJ S_VU.
MTE\_MBZPIYB](5FSV]%2'CEY*@0X_!:MO523--H*:_S.=NDR3TA\1ON*/" #
M;\1RLYC,/N?>XJH.,_1* G_O2%_C14^L<V+.D!NEGW316$@MM(1@M0A3)J1,
ML[&L#3K?;Y F6)\1[!%ZDR'PML@H"4<D2#0VZS+5&_1:9[U QF)I<F:;=;(A
M2;=;]/ZQ=% CKF,[<N93V=H?];:K/86$5H6;$F?H@1/:I-HX3^S")4LFL<^>
MOR@/NHG")EE>[CKK!79*P_4$ZQ]VW3C%K8>1RRD%_S)L_TZH\V3T!R >AU/@
M=P&<,EA_G/U$AT%-=&W=!&[>3498IHS>"_X4K\<1^(\2$)9YDZV]W:IDY?7&
MY/[\Q_JYM9V 7=AQ@G4XQ2-XV-_=ZFQ_#>6\?CH7E.ZUKU^";<3)'U(='W@?
M^ NYU=KV:AG<2LD:X+H03,P5+E0+M11B*^GDG,G:>K-MT7)"F$9:&#AEC#_+
M?<&C<5YFCCZSRM;6$Q4 ^7YX)]A.,?*;:V*F72)F:C8L,Q/S,=EV GUS\ZW#
MR6U%4V1#R)B:6PW"9$PC'<FK;02D,QH0-TF]+\JQG$I7;A:/N35:]12AGUMF
M.7)@.1TA;K,:ZAA2$91J'T 6H*2UY'DG]W(PH ##8&;OAJAKH;P@]13NY"(G
MS[%>N?J8LPDGE)F++\\I<,$*B)BU^E&:X<GE:3G,%7D /7-J<<]-*[BJDFCQ
MT&2=Y<O C"O=2T?>_6U.#\59*7-10JL_5 )WPK5?R6=ON60OI7A5$LY\OVU?
MD^#LYMEP&LSF;!O'24_[9^ZN7K2/7+JO^BLI',"C@NF2Y$<=H)U!B"RT!ABM
M,C6X]/>)KC>:-U[+1A=>P&9#5G![)_HPPC(SE[832<LU0829;Z->*^WI ^12
M7OI/]:L/#3-N-D9*CN6VH]JY'X0VU%8Z^J*%-B8,S%R ?MA;MRUF+[Y-5EFS
M)T>5KN%Q:L_3^6)"ZTFYUJ#\XO*2FY$*I)@]\IK1R!@/,Z"0<.IC77ZI;N8?
M>G/,K_D'V@+=2)F_,(GY FV!+"S&;7"=GTH; X[GJAJ;65PP3XXHK8]%?7 O
MG[;'//["E75*(5V E(EB\)1E(V0<F,^A>*^K;:IN%*.# HH?2!9M[Q6C(ZDS
M*+LF V$L6^7=)PZVUZ$Z!#)ZPMN^KF&VF,J$#QM'=.\J%K>1D$PZJ?<S8<WU
M/&0'BQ]D?W .([2$P-+)$D^I@0K4 M/W<Q1I2&M1N<?"79.-^'"R7IUU^A=(
M*)'WX 4KOK(NRZQ7!#*K_$)Y<L+RY+#%M6K)^7QW$[#G@/WSW>\H8/_GDN4'
M6 =WV\W&F^5VI-*VBC_<ND&D12%<BKK$"V,DVXK\ ,O8$\6O!BBV3@9=EU.O
M8??\H6Q9;A5U1[X'/-3>?9O1./^K-,/Y*7IQN+L'2 AS;OUK1PXD,\O-!KK2
M1]E=9H[; O2;D>+3Y!Z??8GL\%M^Y/3B]++F)X8XVD2W]]*R6V0=BBGHR>'7
M@S;@*QCS< BYPPX3M:CZ"=,;H4J!3Q'P._ F1<>98/AJ4@Y@A2"*6OT]_&>0
M55A(]>@W>8,%>9@.YF'^H:KG+6<Q")_Y A+R&9', ,6$S;Y7=H_7D8>-GZPH
MTKL<3N49^UI"Y ?UIF)987$M0$C+&68?NH,D&\*&RZCAS!21DYC@UQF%$'=C
M$#J@BB'N;ZG-@L5HB^@#WHWDT%@0V[$R>FG<$X=&33^9NY40RO<X!Z2LE_Y#
MZ%%$(C!\%#D+RJ@T]\)P&^L/ ))XQ$EO\@)8D+$0YGTRN@4&[I%<7B-:VHG:
M"V>=8AVQ4X%E&-=>3C.PN;M"G@R-!'.&*!$^%E>%PTB6HWV,<%L,="M<!HRT
M.C=VQG$>8F7/5A\=N2<C#K&#\\$CA5H X85%U,=T2.%^A@.:;Z:V@F71K9':
M<&C^-J^P9!*;#8X8R=L*I3L\ASLC628M08_+YQ230_>DYR9[R=B (I1HYSDF
MC*D]Q,A LJE(;[*26C'"=J%Z(O,'<>(4BH/>\C9MH6JTA4Y0'L)?;=N8!K-W
MTT16*>6%B+ZD0N@P#ZF2,K6^/%GLO#N"H1L)49;3/E!1(LPG/+.2+>)9P()]
MK,^?0V85X/OEN;^7\BFI(B;/41[F4V0[GDHJM=F)S,G:;AV]:S8N6I?7OT6_
MG)U_/#G[^?2WJ'5V')V<7;?/KD_.SUJGI[\9Q7T>7;]K1S]?MEO7[:OKJ/U/
M^#JZ:%^^/[F^;A]';\S/+BY.3XY:;T[;T6GK8QR]:U^VX>,W5^>G'Z[;<)L/
M9T?G9\<G]K[-QLGE9?O7<_B5^1H>W/[GQ67[ZLH,XV/KY-?V5?3VW%S1OC1?
M_A9=GOS\[CHZN8[>MWZ+WK5^;=-O6F9<YLJS\VL8Z&7[_WPP8S1?1?_X</E;
M='UYTCJ%V^ KM([_\>'8#!/&$)V_A=L:S^KDZL(,$8?\X>S8/,U<?7(6F=&>
MM8_P4OCJX\GU._BF=7ER9:8J.O]P#;>X?G=R16-X#Y-R3F.]OFR=7;7HQ^8^
MU^WW%Z<MF"J:EQHR.I2R4Y8>B(++@EN?UNVT<BZ-N6?^,)834IQ32WYNMF(!
M23YD$@6=OK$S%M@97;0S+HQ2)<5F=A"JFY:Y73%*9R6'8R+H'TBVQHGFMA?M
M,1RB C,G0<L")KDHP6>'7<PG3!F(& U*79,W\0HQ[#W$V"6M%R"+C1G.**]G
M&P%Z>&%5HY$-.U-HJB3QNE$^>@:';N4&H'XI(F.K/9/JC$FLT';G*;FXK=ZF
M4-$X0HB&7[/2DA##CF8>2Z:LL\<IO<7W+>;DQQN!OK*$:1=8/_ 6 [S;WV0P
MZQ1YVMM$GB3RM+>)/#U,R+[2GIX#Z*SHF(/#G5>',"?&IC%&S)DQL**/8(><
MOXV9N]ZG7<.B 4Q.]:P-(=P+8I[XI/T=)C/4W)VUF@052M$$BD!FSNU)$!Y!
MS94AL-XE5C2 ?P1T-4T&S\P#=XX]U5%4@A4BUVC+0FOOB];QL3'X_ON'W1_P
M[ZN+UI'\+:).FQSP$<FX--(N_WK(R.ZSWN06+MW]SQ_^#B.XE-O?@6?430:R
MSD8B_(4'U.\/*.G_^_K8&)PPQK/__N'@AP!VMY\,L\'L];+1X+6E62T:/$Z3
M,6C;I\;</6M??SR__.4J-F;RT0Y-&^-_KX]E&(_X:%F>IWP&M+M2KB)U$GQ-
M84?W7/-_EVNX-E]C@K[&,Y[O'KR*C@;9V#BLQE:=%I/'G/Q''.B;V>O 3+C5
MW:^JAD7G_Y]JB;[&,]X6Z3"'W/F164:S&T=9\JB;D'_%"O?Y?WZ5-:@\]?!1
MGXHFVZJ//MA[U&=?3R&6]R8I!NG=\H?O[WZ3Z7[^N(\%)G2(4L+Y\'I-==37
MV*G7@!4)J<)'?,;1;9;V(R:>-W;D.019@8KRSZ[F)K!Q=CJX<?XGZ4[205;N
M=/-A2)[^AO;H%[H2H5HUL>TPN3K'90EY88_LDO_?R_;[U@E%7]]&%ZV?VWX4
MNMDX;;^]CMZ<MLY^^1*?ZK,=RJN3G\]:UQ\NVS0XB"A??+@\>M>Z,D-^>WYZ
M>O[QZO]]DY%]N:/Y15[VTD#*_B:0(H&4_4T@Y6O(_.-6UH8"E6[K5_3"]7ET
MU3[Z<'ER?=*^:C;DNF\2306/71)37X']XIMP;51H-0(A+DP34"T)M3.Y3; R
M[0O#6Y#,"$2T9A3/BAX<SGI:W-MC1;-4C&IU$T",V[DF,8W\!]$P84?:*SR'
M'?[#WS^^.[EN1Z>89&U=G%RW3J/3TR-KK9&])C/AC*DG&8MZS",^N^XS8N1!
M/V350(-=O .X36BXE:?]N.M?]UEOX'NFWN2<)5AS\%N:/O*L6:_$N^O[9)3<
M0$+R."M28,.-'ONQQV:#OZ[>]0HZ% T[:1'MOXB-][M_N,ICE;G_9P?'_A"(
MJX)2M4"'UW\50/L\=?3$C]W?VSW8BWXU9]6T2,R^O^OMF!M,,W/XO-K???+'
MMX&C.X_-*T>O]@[V?GQZ<9IP/YS7D5,A<53;WT__YL\@!/3:&"+)\'_N;S-P
MX/-1-QEGDV1 COQ?0[#U!CY6'125X:0W=+25]8D6&=LG02\U=0."P&W_97;]
MU;0#:'/J5--"SL6_S+NMY-\?_!2=X]N7KZ-3(#G\SIW\@]6=_&]=#O.W-^?'
MOV%X\=WU^].__W]02P,$%     @ S(-"6\5?$U(860  $N8! !T   !E83 R
M-3DX,#0P,65X,3 M-%]A8W1E;&ES+FAT;>V]>W/;5I8O^C^K^!UP<F?Z2K=@
M1;*==,=)NPXET;%Z9$DCT4F[IDZ= DE00DP"; "4HO[T=SWW"P!%QZ]VFUTU
M$XL$@8VU]UY[/7[KMWYZ.7IU^KS?^^GE<' ,_XWP?S^-3D:GP^<_?<O_A6^_
ME:]_.CP_?A-=C=Z<#O_ZS:S(ZV?1P?ZRCD;9(JVBL_0NNBP621[S!W%TE9;9
M[!OX(?STXEU_]V.T2,KK+'\6X:7[/T9U^GO]*)EGU_!1F5W?U-\\_^GP^?#W
MFVR<U7##O:<_?7L(P[[X& _\;575V>S^F^=_RL?5\L>/_92SX<GHY? R&KT\
MN8JNAD>O+T]&;Z*S<_QDJ!^<#*^B%_#1KR]/CE[V>_ZU\._AWX>71R=7@\/3
M8?1R\,LP.AP.SZ++X<\G5Z/AY? X>GUV/&S<<7 TBLY?1 <_/'D21P/X^]40
M+CN.=O"Z/\VG_U@5/\(U?RKI7[MQ!"-HNU&_=SKX]0IO-3A[$YW3Z_P-OKLZ
M/CD:G9R?7>W1W6$\5Z]/1S'^^LH;R*L!OO$(1@TW>8$#AHLN!V=7\&\</3P7
M?GM^>@PO>C2\&.'M+H:7KTY&(_?=^CUZH\MH<'%Q>G)$TK@:#4;>LVBH.Q>O
M+Z]>#\Y&T>A<Q'0YP*'BKT&8KR[H#WR3X8O+\U?X\<D9O *-:D!O12.^>GWX
MMR$\E*X<G>_N?=&+<I+F=5K29KN %W]-J^'H_-4K>-NKT?G1?T4@MZ.7 YB]
M7P>7((K1I]B',!I]ZX_V,//F+\YA4<B=Z8*Z3/)J5I2+9]%JN4S+25*E-*;D
M:#0\/8'%GP]'OYY?_M=5#$OD:(\'B;?Y%QJK*S]_:"/:)4?#T].+P?'QR=G/
M?_UF_QOZ^^IB<*1__\'A/ZJ+);V"^6!<U'6QD,_NLFE]@_?;_T\8Y>A2'W.;
MEG4V2>;ZPG"7CJ6!+W"L/Y/;?;?_G_[5\W0&!\BO20G2J:.KFZ1,JV?1X_C)
MX_WXSX\?P^EW_-RY3>/P,0/]#L=Y4E6K-#I.ZO09O.RR3A?CM(P>?Q]'C_<?
M?T<WPW-T=(G'*@KWPRR!3W,<R8=9/DWIIEG^S7,Z;-K50;\7ZH-HI[Y)]>SX
MZ;5*_:=O7S_78P36+TSO+(.1UC=)'4>P8*/;9 Y2+=-)FMVFTSCZ]2:KT^@T
M*_+H*%EF=3*/3D^/(K@RJZLHJ2H8=14^[&4QGZ:E^ZQ^+ZLB>)6LGN-=5TNX
M'_X&]L\";I-/HVHU_BV=U+#&Z(MYMH"'U?#<*H)KT]]A$V552I?B]Y,BGV;\
M]4U:IEF>S.!>4976^!KU31PE-5Q\']4@>;P#C)@NZ?>:BR4<_TD.MX8W'>I3
M<95YHL-AK.!UYC 8>#-=T_B2\IMIE.71;#6?AS<?P2O#<''L_5[CQN-5'>5%
MC>]8IC3@&$4"TJDF939.:9+PZ<M5.;D!M1+-RF(1#29U.L]PR=5W1?D6EMI)
M/MD#(43'Z3RY@YT&$BN714G/#8=T5"R6("MW('&_MUKBD\WVC"K:L%$QBW:2
MRIVO9(JK=@'32W.Q@D6+HVY;?[+KO5>&&\( %C"LJ[J8O-V+1O!+?;U^;UEF
MDQ0OPAL6><KC"'\5T5/]V8 +0?P@L_0?*YA-65EF4B_PQB"B*IJFLRSG&;N"
M=T()/?[(!D2PP??WOL,M_AE4BSP9IDA?_0!G9R^"3XY1+KS+Z+-^[P6L/IB:
M95'Q2G#ES5,^*^;SXB[+KV5O\R3<)+=I\/4B37+X;_7L@[TN_W]\G\\G\C\V
M!K--!K-9-L]\I=#OH:@JTF87:5F1ZD1]/<U 3]?S>]+&N?FKOBF+U?4-[17X
M9E' ;LG04EFDTRPI,QPZJ,^Z+.;P+Y@_^0,T<S2^C^ENE>RG"6\QN:+?N\OJ
M&U J/ S:.]5J<J-J'!ZT$LV'*@I^5=7E*IW*S2Y7\S1ZNO^=V:LI;K=5"2L,
MY LJ[,/MN7^'I3 'J<(Y 2KP" 29@<A(>3LK(]Q<LJ6B:IE.\&"GF7!V]I.=
MZ2YMY*V<'3G7-1RL*SZ/+Y(2%^-[R/CQ3KJ[DVW%'(KY,,WA-)F 6=7OG=_E
MH$!NLB48EFKF;47^X44^+PJT<Z];#A/S772Z=[&5FBNU507&8%6A<>Z:Q)$]
MA:?)/=CY$_ CZ,^KI%Z5\%G,?\'IIO_&"^]N,C@AX41-HEF*2GP.CO U_/^;
M8I[A!1F[0J_!TH*E?07; =^,S'RZ0[\':YSO,D[RM[@3,CA8LWK%_H_\GGZ(
M-AE*Z0TX 70>)ZOZIBBS?\*=X8XE6,)@)N Y'X%;@!\5Z&E$UP7X^CF:\#"P
MA+<5V,N3.1AZV]5AHS3_Z]&CZ$66SJ?/HHOD.OT1'O&/59I/4AC)C]$OZ#P_
MBQY'CQY)9/^GXY-?=,!N*.;@<4LLYGO\;%R4L$C,9X?S!)R;@[WO8-05+A@8
MS!\003-LM5%H"![FO+&^ZX_1Z'X)[SDHDW$V^3$Z2Q8IR^,,MLGYDI;EL^AE
M-@4AHBQD"IU;?:OWPJ]1NC]]"Y)J$=H8O."WC\8IN+WPC"7)W!WX]RT#1^&Z
M8OKC+Q\.S'T#?%^>Z*]Y9[AZ\_[12>X=-7_H'+_='N2A:#'0D565;R7I2=XX
M.URG"MVPX>^3FR2'Q6IOLY5N(%VT_2F.U#SP.=I(;G!%D28)14G0+ :EI&'3
M_]C?V]_?/XB6&(G$*%5,$X#G.!^SDWE24=RDLE,$KGDAQSOZTK!K['<+, ],
M(! C6>#BXRUX]\#IS3,[W<YGUWQ&0[!X8';@TJK=F'/$[<\LRI<,J]48O&^.
MG,A$W16K^53CV731#86\.6R+MRG BB);J]]S ]%NR#*&J9_,5U-0B7&$@95B
M53MQ;[$@TW$-2ZQ,9VF)AEO%OZ1\"!B)2[[R3B*>QI[+*/)"(5F,%8'YZ8]C
M4N24W!G/4UZ \$N)7"?X&?W)BXO^AN,W-G>_P^BIO'S5\?:208C]T.YVF:X+
MNJM&?[=@_E:HCE"/L\I$<]['%'FR,]F:(0WA_CHX>G_[;BO74*YJH/5[L//;
M#1#'I#/F'%R,)];!#T^>4B0>O#!XPC0V.=)R-1<3L$RO5W/)IB[+8K&:7R=H
M,-8F7[>=$&]".$78[U&.\+U"D^/M>@_%^P(C9!QKZO=&")7AB-,VL_%AY=R
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M3N5)?G\H-'HP<H&Q5!M1)(93^S=Q?UCPL,W#"*:\,/]RZD,<]U&1]IFYB^N
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M/A["=,, M'<>S.?0,/FXJ4JDQPL 1Y@PMA$$S"3=1^DC]'YC]6MMO,7MG#4
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MO?U7IEV#.0D.W69DZ5]E2CXUI+C#KO^4C]XH(/;8B0J=)E6]C8^]7WSLLZ*
M.Q;=MX?GQV\(5_]R].KT^?\/4$L! A0#%     @ S(-"6_1T1#PG P  WPL
M !$              ( !     &%S;G,M,C R-3 Y,C<N>'-D4$L! A0#%
M  @ S(-"6_#TV5;]"@  ?X8  !4              ( !5@,  &%S;G,M,C R
M-3 Y,C=?;&%B+GAM;%!+ 0(4 Q0    ( ,R#0EM6O10=5P<  -)7   5
M          "  88.  !A<VYS+3(P,C4P.3(W7W!R92YX;6Q02P$"% ,4
M" #,@T);AM^"^34?   VKP  &               @ $0%@  96$P,C4Y.# T
M+3AK7V%C=&5L:7,N:'1M4$L! A0#%     @ S(-"6[TZK#%KB   *3H# !T
M             ( !>S4  &5A,#(U.3@P-# Q97@Q,"TQ7V%C=&5L:7,N:'1M
M4$L! A0#%     @ S(-"6]CUHRYE3@  O-P! !T              ( !(;X
M &5A,#(U.3@P-# Q97@Q,"TR7V%C=&5L:7,N:'1M4$L! A0#%     @ S(-"
M6Q?I \>%MP  >/8# !T              ( !P0P! &5A,#(U.3@P-# Q97@Q
M,"TS7V%C=&5L:7,N:'1M4$L! A0#%     @ S(-"6\5?$U(860  $N8! !T
M             ( !@<0! &5A,#(U.3@P-# Q97@Q,"TT7V%C=&5L:7,N:'1M
64$L%!@     (  @ -P(  -0= @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea0259804-8k_actelis_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asns-20250927.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141284</identifier>
        </entity>
        <period>
            <startDate>2025-09-27</startDate>
            <endDate>2025-09-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-27" id="Fact000004">0001141284</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-27" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-27" id="Fact000010">2025-09-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-27" id="Fact000011">Actelis Networks, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-27" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-27" id="Fact000013">001-41375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-27" id="Fact000014">52-2160309</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-27" id="Fact000015">4039 Clipper Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-27" id="Fact000016">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-27" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-27" id="Fact000018">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-27" id="Fact000019">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-27" id="Fact000020">545-1045</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-27" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-27" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-27" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-27" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-27" id="Fact000025">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-27" id="Fact000026">ASNS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-27" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-27" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-27" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
